Bioactive Hydrogel Scaffold for Guided Dental Pulp Regeneration by Prateepchinda, Sagaw
 
 




















Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy                                    
































All rights reserved 
ABSTRACT 
Bioactive Hydrogel Scaffold for Guided Dental Pulp Regeneration 
Sagaw Prateepchinda 
 
Over 15 million root canal treatments (RCT) are performed yearly in the United States to treat 
deep caries and dental pulp infection. This procedure however, removes both the diseased and healthy 
pulp, leading to tooth devitalization. Furthermore, RCTs are associated with a high incidence of re-
infection and dentin fracture, reduced sensitivity and eventual tooth loss. Thus there is an unmet clinical 
need for alternative endodontic therapies that can preserve tooth vitality and ensure long term dental 
health.  The strategy of vital endodontic therapy explored in this thesis centers on the design of a 
bioactive scaffold that guides host cell homing while providing antibiotic release, in effect harnessing the 
intrinsic repair potential of the native pulp while simultaneously eliminating residual bacteria that can 
cause recurrent infection.   
Specifically, a bioactive polyethylene glycol fibrinogen (PEG-fibrinogen) hydrogel is optimized to 
support host cell infiltration, maintain dental pulp cell phenotype, and enable pulp regeneration.  
Ciprofloxacin, a clinically relevant antibiotic for RCT, is incorporated into PEG-fibrinogen to prevent 
infection.  The scaffold and culturing parameters optimized in vitro using either explant or a tooth slice 
model includes fibrinogen, poly(ethylene glycol) diacrylate (PEGDA) and photoinitiator concentration, as 
well as cell source and density.  In addition, dose-dependent antibiotic effects on both anaerobic bacteria 
isolated from deep caries and healthy pulp cells are evaluated.  The collective findings of this thesis 
demonstrate that a cell-instructive hydrogel comprised of a fibrinogen backbone and cross-linked with 
difunctional poly(ethylene glycol) side chains supports pulp cell viability, phenotypic morphology, and host 
cell migration. Furthermore, increasing pulp cell density promotes cell biosynthesis and a higher 
fibrinogen concentration is found to enhance collagen deposition. Photoinitiator and PEGDA 
concentrations have been optimized to enhance hydrogel mechanical properties and gel degradation, 
while supporting pulp cell phenotype. An optimal antibiotic dosage in the hydrogel has been identified that 
significantly reduces bacteria count from infected dental pulp without harmful side effects on dental pulp 
cell phenotype and host cell migration.  
In summary, this thesis focuses on the design of a bioactive hydrogel-based scaffold with 
antibiotic release that can induce dental pulp regeneration without the addition of cells and stimuli such as 
growth factors and minimize post-therapy infection.  The innovative scaffold design strategy presented 
here lays the foundation for the development of vital endodontic therapy that harnesses pulp self-repair 
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1.1 Specific Aims 
 The dental pulp is a vascularized connective tissue encased by dentin and located at the core of 
the tooth; the dentin-pulp complex directs dentin formation and repair, fights infection, provides nutrition, 
and innervates the tooth(4;5). The pulp is susceptible to infection due to dental caries, or trauma. 
Clinically, the most common treatment for pulp inflammation is a root canal therapy (RCT)(6;7), with 
upwards of 15 million root canal procedures performed annually in the United States(8). This procedure 
includes total pulp extirpation, followed by filling of the root canal, resulting in permanent loss of tooth 
vitality, which halts root development in immature teeth and increases risk of infection. Post-treatment, 
RCT failure is most commonly caused by persistent infection(9-11). RCT-revisions, which are costly, have 
a lower success rate than first-time RCT. The root-filled tooth’s lack of self-renewal capacity can also lead 
to dentin-enamel fractures and eventual tooth loss(12). Vital pulp therapy, which is a treatment that 
maintains dental pulp vitality, has been developed as an alternative approach to RCT; however, it is not 
as commonly used, as it depends on the nature of the pulp injury, patient age, and the severity of pulp 
infection. Additionally, one major limitation of this therapy is the long-term success rate, which decreases 
with time(13;14). As a result, there is a significant need for alternative treatment strategies for pulpal 
infection and injury.  
 The challenge for dental pulp tissue engineering is to be able to eliminate residual bacteria after 
treatment, while regenerating pulp tissue with connection to the dentin, thus maintaining the ability to 
support dentin formation. Current tissue engineering approaches for endodontic treatments mainly focus 
on the regeneration of the dentin-pulp complex by utilizing biodegradable scaffolds(15-23), stem 
cells(19;24-26), and growth factors(27-32). However, among the limitations of these approaches are the 
need for an autologous stem cell source for cellular approaches and the lack of non-cell based 
approaches for extensive pulp regeneration. Our long term goal is to devise a functional scaffold for 
dental pulp regeneration that will reduce bacterial infection and restore normal tooth function. The 
working hypothesis of this thesis is that a bioactive hydrogel-based scaffold with antibiotic release can 
be used to harness the intrinsic repair potential of the native pulp while reducing residual bacteria after 
treatment. It is envisioned that clinically, in lieu of RCT, only the inflamed portion of the pulp is removed 




Figure 1.1: Specific Aims and Study Design for Pulp Regeneration (i) Biosynthetic hydrogel-based 
scaffold design supporting dental pulp cell functions; (ii) Scaffold with antibiotic release design to reduce 











Aim 2: Scaffold Design to 
Prevent Bacterial Infection
• Optimize ciprofloxacin 
dosage:
a) No adverse effect on 
dental pulp cell 
b) Reduce anaerobic 
bacteria from infected 
pulp 
Aim 3: Scaffold Testing in  
Explant Models In Vitro
• Effect of optimized 
fibrinogen and 
ciprofloxacin  
concentration in an 
explant model
• Test in a tooth slice 
explant model
Aim 1: Scaffold Design 
for Pulp Cell Functions
residual infection and guide host cell migration and pulp repair, resulting in the restoration of normal tooth 
function, which is critical for the long-term clinical outcome of endodontic therapy. The objective of this 
thesis project is to design a novel poly(ethylene glycol)-fibrinogen (PEG-fibrinogen) hydrogel with 
antibiotic release that: (i) is biocompatible and biodegradable; (ii) will enable cell migration; (iii) maintain 
dental pulp cell phenotype and biosynthesis; (iv) reduce residual bacteria; (v) regenerate the dentin-pulp 
complex. For this purpose, the three specific aims of this thesis are as follows (Figure 1.1): 
 
Aim 1:  Design a hydrogel matrix supporting dental pulp cell functions 
Hypotheses: 1. Incorporating fibrinogen into the synthetic hydrogel network will support dental pulp cell 
viability, growth, phenotypic morphology, collagen deposition, and expression of dental 
pulp cell-related markers such as collagen I, collagen III, and dentin sialophosphoprotein 
(DSPP). 
2. Optimal initial seeding density will modulate cell growth and biosynthesis in PEG-
fibrinogen hydrogel.  
3. The PEG-fibrinogen scaffold can be optimized to enhance cell growth, collagen 
deposition, and hydrogel mechanical properties by altering: 




b) photoinitiator concentration 
c) PEGDA cross-linker concentration 
4. The optimized PEG-fibrinogen hydrogel will support pulp cell migration, differentiation, 
and develop dentin-pulp complex once enclosed in the dental cavity and exposed to 
dentin. 
Aim 2: Design an antibiotic release system to reduce bacteria from infection post-pulpotomy 
Hypotheses: 1. The optimal antibiotic dosage will have no adverse effect on dental pulp cell viability, 
growth, biosynthesis, and expression of pulp cell-related markers. 
2. Incorporation of antibiotics in the hydrogel scaffold will not decrease hydrogel stability 
over time, and at the same time will have no adverse effect on dental pulp cell viability, 
growth, biosynthesis, and expression of pulp cell-related markers. 
3. Antibiotic release from the hydrogel scaffold will reduce anaerobic bacteria count.  
Aim 3: Evaluate efficacy of the hydrogel scaffold for maintenance of the neo pulp tissue 
formation in a tooth slice model in vitro 
Hypotheses: 1. The optimized fibrinogen content within the hydrogel will promote host cell infiltration 
and the formation of pulp-like matrix within the PEG-fibrinogen hydrogel.   
2. The antibiotic-containing scaffold will support host cell infiltration, growth, and 
biosynthesis in PEG-fibrinogen hydrogel in the explant model. 
3. The optimized PEG-fibrinogen hydrogel will support pulp cell migration, differentiation, 
and develop dentin-pulp complex once enclosed in the dental cavity and exposed to 
dentin. 
 
Aim 1 focuses on the design of a bioactive hydrogel-based scaffold comprised of a fibrinogen 
backbone and crosslinked with difunctional poly(ethylene glycol) side chains (PEG-fibrinogen) that will 
support human dental pulp cell growth and differentiation. Due to the irregular geometry of the pulpal 
chamber and high water content of pulp tissue(33), a hydrogel-based scaffold is preferred for filling the 
pulpal space(34). The PEG-fibrinogen hydrogel is uniquely suited for pulp repair because fibrinogen plays 




cell-adhesion motifs of the fibrinogen backbone(2;37) enable pulp cells to exhibit a phenotypic spindle-
shaped morphology within the hydrogel. In addition, PEG-fibrinogen is able to crosslink though in situ 
photopolymerization, making these hydrogels readily injectable and easy to utilize in clinical 
procedures(2). First, pulp cell response, including cell viability, morphology, growth, collagen production, 
mineralization potential, and expression of human dental pulp cell-related markers including collagen I, 
collagen III, and dentin sialophosphoprotein (DSPP)(38) will be evaluated in this scaffold system (Chapter 
2). It is hypothesized that incorporating fibrinogen into the synthetic hydrogel backbone will be able to 
regulate key cellular characteristics such as cell morphology and will support cell growth, biosynthesis, 
and the expression of human dental pulp cell-related markers over time. Next, the effects of cell seeding 
density on cell response will be examined (Chapter 3), as studies have shown that there is an optimal 
range of dental pulp seeding density that sustains pulp cell morphology and proliferation(39). It is 
anticipated that the optimized cell seeding density will allow for cell spreading within the PEG-fibrinogen 
hydrogel and enhance dental pulp cell growth and biosynthesis. Studies have shown that cell response 
and hydrogel properties can be enhanced via fibrinogen concentration(40-42), PEGDA cross-linker 
concentration, molecular weight(42-46), and photoinitiator concentration(47). Therefore, the PEG-
fibrinogen hydrogel will be further optimized by assessing the effects of increasing fibrinogen 
concentration (Chapter 4), photoinitiator concentration (Chapter 5), and PEGDA cross-linker 
concentration (Chapter 6) to pulp cell response and gel mechanical properties. It is hypothesized that 
these scaffold parameters can be optimized to enhance cell growth, cell biosynthesis and hydrogel 
mechanical properties while balancing hydrogel degradation with structural integrity. 
Aim 2 focuses on designing an antibiotic release system based on the PEG-fibrinogen hydrogel, 
optimized from Aim 1, in order to reduce residual bacteria after pulpotomy treatment. Ciprofloxacin is a 
fluoroquinolones antimicrobial agent that has demonstrated antimicrobial activity against most bacteria 
from pulpal infection, exhibits dosage-dependent bacterial death(48) and has minimal side effects(49). 
However, dosage-dependent cell cytotoxicity of ciprofloxacin has also been reported(50). Therefore, the 
design goal for this Aim is that an optimized PEG-fibrinogen with ciprofloxacin release will be able to 
reduce bacteria count from infected pulp without any adverse effects on the dental pulp cells. First, 




growth, collagen production, mineralization potential, and expression of collagen I, collagen III, and DSPP 
(Chapter 7). Next, the optimized ciprofloxacin will be incorporated into PEG-fibrinogen hydrogels and any 
dosage-dependent effects of ciprofloxacin release on dental pulp cell response and hydrogel stability will 
be determined (Chapter 8). Finally, anaerobic bacteria from infected pulp will be exposed to the optimized 
PEG-fibrinogen hydrogels and ciprofloxacin from Chapter 8 to determine bacteria susceptibility (Chapter 
9).  
 Aim 3 focuses on testing the optimized scaffold in both explant and tooth slice models for 
translational potential in terms of antibiotic release and its capacity to guide host pulp repair and reduce 
residual bacteria from infected pulp following pulpotomy treatment. First, the effect of fibrinogen 
concentration from Aim 1 (Chapter 10) and optimized ciprofloxacin dosage from Aim 2 (Chapter 11) on 
the rate and distance of host cell infiltration and cell biosynthesis will be examined using a pulp explant 
model.  For the explant model, pulp tissue sections will be encapsulated in PEG-fibrinogen hydrogel. The 
fibrinogen backbone of the hydrogel is used to initiate cell migration via a cell adhesion site and a 
protease degradation site(2;37), as cells synthesize matrix metalloproteinases (e.g. MMP-2, MMP-9)(42) 
and tunnel through the hydrogel via proteolytic breakdown of fibrinogen fragments. It is anticipated that 
pulp cells will migrate into the PEG-fibrinogen hydrogel and both the rate and distance of cell infiltration 
into the gel will increase with higher fibrinogen concentration. Furthermore, no changes are anticipated 
with addition of ciprofloxacin.  In addition, the migrated cells will elaborate a pulp-like matrix in the PEG-
fibrinogen hydrogel over time. To this end, we will investigate the feasibility of pulp and dentin-pulp 
complex formation by developing a physiologically relevant explant model to test in vitro. In this case, a 
tooth slice explant model has been developed to mimic the interaction between the hydrogel and dentin 
within the pulp chamber after pulpotomy. The tooth slice model has been used to evaluate tooth 
regeneration(18;19;51), with the main advantage being that nutrient transport to both dentin and the 
hydrogel and pulp complex is not compromised. The tooth cavity is also readily accessible, which 
increases ease of analysis. The excised pulp will be embedded in the optimized PEG-fibrinogen in the 
tooth slice, and the subsequent cell infiltration, pulp-like matrix formation in the hydrogel, and integration 




acellular PEG-fibrinogen hydrogel, form a pulp-like matrix within the pulp chamber, and ultimately form an 
interface between the dentin and hydrogel over time.  
In this thesis, to successfully develop a viable endodontic therapy that facilitates dental pulp 
regeneration, protects against residual bacteria, promote dentin-pulp complex formation, and restores 
normal tooth function, (i) biosynthetic hydrogel-based scaffold design; (ii) scaffold design to prevent 
bacterial infection; and (iii) scaffold testing in a tooth slice model are explored. The approach is innovative 
as it: (i) induces dental pulp regeneration by harnessing the natural reparative potential of the dental pulp 
tissue without the addition of cells or stimuli, such as growth factors and (ii) minimizes post-therapy 
infection by incorporating antibiotics in the scaffold. This design will result in a significant advancement 
toward developing a viable endodermic therapy with the potential for long-term clinical success. In lieu of 
RCT, it is anticipated that the inflamed portion of the pulp can be removed via partial or complete 
pulpotomy and, with the aid of the optimized hydrogel-based scaffold and antibiotic release, the remaining 
pulp tissue will regenerate and fill the original pulp chamber. Furthermore, release of antibiotics will 
protect against further infection, while the formation of this neo-pulp tissue will help to promote self-repair, 
preserve tooth vitality, and enable long-term tooth function (Figure 1.2).  
 
Figure 1.2: Proposed Guided Dental Pulp Regeneration. (A) Infected pulp, (B) Removal of 
inflamed portion of pulp via pulpotomy, (C) PEG-fibrinogen hydrogel with antibiotic is injected to fill the 
access cavity and UV cross-linked, (D) a capping agent (in white, Ca(OH)2) is placed on top of the 
hydrogel.  Restorative material for the crown is shown in grey. (E) Antibiotic release from hydrogel will 
fight against residual infection and induction of cell infiltration into PEG-fibrinogen hydrogel from the 



























1.2.1 Dental Pulp and Pulp-Derived Cells 
  Tooth development or odontogenesis involves mesenchymal and epithelial cells interactions, and 
occurs in 4 phases; initiation, morphogenesis, cell differentiation, and matrix apposition. Initiation of tooth 
occurs when the epithelial dental lamina forms. As the dental lamina grows and thickens, 
ectomesenchymal cells proliferate and condense to form the dental papilla which initiates tooth 
development and morphogenesis. In the morphogenetic phase of the tooth development, the junction 
between the dental papilla and inner enamel epithelium is established as the epitheliomesenchymal 
interface folds to initiate crown formation. The cell differentiation phase occurs in bell stage of tooth 
development which the peripheral cells of the dental papilla develop into odontoblasts and the dental 
papilla is called dental pulp. After odontoblasts deposit dentin matrix, enamel matrix formation occurs as 
cells of the internal dental epithelium differentiate into ameloblasts which produce enamel(52).        
Dental pulp is a soft tissue with high water 
content (~80%)(33) encased within mineralized dentin 
to which it is connected through an odontoblast-lined 
peripheral layer (Figure 1.3). Anatomically and 
physiologically, dentin and pulp function together and 
are referred to as the dentin-pulp complex. The dentin-
pulp complex functions collectively to eliminate 
infection, respond to injury, supply nutrients, and 
innervate the tooth.  Developed from dental papilla, the 
pulp plays a regulatory role in odontoblast-mediated 
dentin formation and shaping of the tooth (53).  Odontoblasts derived from the pulp form new dentin to 
protect against infection or respond to injury(4;54). The pulp matrix is a non-mineralized connective tissue 
rich in collagen I (56%) and collagen III (41%), and contains non-collagenous proteins including 
fibronectin, osteonectin, osteopontin, and dental sialoprotein (DSP). In addition, the proteoglycan 
components of the pulp extracellular matrix include decorin, biglycan, and versican(55).  
Figure 1.3: Tooth Structure (©2011 
Encyclopaedia Britannica, Inc.) 
Hematoxylin and Eosin staining of cells in 
the healthy human Dentin-Pulp 
Complex(3) ; d = dentin, pd = predentin, o 
= odontoblasts, dp = dental pulp (scale 















The dental pulp has an extensive vascular supply and a dynamic circulation within the pulp 
space(56). Anatomically, blood vessels and nerves enter the pulp through the apical foramen(57) and 
penetrate through the main part of the pulp to the coronal portion of the pulp space(58). These main 
vessels branch out into terminal arterioles, pre-capillaries and capillaries to supply the pulp space with 
nutrients and facilitate waste removal. It has been reported that over 15% of the pulp is occupied by blood 
vessels, with higher density in the central portion(59). The cells derived from dental pulp represent a 
heterogeneous population of cells, with varying metabolic and proliferative activities. While fibroblasts are 
the dominant cell type, odontoblasts, undifferentiated ectomesenchymal cells, macrophages, and other 
immunocompetent cells are found within a dental pulp tissue(55). Pulp cells can be stimulated to adopt an 
odontoblast-like morphology and form mineralization nodules in vitro and in vivo(60;61). It has been 
postulated that pulp cells play a significant role in angiogenesis. Pulp cells are known to secrete 
angiogenic factors such as fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor 
(VEGF), which may promote vascularization(62). Moreover, injured endothelial cells recruit pulp cells that 
organize and align along the injury site(63). It has been reported that stem cells residing in dental pulp co-
differentiate into osteoblasts and endothelial cells, with 30% of the cells expressing angiogenic markers 
such as CD45, CD31, or platelet endothelium cell adhesion molecule (PECAM-1), and von-willebrand 
factor(64;65). It is likely that these pluripotent stem cells in the pulp tissue may be exploited for 













1.2.2 Clinical Problems and Current Endodontic Treatments for Pulp Infection 
Although dental pulp is encased 
by dentin and enamel (Figure 1.3), it may 
be exposed to the oral cavity through 
caries. The clinical standard for the 
treatment of pulp inflammation is root 
canal therapy (RCT)(6;7) and over 15 
million RCT are performed annually in 
the United States(8), during which 
pulpectomy, or the complete removal of a 
pulp tissue, is performed. The pulpal 
space is subsequently cleaned, shaped, 
disinfected, and then filled with root filling 
material, and the tooth is then restored 
with dental materials (Figure 1.4). While 
the structure of the tooth remains after 
RCT, the tooth is no longer vital resulting in halting root development in immature teeth and increasing 
the risk of infection (66-70). RCT also causes the loss of intra-dental sensory functions, which are 
important for the control of masticatory forces, in order to prevent the overload of teeth(71;72). Thus, non-
vital teeth are exposed to more masticatory load than vital teeth, which may explain why there are more 
fractures in RCT treated teeth(73). In addition, RCT is a complex, time-consuming, and costly procedure, 
and its technical difficulty is reflected in the wide range of reported failure rates (5-35%)(12). Failed RCTs 
necessitate revisions that are associated with increased uncertainty regarding clinical outcome, which 
complicates the treatment regimen and increases costs.  Moreover, dental restorative materials are 
limited by inferior mechanical properties and poor sealing ability(74;75), further compromising clinical 
outcome. 
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Figure 1.4: Root Canal Therapy (RCT) (A) Infected tooth, 
(B) Opening make in anesthetized tooth, (C)Total pulp 
removed and disinfected, (D) Canal filled with gutta percha, 
(E) Opening sealed with filling, (F) Post inserted to support 
crown, (G) Crown cemented onto rebuilt tooth (©2011 




  Vital pulp therapy procedures which preserve pulp vitality 
such as pulp capping, as well as partial and full pulpotomy, have 
emerged as an alternative approach to RCT or pulpectomy (Figure 
1.5). Pulp capping is suitable for pediatric patients whose lack of 
continued tooth growth in pulpectomized teeth is problematic. This 
procedure involves covering the exposed pulp tissue with a wound 
dressing, such as calcium hydroxide(76-78) or mineral trioxide 
aggregate (MTA)(14;79). Pulp capping following carious exposures 
has a low success rate, and the number of failures increases with 
time(67;80-82).  Dentin barriers formed after pulp capping are often 
incomplete and leakage under a filling will bring bacteria in direct 
contact with the pulp tissue(66;80). Partial pulpotomy(83-87) was 
developed to preserve pulp tissue by excising the infected pulp at 1.5-2.0 mm below exposure level 
(Figure 5), while in full pulpotomy(84), more of the pulp is removed, typically to the level of, or just apical 
to, the orifice of the root canal (77;88).  In both cases, calcium hydroxide and a wound dressing are 
placed over the newly cut pulp surface, respectively, and similar to RCT, the tooth is restored with filling 
material. Although the pulpal space decreases in volume after dentin repair following pulp capping, partial 
pulpotomy or pulpotomy, the vital tooth remains capable of self-repair through dentin formation, root 
growth (apexogenesis in immature teeth), and defense against infection through host immune response. 
While these procedures are promising and the long-term success is good, they are limited to young, 
symptom-free teeth with a pulp that is exposed, but not severely damaged or infected(13). Therefore, an 















Figure 1.5: Vital Pulp Therapy 
including, pulp capping, partial 
pulpotomy, and full pulpotomy 
which part of a pulp remains and 
can be harnessed for self-repair.  
Success of pulpotomy is limited 
by patient age, injury type, 
severity of infection and the lack 





1.2.3 Current Efforts in Dental Pulp Tissue Engineering 
Early attempt of dental pulp tissue engineering was done by Östby (1961)(89) which the role of 
blood clot for endodontic treatments was studied based on the important role of blood clot on bone 
fractures healing. Myer and Stuart (1974) used this concept and filled blood and/or blood substitutes into 
root canal in order to regenerate dental pulp after periapical infection treatment in monkey teeth(90). 
However, the tissue ingrowth was found only between 0.10 and 1.00 mm and was not enhance by blood 
and/or blood substitutes. Next attempt for pulp regeneration that use tissue engineering concept was first 
done by Mooney et al. which utilized cells seeded synthetic scaffolds for pulp tissue replacement. To 
illustrate, isolated human fibroblasts were cultured on polyglycolic acid (PGA) and the results showed that 
a new tissue similar to native pulp was formed over 60 days in culture(16). Several studies were done 
using different type of scaffolds for pulp regeneration but were not able to maintain pulp function for 
odontoblasts differentiation and dentin regeneration. 
In the past decade, advances in pulp tissue engineering(34;68;91-99) have been aided by the 
discovery of dental pulp stem cells (DPSC)(24).  Cell- and growth factor-based approaches(27-32), as 
well as scaffolds based on degradable polymers(15-23), calcium phosphates(100-102), and silk(103;104) 
have been shown to be promising for pulp regeneration.  For example, the seminal study by Young et al. 
(2002) demonstrated that a pulp-dentin-like complex can be formed in vivo using tooth bud cells grown on 
polymeric scaffolds (18).  It has been recognized that, given the irregular geometry of the pulpal chamber, 
a hydrogel-based matrix would be optimal for filling and sealing the pulpal space(34).  Thus, 
alginate(105;106), chitosan(107), gelatin(107;108), hyaluronic acid(108;109), and most often, collagen, 
have been tested as cell or factor carriers to the pulpal chamber(15;17;32;107;110-119).  While collagen 
is biomimetic and promotes pulp cell spreading within the gel, its translation is limited by dramatic gel 
contraction(38;120) and batch-to-batch differences(34;93;96).  More recently, self-assembling peptide 
nanofibers(96;121) have been used to induce DPSC differentiation into pulp cells with the aid of growth 
factors. Thus, biomimetic and bioactive hydrogels are promising matrices for pulp regeneration. However, 
challenges remain for dental pulp tissue engineering approach such as 1) elimination of bacterial infection 
after treatment; 2) regeneration of pulp tissue with functional connection to the dentin that is able to 





 While current endodontic treatments show a high success rate and the field of dental pulp tissue 
engineering sounds promising, there remains a significant need for alternative treatment strategies for 
pulpal infection and injury. Specifically, root canal therapy is commonly performed but halts root 
development in immature teeth and increases risk of infection after treatment. As an alternative treatment, 
pulpotomy maintains pulp vitality but it is limited to young, symptom-free teeth with a pulp that is exposed, 
but not severely damaged or infected. The challenge for dental pulp tissue engineering is to be able to 
eliminate residual bacteria after treatment, while regenerating pulp tissue with connection to the dentin, 
thus maintaining the ability to support dentin formation. In order to address this challenge, the studies 
outlined in this thesis consist of (i) biosynthetic hydrogel-based scaffold design; (ii) scaffold design to 
prevent bacterial infection; and (iii) scaffold testing in a tooth slice model.  
This thesis will begin with studies that focus on a bioactive hydrogel-based scaffold design and 
optimization for human dental pulp cell growth, differentiation, and biosynthesis through a series of in vitro 
studies (Chapter 2, 3, 4, 5, and 6). The second part of the thesis will focus on an antibiotic release system 
design based on the scaffold optimized from the previous work, in order to reduce bacteria from infection 
post pulpotomy (Chapter 7, 8, and 9). The antibiotic dosage will be optimized in vitro based on the 
observed effects on dental pulp cell response, scaffold stability, and bacteria susceptibility. The last part 
of this thesis will focus on a scaffold testing in both explant (Chapter 10 and 11) and tooth slice models 
(Chapter 12) for the translational potential of the proposed bioactive hydrogel-based scaffold with 
antibiotic release to guide host pulp repair and reduce residual bacteria from infected pulp after 
pulpotomy treatment. This thesis will conclude with a summary and recommendations for future directions 
(Chapter 13).  
In summary, the approach outlined in this thesis for endodontic treatment is to develop a 
bioactive hydrogel-based scaffold with antibiotic release that induces dental pulp regeneration by 
harnessing the natural reparative potential of the dental pulp tissue without the addition of cells or stimuli 
while minimizing post-therapy infection, resulting in the development of a viable endodermic therapy with 


















CHAPTER 2: A HYDROGEL MATRIX FOR 












 This thesis begins with a study that focuses on the design of a bioactive hydrogel-based scaffold 
that is (i) biocompatible and biodegradable and (ii) able to support human dental pulp cell phenotype and 
biosynthesis. A hydrogel-based scaffold is suitable for dental pulp regeneration, as 1) it can completely fill 
the pulpal chamber, which has an irregular geometry and 2)  the dental pulp is a soft tissue with high 
water content (~80%)(33). Guided by these design parameters, PEG-fibrinogen, a biosynthetic hydrogel 
that incorporates fibrinogen into PEGDA hydrogel, is suitable because cell-mediated proteolytic 
degradation and cell-adhesion motifs of the fibrinogen backbone(2;37) enable pulp cells to exhibit a 
phenotypic spindle-shaped morphology within the hydrogel. In addition, fibrinogen also plays an important 
role in pulp wound healing(35;36).  Thus, this study will evaluate the potential of PEG-fibrinogen hydrogel 
for supporting pulp cell response. 
2.1.1 Background and Motivation 
Synthetic scaffolds are widely used in tissue engineering applications due to the ability to 
precisely control their mechanical properties(122). But, without the addition of bioactive molecules, they 
are unable to provide enough biological information to regulate cell response.  In contrast, biological 
scaffolds can provide an extensive variety of biofunctional motifs that regulate adhesion, proliferation, cell 
phenotype, matrix production, and enzyme activity for native cells(123). Still, these scaffolds have too 
many inherent signals to precisely regulate specific cellular events(2) in a manner that can be well-
characterized or understood. Therefore, an ideal scaffold for tissue engineering should express both the 
structural characteristics of synthetic materials and the functionality of bioactive materials(124;125). To 
illustrate this concept, an example includes: the control over structural properties, including porosity, 
compliance, bulk density, and degradability are directed through the synthetic polymer network(126-128), 
while the biological cell signaling is controlled through the incorporation of biological macromolecules, 
which may include protein fragments(129), growth factors(130-132), or biologically active peptide 
sequences(133;134).  These biological factors are used to initiate important cellular functions, including 




For dental pulp tissue 
engineering applications, we 
utilized a bioactive synthetic 
scaffold developed by Almany and 
Seliktar(2), which combines 
poly(ethylene glycol) diacrylate-
based hydrogel (PEGDA) and 
fibrinogen fragments into a 
composite polymeric hydrogel 
(PEG-fibrinogen) (Figure 2.1). 
PEGDA hydrogels are suitable for dental pulp tissue engineering, as they are highly biocompatible, 
exhibit adaptable physical characteristics based on their weight percent, molecular chain length, and 
crosslinking density(135;136), and are able to undergo a controlled liquid-to-solid transition in the 
presence of a cell suspension(137).  The PEGDA polymerization can be carried out in the presence of a 
photoinitiator(138;139) or by mixing a two-part reactive solution of functionalized PEG and crosslinking 
constituents(140).  The fibrinogen backbone of the scaffold is chosen because it is a natural substrate for 
tissue remodeling and has been shown to be important for dental pulp wound healing(37). In addition, 
fibrinogen molecules contain several cell signaling domains, including a protease degradation 
substrate(141) and cell-adhesion motifs (Arg-Gly-Asp or RGD) (37), that enable PEG-fibrinogen 
hydrogels to exhibit  inherent degradability by way of cell-activated protease activity and cell-specific 
adhesivity that are not available with PEGDA alone(137). This affords PEG-fibrinogen the ability to 
regulate cellular characteristics through structural modifications to the PEG-fibrinogen scaffold(42;43). 
Importantly, studies have shown that PEG-fibrinogen hydrogels are able to regulate cellular outgrowth 
into the hydrogel network, including smooth muscle cells(43) and dorsal root ganglion (DRG) cells(41). 
During this process, cells synthesize matrix metalloproteinases (e.g. MMP-2, MMP-9)(42) and tunnel 
through the hydrogel via proteolytic breakdown of fibrinogen fragments. This concept can be applied for 
non-cell based approach in which PEG-fibrinogen is used to guide host cell migration and pulp repair for 
extensive pulp regeneration in vital endodontic therapy. 
Figure 2.1: PEG-fibrinogen Hydrogel Network (A) PEG-
fibrinogen assembly is accomplished by radical chain 
polymerization of unreacted PEGDA, resulting in (B) a hydrogel 





The objective of this study is to evaluate the effect of incorporating fibrinogen into PEGDA 
hydrogel structure on human dental pulp cell response, including cell viability, morphology, growth, 
collagen production, mineralization potential, and expression of human dental pulp cell-related markers 
including collagen I, collagen III, and DSPP(38) over time. It is hypothesized that incorporating fibrinogen 
into the synthetic hydrogel backbone will regulate key cellular characteristics such as cell morphology and 
will support cell growth, biosynthesis, and the expression of pulp cell-related markers. 
2.2 Materials and Methods 
2.2.1 Cells and Cell Culture 
Human dental pulp cells were isolated from an intact molar of a healthy 20-year-old female 
(College of Dental Medicine, Columbia University, NY) via enzymatic digestion. Briefly, minced pulp 
tissues were digested for 45 minutes at 37ºC with 0.1% w/v collagenase type II (Sigma, St. Louis, MO) in 
Dulbecco’s modified Eagle’s medium (DMEM, Cellgro-Mediatech, Manassas, VA) supplemented with 5% 
fetal bovine serum (FBS, Atlanta Biologicals, Atlanta, GA), 2% penicillin streptomycin (P/S, Cellgro-
Mediatech),  and 0.1% amphotericin B (AMP-B, Cellgro-Mediatech). The cell suspension was then filtered 
(30 μm, Spectrum, Rancho Dominguez, CA)  before plating at 30% confluence and maintained in fully 
supplemented DMEM with 10% FBS, 1% P/S, 0.1% AMP-B, 0.1% gentamicin (Cellgro-Mediatech), and 
1% non-essential amino acids (NEAA, Cellgro-Mediatech) under humidified conditions at 37ºC and 5% 
CO2. Cells were continuously passaged at a 1:3 ratio when confluent until passage 4 and kept frozen in 
liquid nitrogen. 
2.2.2 PEG-fibrinogen and PEGDA Hydrogels Fabrication, Characterization, and Culture 
PEG-fibrinogen and PEGDA hydrogels were made according to Dikovsky et al. (2006)(43). 
Briefly, PEG-fibrinogen precursor solution in 50 mM phosphate buffered saline (PBS, Sigma, St. Louis, 
MO) (7.7 mg/ml fibrinogen, 10 kDa, provided from Dr.Dror Seliktar, Technion-Israel Institute of 
Technology, Haifa, ISRAEL) was mixed with 19.75 mg/ml PEGDA in 50 mM PBS (10 kDa, provided from 
Dr.Dror Seliktar). 0.1% w/v photoinitiator stock solution made of 10% w/v Irgacure2959® (Ciba Specialty 
Chemical Corp., Tarrytown, NY) in 70% ethanol and deionized water. PEGDA (10 kDa) precursor solution 




PEG-fibrinogen and PEGDA hydrogels were made by mixing dental pulp cell (passage 6) suspension into 
the precursor solution at 1.6 million cells/ml.  All hydrogel samples were made from 100 µl aliquots in a 
flat bottom 96-assay plate (Corning, NY) and the solution was crosslinked under a UV light (365 nm, 730 
µW/cm2, Cole-Parmer, IL) for 5 minutes.  
Acellular and cellular hydrogel samples were cultured in 48 well-plates. For monolayer controls, 
pulp cells were seeded at 25% confluence and cultured in 24 well-plates. All samples were maintained 
under humidified conditions at 37ºC and 5% CO2 with 1 ml of fully supplemented medium with 10% FBS, 
1% antibiotics, 0.1% antifungal, 0.1% gentamicin, and 1% non-essential amino acids. The medium was 
changed every other day and freshly supplemented with 50 µg/ml ascorbic acid. The experimental groups 
consisted of cells seeded in PEG-fibrinogen hydrogels, whereas the control groups included cells seeded 
in PEGDA hydrogels and monolayer, as well as corresponding acellular controls for PEG-fibrinogen and 
PEGDA groups. 
In this study, human dental pulp cell responses in the PEG-fibrinogen and PEGDA hydrogels 
were evaluated after 2, 7, 14, 21, 28, and 35 days of culture. Specifically, (i) cell viability, (ii) cell 
morphology, (iii) cell proliferation, (iv) mineralization, (v) collagen deposition, and (vi) human dental pulp 
cell-related markers were determined and compared between groups as well as over time.  In addition, 
samples were weighed and desiccated for 24 hours (CentriVap Concentrator, Labconco Co., Kansas 
City, MO), after which the scaffold swelling ratio (n=6, wet weight/dry weight) was calculated.   
2.2.3 Cell Viability and Morphology 
Cell viability (n=2) was visualized using Live/Dead staining (Molecular Probes, Eugene, OR), 
following the manufacturer’s suggested protocol. After washing in PBS, samples were visualized under 
confocal microscopy (Olympus Fluoview FV1000, Center Valley, PA) at 473 nm excitation/ 519nm 
emission wavelengths for FITC and 559 nm excitation/ 612 nm emission for Texas Red.   
Cell morphology (n=2) was assessed by Alexa Fluor® 488 phalloidin (Molecular Probes, Eugene, 
OR) and DAPI staining (Sigma-Aldrich, St.Louis, MO) according to the manufacturer’s recommended 
protocol. Briefly, samples were washed in PBS, fixed with 4% w/v paraformaldehyde (Sigma-Aldrich, 
St.Louis, MO) in PBS for 1 hour, then lysed in 0.1% triton-x in PBS for 5 minutes, stained for actin for 30 




microscopy at 473 nm excitation/ 520nm emission wavelengths for actin staining and at 405 nm 
excitation/ 461nm emission wavelengths for DAPI staining. 
2.2.4 Cell Proliferation 
Cell proliferation (n=6) was determined using the PicoGreen® total DNA assay (Molecular 
Probes, Eugene, OR).  Briefly, samples were first rinsed with PBS, followed by the addition of 500 μl 0.1% 
Triton-X solution (Sigma-Aldrich, St.Louis, MO) to lyse the cells.  An aliquot of the sample (25 μl) was then 
added to 175 μl of the PicoGreen® working solution.  Fluorescence was measured with a microplate 
reader (Tecan, Research Triangle Park, NC), at the excitation and emission wavelengths of 485 and 535 
nm, respectively.  Total cell number was obtained by converting the amount of DNA per sample to cell 
number using the conversion factor of 8 pg DNA/cell. 
2.2.5 Mineralization 
Mineralization potential was determined by measuring alkaline phosphatase (ALP) activity (n=6) 
using a colorimetric assay based on the hydrolysis of p-nitrophenyl phosphate (pNPP) to p-nitrophenol 
(pNP)(142).  Briefly, samples were lysed in 0.1% Triton-X solution, then added to pNPP solution (Sigma-
Aldrich, St.Louis, MO) and allowed to react for 30 min at 37°C. The reaction was terminated with 0.1 N 
sodium hydroxide (NaOH) (Sigma-Aldrich, St.Louis, MO), and sample absorbance was measured at 415 
nm using a microplate reader (Tecan, Research Triangle Park, NC). 
2.2.6 Collagen Deposition 
Collagen deposition (n=6) was quantified using the hydroxyproline assay, based on alkaline 
hydrolysis of the tissue homogenate and subsequent determination of the free hydroxyproline in 
hydrolyzates(143). Briefly, samples were first desiccated for 24 hours and then digested for 16 hours at 
65ºC with papain (600 mg protein/ml, Sigma-Aldrich, St.Louis, MO) in 0.1 M sodium acetate (Sigma-
Aldrich, St.Louis, MO), 10 mM cysteine HCl (Sigma-Aldrich, St.Louis, MO), and 50 mM 
ethylenediaminetetraacetate (EDTA) (Sigma-Aldrich, St.Louis, MO). Samples were then hydrolyzed with 2 
N NaOH for 25 minutes and chloramine-T (Sigma) was added to the hydrolyzed sample to oxidize the 
free hydroxyproline for the production of a pyrrole at room temperature for 25 minutes. Then, Ehrlich's 
reagent (Sigma-Aldrich, St.Louis, MO) was added to the products and incubated at 65ºC for 20 minutes 




absorbance was measured at 555 nm using a microplate reader (Tecan, Research Triangle Park, NC). 
Additionally, collagen distribution (n=3) was visualized histologically with picrosirius red staining of paraffin 
embedded samples. 
2.2.7 Human Dental Pulp Cell-related Gene Expression 
The expression of HDPC-related marker (n=3), such as collagen I, collagen III, and dentin 
sialophosphoprotein (DSPP) were determined using reverse transcription followed by polymerase chain 
reaction (RT-PCR). The total RNA content of dental pulp cells was isolated using the TRIzol® (Invitrogen, 
Carlsbad, CA) extraction method, with the isolated RNA reverse-transcribed into cDNA using the 
SuperScript III First-Strand Synthesis System (Invitrogen).  The cDNA product was then amplified for 40 
cycles with recombinant Platinum Taq DNA polymerase (Invitrogen).  PCR products were size-
fractionated on a 1% w/v agarose gel and visualized by ethidium-bromide staining. Expression band 
intensities of relevant genes were analyzed semi-quantitatively by ImageJ and normalized to the 
housekeeping gene human glyceraldehyde-3-phosphate dehydrogenase (GAPDH).  The 
olignonucleiotide primer sequences are: GAPDH (target size, 177bp) 5’-ATCATCCCTGCCTCTACTGG-3’ 
(sense), 5’-CTGCTTCACCACCTTCTTGA-3’ (antisense); Collagen I (target size, 152bp) 5’-
GCCATCAAAGTCTTCTGCAA-3’ (sense), 5’-AACTGGAATCCATCGGTCAT-3’ (antisense); Collagen III 
(target size, 154bp) 5’-AGCTACGGCAATCCTGAACT-3’ (sense),  5’-GGGCCTTCTTTACATTTCCA-3’ 
(antisense); DSPP (target size, 172bp) 5’-AGCCGAGGAGATGCTTCTTA-3’ (sense),  5’-
TGCCACTGTCTGATTTGTCA-3’ (antisense). 
2.2.8 Statistical Analysis 
Results are presented in the form of mean ± standard deviation, with n equal to the number of 
samples analyzed.  Two-way analysis of variance (ANOVA) was performed on all quantitative data to 
determine effects of hydrogel type and culture time on cell response (proliferation, mineralization, 
collagen deposition, and gene expression), as well as hydrogel parameters (weight and swelling ratio).  
The Tukey–Kramer post-hoc test was used for all pair-wise comparisons, and statistical significance was 






2.3.1 Scaffold Characterization 
Hydrogel wet weight increased significantly over time for all groups except cell-seeded PEG-
fibrinogen, which exhibited a weight increase only at earlier time points (Figure 2.2B). Also, acellular 
PEG-fibrinogen completely degraded after day 21. While there was no change in dry weight of PEGDA 
hydrogels, the dry weight of PEG-fibrinogen hydrogels decreased over time (Figure 2.2C). Swelling ratios 
for both PEG-fibrinogen and PEGDA hydrogels significantly increased over time and the swelling ratio of 
PEGDA without cells was significantly higher than PEGDA with human dental pulp cells after day 7 
(Figure 2.2D).  
2.3.2 Dental Pulp Cell Viability, Morphology, and Proliferation 
Most cells seeded within PEG-fibrinogen were viable over time, and all cells, which were initially 
rounded, began to spread within the hydrogel over time (Figure 2.3). In contrast, a large number of dead 
cells were found within PEGDA hydrogels and remained spherical over time (Figure 2.3). Observation 
made from live/dead images were further supported by the quantitative results of the Picogreen DNA 
assay, which showed that cell number decreased over time in the PEGDA hydrogel and was significantly 
lower than that of PEG-fibrinogen group on day 28 and 35. In contrast, cell number in PEG-fibrinogen 
increased significantly on day 35 when compared to day 7 (Figure 2.3C).  
2.3.3 Cell Mineralization and Collagen Deposition 
ALP activity remained at basal levels for PEG-fibrinogen group, but increased significantly on day 
21 for PEGDA group, as well as monolayer controls (Figure 2.4A). Collagen content in PEG-fibrinogen 
was stable over time, while no detectable collagen production was observed in the PEGDA hydrogels 
(Figure 2.4B). This result was confirmed with picrosirius red staining of PEG-fibrinogen and PEGDA 
paraffin sections on day 21, which exhibited no detectable staining for the PEGDA group. 
2.3.4 Dental Pulp Phenotypic Response 
The expression for DSPP, collagen I and collagen III was detected in both PEGDA and PEG-
fibrinogen hydrogels. Interestingly, DSPP gene expression in PEGDA hydrogel increased over time and 




2.4 Discussion  
Both live and dead staining and Alexa Fluor® 488 phalloidin staining showed that cells inside 
PEG-fibrinogen spread and became spindle-shaped over time. Pulp cells, consisting mostly of fibroblasts, 
were able to spread and exhibit a spindle-shaped morphology due to cell-adhesion motifs and cell-
mediated proteolytic degradation of the fibrinogen backbone in PEG-fibrinogen hydrogel(43). However, 
the results showed a significant decrease in cell number for all groups on day 2, which might be due to 
the presence of photoinitiator and/or UV light exposure. Many investigators showed that UV (above 320 
nm) exposure did not affect cell viability. However, free radicals that are released from the photoinitiator 
can cause cytotoxic effects to cells, dependent on photoinitiator type and concentration, cell type, 
crosslinking time, and UV light irradiation (47;144-148).   We found that cell number in PEGDA hydrogel 
decreased over time, which might be due to morphological constraints, causing the cells to undergo 
transdifferentiation, as well as apoptosis due to harsher environmental conditions (43). DSPP is normally 
used for odontoblast-specific marker(149) which can use to indicate mineralization capacity of dental pulp 
cell. DSPP was shown to be upregulated in the cell culture within PEGDA hydrogels which are related to 
a significant increase of ALP activity indicating cells differentiate into odontoblast-like cells and induce 
mineralization.  
2.5 Conclusions 
 The results of this study suggest that human dental pulp cells were able to maintain their 
morphology, viability and phenotypic response over time in PEG-fibrinogen hydrogels, demonstrating that 
PEG-fibrinogen hydrogel is a promising matrix for dental pulp tissue engineering. Future studies will focus 











Figure 2.2: Scaffold Characterization (A) Images of 
cell-seeded PEG-fibrinogen and PEGDA scaffolds on 
day 1. (B) Wet Weight increased significantly over 
time for all groups except cell-seeded PEG-
fibrinogen, which exhibited a weight increase only at 
earlier time points. Note that acellular PEG-fibrinogen 
hydrogel was completely degraded after day 21. (C) 
Dry Weight decreased significantly over time for all 
PEG-fibrinogen groups. (D) Swelling Ratio 
increased significantly over time for all groups and 
was higher in the acellular PEGDA group.        















































































Figure 2.3: (A) Cell Viability of human dental pulp cells seeded within PEG-fibrinogen and 
PEGDA hydrogels over time. Cells were viable (green) in PEG-fibrinogen hydrogels after 2 to 
35 days in culture.  Cells were less viable (red) in PEGDA hydrogels after 7 days in culture. 
(n=2, 10x, scale = 200 µm) (B) Actin and DAPI Staining showed that cells inside PEG-
fibrinogen hydrogels were initially rounded began to spread within the hydrogels over time but 
cells in PEGDA were rounded over time. (Actin-red, DAPI-blue, n=2, 100x, scale bar = 30 µm) 
(C) Cell Number within PEG-fibrinogen and PEGDA over time. Both cell number in PEG-
fibrinogen and PEGDA decreased significantly on day 7. Cell number inside PEGDA gel 
decreased overtime but cell inside PEG-fibrinogen remained stable and increased significantly 


























































































Figure 2.4: Cell Mineralization and Collagen 
Deposition within PEG-fibrinogen and PEGDA 
overtime. (A) ALP Activity remained at basal levels 
for PEG-fibrinogen group but increased significantly 
on day 21 for monolayer and PEGDA group. 
(n=6,*,^p<0.05). (B) Collagen Content within PEG-
fibrinogen remained stable over time and there was 
no collagen production in PEGDA hydrogels. This 
result was confirmed with picrosirius red staining on 



















































Figure 2.5: Collagen I, Collagen III, and DSPP Gene Expression of cells within PEG-fibrinogen and 
PEGDA on day 7 and day 28. Cell cultured in both PEG-fibrinogen and PEGDA hydrogels expressed 
all human dental pulp cell phenotypic markers as well as in monolayer. DSPP gene expression of 




























































































CHAPTER 3: EFFECT OF CELL DENSITY ON 



















The previous chapter showed that PEG-fibrinogen supports human dental pulp cell phenotypic 
morphology and pulp cell-related gene expression. However, there was no cell biosynthesis, in terms of 
ALP activity and collagen production, over time. To this end, studies have shown that there is an optimal 
cell density that sustains pulp cell morphology and proliferation. Therefore, this study will evaluate the 
effect of cell seeding density on dental pulp cell response in PEG-fibrinogen hydrogel.  
3.1.1 Background and Motivation 
Many studies have shown that alteration of seeding density can affect pulp cell response, in 
terms of cell viability, morphology, proliferation, and ALP activity. To illustrate, Govindasamy et al. 
(2010)(39) evaluated the effect of seeding density on the expansion of dental pulp–mesenchymal stromal 
cells by plating cells on T25 tissue culture flasks at 200, 400, 600, 800, 1,000, 2,000, 5,000,or 10,000 
cells/cm2 and observed differences in cell morphology and proliferation at different cell densities. In 
addition, Zheng et al. (2012)(150) seeded porcine deciduous pulp stem cells on a beta-tricalcium 
phosphate (β-TCP) scaffold at 5 different densities (0.01, 0.05, 0.1, 0.5, 1, and 2 million cells/ml) and 
discovered that both cell proliferation and ALP activity depend on seeding density, and were optimal 
when seeded at 0.5 million cells/ml. In addition, several studies have shown that optimization of cell 
seeding density is important for cell proliferation, differentiation, biosynthesis, and cell-matrix interactions, 
including matrix degradation(151-153). Therefore, it is necessary to evaluate the effect of seeding density 
in PEG-fibrinogen hydrogel on cell behavior.  
3.1.2 Objectives 
The objective of this study is to evaluate the effect of initial cell seeding density on human dental 
pulp cell response in PEG-fibrinogen hydrogel. It is anticipated that optimized cell seeding density will 






3.2 Materials and Methods 
3.2.1 Cells and Cell Culture 
Human dental pulp cells were isolated from an intact molar of a healthy 20-year-old female 
(College of Dental Medicine, Columbia University, NY) via enzymatic digestion. Briefly, minced pulp 
tissues were digested for 45 minutes at 37ºC with 0.1 % w/v collagenase type II (Sigma, St. Louis, MO) in 
Dulbecco’s modified Eagle’s medium (DMEM, Cellgro-Mediatech, Manassas, VA) supplemented with 5% 
fetal bovine serum (FBS, Atlanta Biologicals, Atlanta, GA), 2% penicillin streptomycin (P/S, Cellgro-
Mediatech),  and 0.1% amphotericin B (AMP-B, Cellgro-Mediatech). The cell suspension was then filtered 
(30 μm, Spectrum, Rancho Dominguez, CA)  before plating at 30% confluence seeding density and 
maintained in fully supplemented DMEM with 10% FBS, 1% P/S, 0.1% AMP-B, 0.1% gentamicin (Cellgro-
Mediatech), 1% non-essential amino acids (NEAA, Cellgro-Mediatech) under humidified conditions at 
37ºC and 5% CO2. Cells were continuously passaged at a 1:3 ratio when confluent until passage 4 and 
kept frozen in liquid nitrogen. 
3.2.2 PEG-fibrinogen and PEGDA Hydrogels Fabrication, Characterization, and Culture 
PEG-fibrinogen and PEGDA hydrogels were made according to Dikovsky et al. (2006)(43). 
Briefly, PEG-fibrinogen precursor solution in 50 mM PBS (Sigma, St. Louis, MO) (7.7 mg/ml fibrinogen, 10 
kDa, provided from Dr.Dror Seliktar, Technion-Israel Institute of Technology, Haifa, ISRAEL) was mixed 
with 19.75 mg/ml PEGDA in PBS (10 kDa, provided from Dr.Dror Seliktar) and 0.1% w/v photoinitiator 
stock solution, made from 10% w/v Irgacure®2959 (Ciba Specialty Chemical Corp., Tarrytown, NY) in 
70% ethanol and deionized water. PEGDA (10 kDa) precursor solution (4.06% w/v) was made in PBS 
and mixed with 0.1% w/v photoinitiator stock solution. All hydrogel samples were made from 100 µl 
aliquots in a flat bottom 96-assay plate (Corning, NY) and the solution was crosslinked under a UV light 
(365 nm, 730 µW/cm2, Cole-Parmer, IL) for 5 minutes.  
Cell-seeded PEG-fibrinogen and PEGDA hydrogels were polymerized in the presence of passage 
6 human dental pulp cells at varying concentrations (1.6, 3.2, and 4.8 million cells/ml) and were 
subsequently cultured in 48 well plates. For monolayer controls, pulp cells were seeded at 25% 
confluence and cultured in 24 well plates. All samples were maintained under humidified conditions at 




antifungal, 0.1% gentamicin, and 1% non-essential amino acids. The medium was changed every other 
day and freshly supplemented with 50 µg/ml ascorbic acid. The experimental groups consisted of cells in 
PEG-fibrinogen hydrogels, whereas the control groups included cells cultured in PEGDA at the same 
seeding density and monolayer, as well as corresponding acellular controls.  
In this study, human dental pulp cell responses in the PEG-fibrinogen and PEGDA hydrogels 
were evaluated after 2, 7, 14, 21, 28, and 35 days of culture. Specifically, (i) cell viability, (ii) cell 
morphology, (iii) cell gap junction, (iv) proliferation, (v) mineralization, (vi) collagen deposition, and (v) 
phenotypic response were determined and compared between different hydrogel groups, varying seeding 
densities, and over time.  In addition, samples were weighed and desiccated for 24 hours (CentriVap 
Concentrator, Labconco Co., Kansas City, MO), at which point the scaffold swelling ratio (n=6, wet 
weight/dry weight) was calculated.   
3.2.3 Cell Viability, Morphology, and Gap Junction 
Cell viability (n = 2) was visualized using Live/Dead staining (Molecular Probes, Eugene, OR), 
following the manufacturer’s suggested protocol. After washing in PBS, samples were visualized under 
confocal microscopy (Olympus Fluoview FV1000, Center Valley, PA) at 473 nm excitation/ 519 nm 
emission wavelengths for FITC and 559 nm excitation/ 612 nm emission for Texas Red.   
Cell morphology (n=2) was assessed by Alexa Fluor® 488 phalloidin, a fluorophore which stains 
for f-actin (Molecular Probes), and DAPI (Sigma-Aldrich, St.Louis, MO), according to the manufacturer’s 
recommended protocol. Briefly, samples were washed in PBS, fixed with 4% w/v paraformaldehyde 
(Sigma-Aldrich, St.Louis, MO) in PBS for 1 hour, then lysed in 0.1% triton-x in PBS for 5 minutes, followed 
by phalloidin staining  for 30 minutes, and DAPI staining for 30 minutes. The samples were then 
visualized under confocal microscopy at 473 nm excitation/ 520 nm emission wavelengths for f-actin 
staining and at excitation and 405 nm excitation/ 461 nm emission wavelengths for DAPI staining. In 
addition, cell aspect ratio (n=2) was determined by calculating the ratio of the length of the cell’s longer 
axis to its shorter axis using images obtained from f-actin staining. 
Cell gap junction (n=2) was visualized using connexin 43 (Rabbit, Abcam, Cambridge, MA) as the 




manufacturer’s suggested protocol. The samples were then visualized using confocal microscopy at 
excitation and emission wavelengths of 473 nm and 519 nm, respectively.  
3.2.4 Cell Proliferation 
Cell proliferation (n=6) was determined using the PicoGreen® total DNA assay (Molecular 
Probes, Eugene, OR).  Briefly, samples were first rinsed with PBS, followed by the addition of 500 μl of 
0.1% Triton-X solution (Sigma-Aldrich, St.Louis, MO) to lyse the cells.  An aliquot of the sample (25 μl) 
was then added to 175 μl of the PicoGreen® working solution.  Fluorescence was measured with a 
microplate reader (Tecan, Research Triangle Park, NC), at the excitation and emission wavelengths of 
485 and 535 nm, respectively.  Total cell number was obtained by converting the amount of DNA per 
sample to cell number using the conversion factor of 8 pg DNA/cell. 
3.2.5 Mineralization 
Mineralization potential was determined by measuring ALP activity (n=6) using a colorimetric 
assay based on the hydrolysis of p-nitrophenyl phosphate (pNPP) to p-nitrophenol (pNP)(142).  Briefly, 
samples were lysed in 0.1% Triton-X solution, then added to pNPP solution (Sigma-Aldrich, St. Louis, 
MO) and allowed to react for 30 min at 37°C. The reaction was terminated with 0.1 N NaOH (Sigma-
Aldrich, St. Louis, MO), and sample absorbance was measured at 415 nm using a microplate reader 
(Tecan, Research Triangle Park, NC). 
3.2.6 Collagen Deposition 
Collagen deposition (n=6) was quantified using hydroxyproline assay based on alkaline 
hydrolysis of the tissue homogenate and subsequent determination of the free hydroxyproline in 
hydrolyzates(143). Briefly, samples were first desiccated for 24 hours and then digested for 16 hours at 
65ºC with papain (600 mg protein/ml, Sigma-Aldrich, St.Louis, MO) in 0.1 M sodium acetate (Sigma-
Aldrich, St.Louis, MO), 10 mM cysteine HCl (Sigma-Aldrich, St.Louis, MO), and 50 mM EDTA (Sigma-
Aldrich, St.Louis, MO). Samples were then hydrolyzed with 2 N NaOH for 25 minutes and chloramine-T 
(Sigma) was added into hydrolyzed sample to oxidize the free hydroxyproline for the production of a 
pyrrole at room temperature for 25 minutes. Then, Ehrlich's reagent (Sigma-Aldrich, St.Louis, MO) was 
added to the products and incubated at 65ºC for 20 minutes resulting in the formation of a chromophore. 




microplate reader (Tecan, Research Triangle Park, NC). Additionally, collagen distribution (n=3) was 
visualized histologically with picrosirius red staining of paraffin embedded. 
3.2.7 Human Dental Pulp Cell-related Gene Expression 
The expression of HDPC-related marker (n=3), such as collagen I, collagen III, and dentin 
sialophosphoprotein (DSPP) were determined using reverse transcription followed by polymerase chain 
reaction (RT-PCR). Total RNA of dental pulp cells was isolated using the TRIzol® (Invitrogen, Carlsbad, 
CA) extraction method, with the isolated RNA reverse-transcribed into cDNA using the SuperScript III 
First-Strand Synthesis System (Invitrogen).  The cDNA product was then amplified for 40 cycles with 
recombinant Platinum Taq DNA polymerase (Invitrogen).  PCR products were size-fractionated on a 1% 
w/v agarose gel and visualized by ethidium-bromide staining. Expression band intensities of relevant 
genes were analyzed semi-quantitatively by ImageJ and normalized to the housekeeping gene human 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH).  The olignonucleotide primer sequences are: 
GAPDH (target size, 177bp) 5’-ATCATCCCTGCCTCTACTGG-3’ (sense), 5’-
CTGCTTCACCACCTTCTTGA-3’ (antisense); Collagen I (target size, 152bp) 5’-
GCCATCAAAGTCTTCTGCAA-3’ (sense), 5’-AACTGGAATCCATCGGTCAT-3’ (antisense); Collagen III 
(target size, 154bp) 5’-AGCTACGGCAATCCTGAACT-3’ (sense),  5’-GGGCCTTCTTTACATTTCCA-3’ 
(antisense); DSPP (target size, 172bp) 5’-AGCCGAGGAGATGCTTCTTA-3’ (sense),  5’-
TGCCACTGTCTGATTTGTCA-3’ (antisense). 
3.2.8 Statistical Analysis 
Results are presented in the form of mean ± standard deviation, with n equal to the number of 
samples analyzed.  Multi-way analysis of variance (ANOVA) was performed on all quantitative data to 
determine effects of hydrogel type, cell seeding density, and time on cell response (proliferation, 
mineralization, collagen deposition, and gene expression), as well as changes in hydrogel parameters 
(weight and swelling ratio).  The Tukey–Kramer post-hoc test was used for all pair-wise comparisons, and 
statistical significance was attained at p<0.05.  All statistical analyses were performed using JMP IN 





3.3.1 Scaffold Characterization 
All groups showed an increase in wet weight overtime except for the PEG-fibrinogen seeded with 
1.6 million cells/ml group, which exhibited a weight increase only at early time points (Figure 3.1A). There 
was no change in the dry weight of PEGDA or PEG-fibrinogen hydrogels over time, except in acellular 
and 1.6 million cells/ml seeding density PEG-fibrinogen groups, which showed a significant decrease in 
dry weight over time (Figure 3.1B). Also, acellular PEG-fibrinogen hydrogels were completely degraded 
after day 21. Both PEG-fibrinogen and PEGDA hydrogel swelling ratios were significantly increased over 
time (Figure 3.1C). For the PEGDA group, swelling ratio of acellular PEGDA was significantly higher than 
PEGDA gels with human dental pulp cells after day 14. In contrast, in the PEG-fibrinogen groups, the 
swelling ratio of acellular gels was significantly lower than those containing human dental pulp cells on 
days 2 and 7, but was higher on day 21. This trend might relate to scaffold degradation, as acellular PEG-
fibrinogen dry weight significantly decreased on day 21 (Figure 3.1C).   
3.3.2 Dental Pulp Cell Viability and Proliferation 
Cell viability images showed that the majority of cells inside PEG-fibrinogen gels remained viable 
over time (Figure 3.2A). In contrast, a large number of dead cells were found within PEGDA hydrogels. 
Observations made via live/dead imaging were further supported by the quantitative results of the 
Picogreen DNA assay (Figure 3.2B). To illustrate, cell number decreased over time in PEGDA hydrogels 
and was significantly lower than that of PEG-fibrinogen groups. In contrast, no significant change in cell 
number was measured after day 2 in the PEG-fibrinogen hydrogel for the 1.6 and 4.8 million density 
groups.  Interestingly, for the 3.2 million cells/ml density group, cell number increased significantly by day 
35. 
3.3.3 Cell Morphology and Gap Junction 
Cell morphology and gap junction images are shown in Figure 3.3. Cells inside PEG-fibrinogen 
hydrogels, which were initially rounded, began to spread within the hydrogels, as shown in both 
Live/Dead staining and f-actin staining (Figure 3.2A and 3.3A). Cells in the 4.8 million cells/ml seeding 
density group spread earlier than 1.6 million cells/ml seeding density group and exhibit more cellular 




difference in cell morphology in PEGDA groups, as shown by Live/Dead staining and f-actin staining 
(Figure 3.2A and 3.3A). These results were confirmed through cell aspect ratio, which decreased 
significantly over time in PEG-fibrinogen gels, indicating more cellular extension. In contrast, cell aspect 
ratio remained stable in PEGDA gels over time, showing that cells remained rounded within PEGDA over 
time.  Images of connexin 43 staining for human fibroblast gap junction protein show that cells cultured in 
PEGDA exhibited less gap junction staining compared to cells cultured in PEG-fibrinogen on day 28 
(Figure 3.3B). 
3.3.4 Cell Mineralization and Collagen Deposition 
ALP activity remained at basal levels for all PEG-fibrinogen groups (Figure 3.4A). However, there 
were significant increases in ALP activity in both PEGDA with 1.6 and 3.2 million cells/ml groups on day 
21. The hydroxyproline assay showed that no detectable collagen production was found in the PEGDA 
hydrogels over time. However, collagen content in PEG-fibrinogen hydrogels was stable over time, and 
interestingly, there was a significant increase in collagen content on day 35 for PEG-fibrinogen gels 
containing 4.8 million cells/ml (Figure 3.4B). These results were confirmed with picrosirius red staining, 
shown in Figure 3.4C. 
3.3.5 Dental Pulp Phenotypic Response 
The expression of DSPP, collagen I and collagen III was detected in both PEGDA and PEG-
fibrinogen hydrogels, and was similar to that observed for monolayer controls. Interestingly, DSPP gene 
expression in PEGDA hydrogel increased over time and was significantly higher than expression in PEG-
fibrinogen on day 28 (Figure 3.5). 
3.4 Discussion  
These results demonstrate that varying dental pulp cell seeding density in PEG-fibrinogen affects 
pulp cell morphology, proliferation, and collagen deposition. To illustrate, cells seeded at high densities 
spread earlier than those seeded at lower densities, and exhibit more cellular extension and a spindle-
shaped morphology during the 21 day culture period. Cells were able to spread and exhibit a spindle 
shape due to proteolytic degradation of the PEG-fibrinogen hydrogel, a process dependent on the 
diffusion of enzymes, including matrix metalloproteinases (MMPs) 2, 8, and 9 (43),secreted by dental pulp 




seeding density exhibited a greater swelling ratio, resulting in increased enzyme diffusion. In addition, cell 
number inside PEG-fibrinogen gels remained stable after day 2 over time for all groups but increased 
significantly on day 35 for 3.2 million cells/ ml group only.  However, this might be due to the lack of 
adequate nutrient supply in the 4.8 million cells/ ml group. Also, there was a significant increase in 
collagen content on day 35 for the 4.8 million cells/ml PEG-fibrinogen group only. Similar findings were 
observed by Govindasamy et al. (2010)(39) and Zheng et al. (2012)(150), indicating that it is necessary to 
optimize dental pulp cell seeding density for cell viability, proliferation, and biosynthesis. 
3.5 Conclusions 
 We investigated the effect of cell seeding density in PEG-fibrinogen gels on dental pulp cell 
response over time and found that there is a critical cell seeding density, 4.8 million cells/ml, which results 
in optimal dental pulp cell biosynthesis in PEG-fibrinogen hydrogel. Future studies will focus on further 
optimizing dental pulp cell response in PEG-fibrinogen hydrogel by adjusting fibrinogen concentration 
















Figure 3.1: Scaffold Characterization (A) Wet Weight increased significantly over time for all 
groups except cell-seeded PEG-fibrinogen at 1.6 million cells/ml group which weight increase was 
only observed at earlier time point. Note that acellular PEG-fibrinogen hydrogel was completely 
degraded after day 21. (B) Dry Weight decreased significantly over time for acellular and 1.6 million 
cells/ml seeding density PEG-fibrinogen groups. (C) Swelling Ratio increased significantly over time 
















































































































































Figure 3.2: (A) Cell Viability of human dental pulp cells seeded within PEG-fibrinogen and PEGDA 
hydrogels over time. Cells were viable (green) in PEG-fibrinogen hydrogels after 2 to 35 days in 
culture.  Cells were less viable (red) in PEGDA hydrogels after 7 days in culture. (n=2, 10x, scale = 
200 µm) (B) Cell Number within PEG-fibrinogen and PEGDA over time. Both cell number in PEG-
fibrinogen and PEGDA decreased significantly on day 7. Cell number inside PEGDA gel decreased 
overtime. Interestingly, cell inside PEG-fibrinogen remained stable and increased significantly on day 
35 for 3.2 million cells/ ml group. (n=6, *over time, ^between groups, p<0.05) 

























































































































Figure 3.3: (A) Cell Morphology F-actin staining (100 x, scale bar = 30 µm) showed that cells inside 
PEG-fibrinogen hydrogels began to spread within the hydrogels overtime. Cells in higher seeding 
density group spread earlier than lower seeding density group and exhibit more cellular extension and 
spindle morphology during 21 days culture period. There was no difference in cell morphology in all 
PEGDA groups over 35 days culture period as confirmed by cell aspect ratio (1=rounded, n=2, 
*,^p<0.05). (n=2, 100x, scale = 30 µm) (B) Cell Gap Junction. Images of connexin 43 staining for 
human fibroblast gap junction protein (yellow) on day 28. DAPI staining showed cell nucleus in blue. 
Cells cultured in PEGDA  at highest cell seeding density exhibited less gap junction staining compared 









































































































Figure 3.4: Cell Mineralization and Collagen Deposition within PEG-fibrinogen and PEGDA 
overtime. (A) ALP activity remained at basal levels for cells in PEG-fibrinogen hydrogels. However, 
there was a significant increase in ALP activity in PEGDA groups on day 21. (n=6, *,^p<0.05)  
(B) A significant increase in collagen content was measured on day 35 for the PEG-fibrinogen group 
with the highest seeding density. (n=6, *over time, ^between groups, p<0.05) (C) Picrosirius red 
staining on day 35 showed higher collagen stained in PEG-fibrinogen with 4.8 million cells/ml seeding 


























Figure 3.5: Collagen I, Collagen III, and DSPP 
Gene Expression of cells within PEG-fibrinogen 
and PEGDA on day 7 and day 28. Cell cultured in 
both PEG-fibrinogen and PEGDA hydrogels 
expressed all human dental pulp cell phenotypic 
markers as well as in monolayer. DSPP gene 
expression of cells inside PEGDA hydrogel was 



























































































CHAPTER 4: EFFECT OF FIBRINOGEN 
CONCENTRATION IN PEG-FIBRINOGEN 

















In Chapter 3, we evaluated the effect of cell seeding concentration on human dental pulp cellular 
response and found that 4.8 million cells/ml seeding density is optimal for dental pulp cell phenotypic 
morphology and biosynthesis. However, ALP activity remained at basal level and there was no cell 
proliferation at this seeding density. Studies have shown that varying the fibrinogen content within PEG-
fibrinogen hydrogel effects cell migration and hydrogel properties including shear modulus and 
crosslinking time(42;47). Therefore, in next study we evaluate effect of fibrinogen concentration to dental 
pulp cell response.   
4.1.1 Background and Motivation 
PEG-fibrinogen hydrogel induces pulp cell spreading and collagen synthesis.  This hydrogel is 
also uniquely suited for pulp repair because fibrinogen plays a key role in pulp wound healing(35;36).  
Furthermore, fibrinogen contains a protease degradation substrate(141) and three potential integrin 
binding sites including two RGD sequences within the Aα chain (RGDS α572-575 and RGDF α95-98) and 
a non-RGD sequence in the γ chain (carboxy terminal γ400-411) (2;37) that enable pulp cells to exhibit a 
phenotypic spindle-shaped morphology within the hydrogel. In addition, fibrinogen has been shown to 
regulates fibroblast cell functions such as; (i) αvβ3 integrin receptor binds to Aα572-574 recognition site for 
cell adhesion and spreading, (ii) calreticulin receptor binds to Bβ chain of fibrinogen for cell proliferation, 
(iii) ICAM-1 receptor binds to γ117-133 for cell adhesion, (iv) the cleavage products of fibrinogen including 
fibrinopeptides A and B regulate fibroblast proliferation(37), and (v) Aα and Bβ chains of fibrinogen 
stimulate proliferation(154). Therefore, it is possible to enhance dental pulp cell response by increasing 
fibrinogen concentration within PEG-fibrinogen hydrogel. 
4.1.2 Objectives 
The objective of this study is to evaluate the effect of fibrinogen concentration within PEG-
fibrinogen to human dental pulp cell response over time. It is anticipated that increasing fibrinogen 





4.2 Materials and Methods 
4.2.1 Cells and Cell Culture 
Human dental pulp cells were isolated from 6 intact molars of a healthy 19-year-old male (College 
of Dental Medicine, Columbia University, NY) by cellular outgrowth according to published 
protocols(155;156). Briefly,  four pulp tissues (2x2x1 mm fragments) were placed in 75cm2 tissue culture 
plate (Corning,Tewksbury,MA) with 7 ml of fully supplemented medium (F/S medium), consisting of 
Dulbecco’s modified Eagle’s medium (DMEM, Cellgro-Mediatech, Manassas, VA), 10% fetal bovine 
serum (FBS, Atlanta Biologicals, Atlanta, GA), 0.1% amphotericin B (AMP-B, Cellgro-Mediatech, 
Manassas, VA), 1% penicillin streptomycin (P/S, Cellgro-Mediatech, Manassas, VA), 0.1% gentamicin 
(Cellgro-Mediatech, Manassas, VA), 1% non-essential amino acids (NEAA, Cellgro-Mediatech, 
Manassas, VA) and maintained under humidified conditions at 37ºC and 5% CO2 until outgrowth cells 
reach confluence. Once confluence was reached, the pulp tissues were removed and plated on new 
tissue culture plates.  First migration cells were discarded. Only second and third migration cells were 
used for all subsequent analysis. Briefly, medium was removed from plates, and the plates were washed 
thoroughly with 15ml phosphate buffered saline (PBS, Sigma-Aldrich, St.Louis, MO). Trypsin (Cellgro-
Mediatech, Manassas, VA) 5 ml was added per plate and incubated for 3 minutes. F/S medium (15 mI) 
was used to wash the plates, and the cell suspension was again collected.  The plates were also washed 
with PBS to make sure all the cells have been collected.  The cell suspension was then centrifuged at 
4,000 rpm for 10 minutes, and 10 ml fresh F/S medium was added to the cell pellet.  The cells were 
counted by diluting (1:10) the cell suspension with trypan blue (Cellgro-Mediatech, Herndon, VA) and 
using a hemacytometer. Cells were continuously passaged at a 1:3 ratio when confluence until passage 4 
and kept frozen in liquid nitrogen. 
4.2.2 PEG-fibrinogen Synthesis 
PEG-fibrinogen was synthesized according to Almany et al. (2005)(2). Briefly, PEGDA molecules 
were attached to the 29 cysteines (HO2CCH(NH2)CH2SH)  residue in the sequence of the fibrinogen 
protein by Michael-type reaction. First, 48.9 mg of tris (2-carboxyethyl) phosphine hydrochloride (TCEP 
HCl, 4x excess, Sigma-Aldrich, St.Louis, MO) was added to 71 ml of a 7 mg/ml solution of fibrinogen (I-S 




min at room temperature to fully dissolve. After dissolution, the solution was adjusted to pH 8, then adds 
12.2 ml of a 280 mg/ml solution of PEGDA (4x excess, 10 kDa, provided from Dr.Seliktar) in 50mM PBS 
and 8M urea and reacted for 3 hours in the dark at room temperature. PBS with 8M urea (84 ml) was 
added after the reaction and the final PEG-fibrinogen product was precipitated in 4X excess acetone at 
20ºC for 10 minutes in separatory funnel. The precipitated solution was homogenized and centrifuged for 
1 minute at 2,500 RPM (Fisher Scientific) and the pellet was dissolved to approximately 20 mg/ml protein 
concentration in 50mM PBS and 8M urea. The PEG-fibrinogen product solution was dialyzed against 2 
liters of 50mM PBS at 4ºC for 2 days with twice-daily changes of PBS (6–8 kDa MW cutoff, Fisher 
Scientific). The dialyzed product was kept frozen at -30ºC. The net fibrinogen concentration was 
determined using a standard BCATM Protein Assay (Thermo Scientific). 
4.2.3 PEG-fibrinogen Hydrogels Fabrication, Characterization, and Culture 
PEG-fibrinogen hydrogels were made according to Dikovsky et al. (2006)(43). Briefly, PEG-
fibrinogen hydrogel are made from a precursor solution of PEGylated by a radical chain polymerization 
reaction of acrylate end groups. Additional PEGDA (10 kDa) was added to increase cross-linking density 
of the PEGylated protein network as well as to minimize steric hindrances that may result in poor gelation. 
Total PEGDA concentration (32.92 mg/ml) was the same for all groups. PEG-fibrinogen precursor 
solution (7.7, 8.5, and 9 mg/ml fibrinogen ,10 kDa) was mixed with additional of 19.75, 18.39, and 17.53 
mg/ml PEGDA, respectively (10 kDa, provided from Dr.Seliktar) and 0.1% (v/v) photoinitiator stock 
solution made of 10% w/v Irgacure®2959 (Ciba Specialty Chemical Corp., Tarrytown, NY) in 70% ethanol 
and deionized water. PEG-fibrinogen hydrogels were made from 100 µl aliquots in a flat bottom 96-assay 
plate (Corning, Corning, NY). The solution was placed under a UV light (365 nm, 730 µW/cm2, Cole-
Parmer, IL) for 5 min to polymerize. Cell seeded hydrogels were polymerized in the presence of passage 
6 from 2nd migration human dental pulp cells at 4.8 million cells/ml. PEG-fibrinogen cellular constructs as 
well as monolayer (25% confluence) were cultured in 24 well-plates under humidified conditions at 37ºC 
and 5% CO2 with 2 ml of F/S DMEM medium. The media was changed every other day and freshly 
supplemented with 50 µg/ml ascorbic acid. The experimental groups consisted of cells in PEG-fibrinogen 




In this study, human dental pulp cell responses in the PEG-fibrinogen hydrogels were evaluated 
during six weeks of culture.  Specifically, (i) cell viability, (ii) cell morphology, (iii) proliferation, (v) 
mineralization, (vi) collagen production, and (v) gene expression were determined and compared 
between groups as well as over time.  In addition, hydrogel diameter was measured over time with a 
stereomicroscope (Bausch and Lomb) using Image J, then samples was weighed and desiccated for 24 
hours (CentriVap Concentrator, Labconco Co., Kansas City, MO), after which the scaffold swelling ratio 
(n=6, wet weight/dry weight) was calculated.   
4.2.4 Cell Viability and Morphology 
Cell viability (n = 2) was visualized using Live/Dead staining (Molecular Probes, Eugene, OR), 
following the manufacturer’s suggested protocol. After washing in PBS, samples were visualized under 
confocal microscope (Olympus Fluoview FV1000, Center Valley, PA) at 473 nm excitation/ 519nm 
emission wavelengths for FITC and 559 nm excitation/ 612 nm emission for Texas Red. In addition, 
overall matrix deposition and cell morphology were determined histologically with hematoxylin and eosin 
staining of paraffin embedded.   
4.2.5 Cell Proliferation 
Cell proliferation (n=6) was determined using the PicoGreen® total DNA assay (Molecular 
Probes, Eugene, OR).  Briefly, samples were first rinsed with PBS and 500 μl of 0.1% Triton-X solution 
(Sigma-Aldrich, St.Louis, MO) was used to lyse the cells.  An aliquot of the sample (25 μl) was then 
added to 175 μl of the PicoGreen® working solution.  Fluorescence was measured with a microplate 
reader (Tecan, Research Triangle Park, NC), at the excitation and emission wavelengths of 485 and 535 
nm, respectively.  Total cell number was obtained by converting the amount of DNA per sample to cell 
number using the conversion factor of 8 pg DNA/cell. 
4.2.6 Mineralization 
Mineralization potential was determined by measuring ALP activity (n=6) using a colorimetric 
assay based on the hydrolysis of p-nitrophenyl phosphate (pNPP) to p-nitrophenol (pNP)(142).  Briefly, 
samples were lysed in 0.1% Triton-X solution, then added to pNPP solution (Sigma-Aldrich, St.Louis, MO) 
and allowed to react for 30 min at 37°C. The reaction was terminated with 0.1 N NaOH (Sigma-Aldrich, 




Research Triangle Park, NC). Additionally, mineral distribution (n=3) was visualized histologically for 
calcium with alizarin red staining of paraffin embedded. 
4.2.7 Collagen Deposition 
Collagen deposition (n=6) was quantified using the hydroxyproline assay based on alkaline 
hydrolysis of the tissue homogenate and subsequent determination of the free hydroxyproline in 
hydrolyzates(143). Briefly, samples were first desiccated for 24 hours and then digested for 16 hours at 
65ºC with papain (600 mg protein/ml, Sigma-Aldrich, St.Louis, MO) in 0.1 M sodium acetate (Sigma-
Aldrich, St.Louis, MO), 10 mM cysteine HCl (Sigma-Aldrich, St.Louis, MO), and 50 mM EDTA (Sigma-
Aldrich, St.Louis, MO). Samples were then hydrolyzed with 2 N NaOH for 25 minutes and chloramine-T 
(Sigma) was added into hydrolyzed sample to oxidize the free hydroxyproline for the production of a 
pyrrole at room temperature for 25 minutes. Then, Ehrlich's reagent (Sigma-Aldrich, St.Louis, MO) was 
added to the products and incubated at 65ºC for 20 minutes resulting in the formation of a chromophore. 
The solution was transferred to 96-well plate and sample absorbance was measured at 555 nm using a 
microplate reader (Tecan, Research Triangle Park, NC).  
Additionally, samples were fixed with 4% paraformaldehyde for 3 hours and were embedded with 
paraffin. Collagen distribution (n=3) was visualized histologically with picrosirius red staining. Deposition 
of collagen I and collagen III (n = 2) was evaluated using immunohistochemistry.  After rehydration, 
samples were incubated with primary antibody (collagen I or collagen III (1:100 dilution, Abcam)) 
overnight. Then, a FITC-conjugated secondary antibody (1:200 dilution, Abcam) was added and 
incubated for 1 hour. Finally, samples were stained with DAPI staining. Sections were visualized under 
confocal microscopy at excitation and emission wavelengths of 488 nm and 568 nm, respectively. 
4.2.8 Gene Expression 
The expression of dentin sialophosphoprotein (DSPP) and alkaline phosphatase (ALP) were 
determined using reverse transcription followed by polymerase chain reaction (RT-PCR). Total RNA of 
dental pulp cells was isolated using the TRIzol® (Invitrogen, Carlsbad, CA) extraction method, with the 
isolated RNA reverse-transcribed into cDNA using the SuperScript III First-Strand Synthesis System 
(Invitrogen).  The cDNA product was then amplified for 40 cycles with recombinant Platinum Taq DNA 




by ethidium-bromide staining. Expression band intensities of relevant genes were analyzed semi-
quantitatively by ImageJ and normalized to the housekeeping gene human glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH).  The olignonucleiotide primer sequences are: GAPDH (target size, 177bp) 5’-
ATCATCCCTGCCTCTACTGG-3’ (sense), 5’-CTGCTTCACCACCTTCTTGA-3’ (antisense); DSPP (target 
size, 172bp) 5’-AGCCGAGGAGATGCTTCTTA-3’ (sense), 5’-TGCCACTGTCTGATTTGTCA-3’ 
(antisense). ALP (target size, 205bp) 5’-AGCTGAACAGGAACAACGTG-3’ (sense), 5’-
GTGGTCAATTCTGCCTCCTT-3’ (antisense). 
4.2.9 Statistical Analysis 
Results are presented in the form of mean ± standard deviation, with n equal to the number of 
samples analyzed.  Two-way analysis of variance (ANOVA) was performed on all quantitative data to 
determine effects of fibrinogen concentration and time on cell response (proliferation, mineralization, 
collagen deposition, and gene expression), as well as hydrogel parameters (diameter, weight, and 
swelling ratio).  The Tukey–Kramer post-hoc test was used for all pair-wise comparisons, and statistical 
significance was attained at p<0.05.  All statistical analyses were performed using the JMP IN software 
(4.0.4, SAS Institute, Cary, NC). 
4.3 Results 
4.3.1 Scaffold Characterization  
Gel diameter increased significantly on day 28 for all groups except in 9 mg/ml fibrinogen group 
(Figure 4.1A-B). Gel wet weight significantly increased on day 21 and decreased on day 42 for all groups 
(Figure 4.1C). Gel dry weight significantly decreased on day 42 for all groups (Figure 4.1D). Gel swelling 
ratio changed overtime. Specially, swelling ratio of the highest fibrinogen concentration group was 
significantly lower than the lowest fibrinogen concentration group on day 42 (Figure 4.1E). 
4.3.2 Cell Viability, Morphology, and Proliferation 
Cells were viable in PEG-fibrinogen hydrogels over the 42 day culture period. Changes in cell 
morphology and spreading were found over time for all groups in live and dead staining as well as in 
hematoxylin and eosin staining (Figure 4.2A). Interestingly, cell network was densest in the group with the 




significantly on day 7 and 21 except in the 9 mg/ml group. By day 42, cell number in the 9 mg/ml group 
was the highest and it increased significantly over time (Figure 4.2B). 
4.3.3 Cell Biosynthesis 
ALP activity increased overtime for cells cultured in PEG-fibrinogen hydrogels (Figure 4.3A). The 
highest ALP activity was detected in the 9 mg/ml group on both day 28 and 42. However, alizarin red 
staining showed no mineral deposition in all groups overtime (Figure 4.3A). A significant increase in 
collagen content was found for all groups over time as confirmed by picrosirius red staining. Interestingly, 
collagen production was observed earlier, and overall was higher per cell in the higher fibrinogen 
concentration group (Figure 4.3B). Immunohistochemical staining on day 42 showed that cells produced 
both collagen I and collagen III in the PEG-fibrinogen hydrogel (Figure 4.3C).  
4.3.4 Gene Expression 
Both dentin sialophosphoprotein and ALP gene expression of cells cultured in PEG-fibrinogen 
with lowest fibrinogen concentration were down regulated compared to monolayer on day 7 (Figure 4.4). 
4.4 Discussion  
As a result of increasing fibrinogen in PEG-fibrinogen hydrogel, (i) the cells form denser 
interconnected networks since increasing fibrinogen concentration results in more integrin binding sites 
and other active sites for fibroblasts to attach to, including αvβ3 integrin receptor which binds to Aα572-
574 recognition site and ICAM-1 receptor which binds to γ117-133 site (37), (ii) cell proliferation was 
enhanced, as Aα and Bβ chains of fibrinogen, previously shown to stimulate fibroblasts proliferation(154) 
and the cleavage products of fibrinogen and regulate cell proliferation including fibrinopeptides A and B, 
as well as partially degraded fibrinogen products released following cleavage by thrombin, are mitogens 
for fibroblasts in vitro and therefore may provide an early stimulus for proliferation, and (iii) collagen 
production, cell mineralization potential, and gel stiffness also increased, likely due to the increased 
density of bioactive sites for cellular interaction(40), 
4.5 Conclusions 
These results demonstrated that the PEG-fibrinogen hydrogel is a promising scaffold for dental 




Future studies will focus on further scaffold optimization including photoinitiator and PEGDA 




Figure 4.1: Gel Diameter, Wet Weight, Dry 
Weight, and Swelling Ratio of PEG-fibrinogen 
hydrogels over time. (A-B) Gel diameter increased 
significantly on day 28 for all groups except in 9 
mg/ml fibrinogen group. (scale = 1 mm). (C) Gel wet 
weight significantly increased on day 21 and 
decreased on day 42 for all groups. (D) Gel dry 
weight significantly decreased on day 42 for all 
groups. (E) Swelling ration in the highest fibrinogen 
was significantly lower than the lowest on day 42. 
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Figure 4.2: (A) Cell Viability and Morphology of human dental pulp cells seeded within PEG-
fibrinogen hydrogels over time. Cells were viable in PEG-fibrinogen hydrogels over 42 days culture 
period. Changes in cell morphology and spreading were found over time for all groups in live and 
dead staining as well as in hematoxylin and eosin staining. The cell network was densest in the group 
with the highest fibrinogen concentration on day 42. (n=2, 10x, scale = 300 µm) (B) Cell Proliferation 
within PEG-fibrinogen hydrogels over time. Cell number in all PEG-Fibrinogen groups decreased 
significantly on day 7 and stabilized overtime. By day 42, cell number in the 9 mg/ml group was the 
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Figure 4.3: Cell Mineralization and Collagen Deposition within PEG-fibrinogen and PEGDA 
overtime. (A) ALP activity increased overtime for cells cultured in PEG-Fibrinogen hydrogels. The 
highest ALP activity was detected in the 9 mg/ml group on both day 28 and 42. (n=6, *,^p<0.05)  
However, alizarin red staining (top) showed no calcium staining in all groups overtime. (n=3, 10x, 
scale = 200 µm) (B) A significant increase in collagen content was found for all groups over time as 
confirmed by picrosirius red staining (middle, n=3, 10x, scale = 200 µm). Interestingly, there was an 
earlier and higher collagen production per cell for higher fibrinogen concentration group. (n=6,*, 
^p<0.05) (C) Immunohistochemical staining on day 42 (bottom) showed that cells produced both 
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Figure 4.4: ALP and DSPP Gene Expression of cells within PEG-fibrinogen on day 7 and day 28. 
Both dentin sialophosphoprotein (DSPP) and ALP gene expression of cells cultured in PEG-fibrinogen 






























































CHAPTER 5: EFFECT OF PHOTOINITIATIOR 
CONCENTRATION IN PEG-FIBRINOGEN 

















 In Chapter 4, we optimized fibrinogen concentration in PEG-fibrinogen and showed that 9 mg/ml 
concentration enhance cell proliferation, mineralization, and collagen deposition. However, cell number 
still decreased significantly at early time point. Studies showed that free radicals from photoinitiator may 
cause cytotoxic effects to cells. Therefore, this study will evaluate the effect of photoinitiator concentration 
on dental pulp cell response over time. 
5.1.1 Background and Motivation 
One of the advantages of the PEG-fibrinogen hydrogel is that it is able to crosslink in situ, with 
fast reaction rates via a radical chain polymerization (photopolymerization). This reaction uses a 
photoinitiator to absorb UV light and produce radicals to initiate a hydrogel network formation between 
unreacted acrylates on PEGDA (2;139). However, the free radicals from the photoinitiator may cause cell 
damage, affecting cell proliferation and differentiation. This cytotoxic effect depends on photoinitiator type, 
cell types, crosslinking time, and UV light irradiation(47;144;146-148). The photoinitiator 2-hydroxy-1-[4-
(hydroxyethoxy)phenyl]-2-methyl-1-propanone (Irgacure®2959) is used due to its moderate water 
solubility, stability, and lower cytotoxicity among other commercially available photoinitiators.   
Photoinitiators also play an important role in PEG-fibrinogen hydrogel crosslinking density and 
mechanical properties. Mironi-Harpaz et al. (2012) demonstrated that there is an optimal photoinitiator 
concentration for maximum gel shear modulus, and that increasing photoinitiator concentration will 
decrease hydrogel crosslinking time(47). Therefore, it is important to balance hydrogel properties with cell 
cytotoxicity. 
5.1.2 Objectives 
The objective of this study is to evaluate the effect of photoinitiator concentration to human dental 
pulp cell response and hydrogel mechanical properties over time. It is anticipated that optimized 
photoinitiator concentration within PEG-fibrinogen hydrogel will enhance hydrogel mechanical properties 
and degradation and at the same time, support human dental pulp cell phenotypic response including 




5.2 Materials and Methods 
5.2.1 Cells and Cell Culture 
Human dental pulp cells were isolated from 7 third molars of healthy 19 and 24 years old male 
and female (College of Dental Medicine, Columbia University, NY) by cellular outgrowth according to 
published protocols(155;156). Briefly,  four pulp tissues (2x2x1 mm fragments) were placed in 75cm2 
tissue culture plate (Corning,Tewksbury,MA) with 7 ml of fully supplemented medium (F/S medium), 
consisting of Dulbecco’s modified Eagle’s medium (DMEM, Cellgro-Mediatech, Manassas, VA), 10% fetal 
bovine serum (FBS, Atlanta Biologicals, Atlanta, GA), 0.1% amphotericin B (AMP-B, Cellgro-Mediatech, 
Manassas, VA), 1% penicillin streptomycin (P/S, Cellgro-Mediatech, Manassas, VA), 0.1% gentamicin 
(Cellgro-Mediatech, Manassas, VA), 1% non-essential amino acids (NEAA, Cellgro-Mediatech, 
Manassas, VA) and maintained under humidified conditions at 37ºC and 5% CO2 until outgrowth cells 
reach confluence. Once confluence was reached, the pulp tissues were removed and plated on new 
tissue culture plates.  First migration cells were discarded. Only second and third migration cells were 
used for all subsequent analysis. Briefly, medium was removed from plates, and the plates were washed 
thoroughly with 15ml phosphate buffered saline (PBS, Sigma-Aldrich, St.Louis, MO). Trypsin (Cellgro-
Mediatech, Manassas, VA) 5 ml was added per plate and incubated for 3 minutes. F/S medium (15 mI) 
was used to wash the plates, and the cell suspension was again collected.  The plates were also washed 
with PBS to make sure all the cells have been collected.  The cell suspension was then centrifuged at 
4,000 rpm for 10 minutes, and 10 ml fresh F/S medium was added to the cell pellet.  The cells were 
counted by diluting (1:10) the cell suspension with trypan blue (Cellgro-Mediatech, Herndon, VA) and 
using a hemacytometer. Cells were continuously passaged at a 1:3 ratio when confluent until passage 4 
and kept frozen in liquid nitrogen. 
5.2.2 PEG-fibrinogen Hydrogels Fabrication, Characterization, and Culture 
PEG-fibrinogen hydrogels were made according to Dikovsky et al. (2006)(43). Briefly, PEG-
fibrinogen precursor solution in 50 mM PBS (Sigma, St. Louis, MO) (9 mg/ml fibrinogen, 10 kDa, provided 
from Dr.Dror Seliktar, Technion-Israel Institute of Technology, Haifa, ISRAEL) was mixed with 19.75 
mg/ml PEGDA in PBS (10 kDa, provided from Dr.Dror Seliktar) and photoinitiator stock solution at three 




Specialty Chemical Corp., Tarrytown, NY) in 70% ethanol and deionized water. PEG-fibrinogen hydrogels 
were made from 100 µl aliquots in a flat bottom 96-assay plate (Corning, Corning, NY). The solution was 
placed under a UV light (365 nm, 730 µW/cm2, Cole-Parmer, IL) for 5 min to polymerize. Cell seeded 
hydrogels were polymerized in the presence of passage 4 from 3rd migration human dental pulp cells at 
4.8 million cells/ml. PEG-fibrinogen cellular constructs as well as monolayer (25% confluence) were 
cultured in 24 well-plates under humidified conditions at 37ºC and 5% CO2 with 1.5 ml of F/S DMEM 
medium. The media was changed every other day and freshly supplemented with 50 µg/ml ascorbic acid. 
The experimental groups consisted of cells in PEG-fibrinogen hydrogels at different photoinitiator 
concentration, whereas the control group included monolayer. 
In this study, hydrogel mechanical properties and human dental pulp cell responses in the PEG-
fibrinogen hydrogels were evaluated over six weeks of culture.  Specifically, (i) gel young’s modulus (ii) 
gel storage modulus, (iii) cell viability, (iv) proliferation, (v) mineralization, and (vi) collagen deposition 
were determined and compared between groups as well as over time. In addition, hydrogel diameter was 
measured, then samples was weighed and desiccated for 24 hours (CentriVap Concentrator, Labconco 
Co., Kansas City, MO), after which the scaffold swelling ratio (n=6, wet weight/dry weight) was calculated. 
5.2.3 Hydrogel Rheological Characterization 
Hydrogel mechanical properties (n = 5) were determined according to published 
protocols(157;158) using a strain-controlled rheometer (ARES,TA Instruments, New Castle, DE). Briefly, 
hydrogels diameter (d) was measured using a vernier caliper and placed between two flat porous patterns 
using 2.5g tare load. The equilibrium compressive Young’s modulus (Eeq) of the sample was calculated 
using 50 sec of the measurement at the equilibrium.  
The equilibrium compressive Young’s modulus (Eeq) of the sample was calculated at 15% 
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The dynamic frequency-sweep test was done with a frequency range of 0.1–10Hz up to 15% maximum 




5.2.4 Cell Viability and Morphology 
Cell viability and morphology (n=2) was visualized using Live/Dead staining (Molecular Probes, 
Eugene, OR), following the manufacturer’s suggested protocol. After washing in PBS, samples were 
visualized under confocal microscope (Olympus Fluoview FV1000, Center Valley, PA) at 473 nm 
excitation/ 519nm emission wavelengths for FITC and 559 nm excitation/ 612 nm emission for Texas 
Red.  
5.2.5 Cell Proliferation 
Cell proliferation (n=6) was determined using the PicoGreen® total DNA assay (Molecular 
Probes, Eugene, OR).  Briefly, samples were first rinsed with PBS and 500 μl of 0.1% Triton-X solution 
(Sigma-Aldrich, St.Louis, MO) was used to lyse the cells.  An aliquot of the sample (25 μl) was then 
added to 175 μl of the PicoGreen® working solution.  Fluorescence was measured with a microplate 
reader (Tecan, Research Triangle Park, NC), at the excitation and emission wavelengths of 485 and 535 
nm, respectively.  Total cell number was obtained by converting the amount of DNA per sample to cell 
number using the conversion factor of 8 pg DNA/cell. 
5.2.6 Mineralization 
Mineralization potential was determined by measuring ALP activity (n=6) using a colorimetric 
assay based on the hydrolysis of p-nitrophenyl phosphate (pNPP) to p-nitrophenol (pNP)(142).  Briefly, 
samples were lysed in 0.1% Triton-X solution, then added to pNPP solution (Sigma-Aldrich, St.Louis, MO) 
and allowed to react for 30 min at 37°C. The reaction was terminated with 0.1 N NaOH (Sigma-Aldrich, 
St.Louis, MO), and sample absorbance was measured at 415 nm using a microplate reader (Tecan, 
Research Triangle Park, NC). Additionally, samples were fixed with 4% paraformaldehyde for 48 hours, 
embedded with paraffin, and mineral distribution (n=3) was visualized histologically for calcium with 
alizarin red staining. 
5.2.7 Collagen Deposition 
Collagen deposition (n=6) was quantified using hydroxyproline assay based on alkaline 
hydrolysis of the tissue homogenate and subsequent determination of the free hydroxyproline in 
hydrolyzates(143). Briefly, samples were first desiccated for 24 hours and then digested for 16 hours at 




Aldrich, St.Louis, MO), 10 mM cysteine HCl (Sigma-Aldrich, St.Louis, MO), and 50 mM EDTA (Sigma-
Aldrich, St.Louis, MO). Samples were then hydrolyzed with 2 N NaOH for 25 minutes and chloramine-T 
(Sigma-Aldrich, St.Louis, MO) was added into hydrolyzed sample to oxidize the free hydroxyproline for 
the production of a pyrrole at room temperature for 25 minutes. Then, Ehrlich's reagent (Sigma-Aldrich, 
St.Louis, MO) was added to the products and incubated at 65ºC for 20 minutes resulting in the formation 
of a chromophore. The solution was transferred to 96-well plate and sample absorbance was measured 
at 555 nm using a microplate reader (Tecan, Research Triangle Park, NC). Additionally, samples were 
fixed with 4% paraformaldehyde for 48 hours, embedded with paraffin, and collagen distribution (n=3) 
was visualized histologically with picrosirius red staining.  
5.2.8 Statistical Analysis 
Results are presented in the form of mean ± standard deviation, with n equal to the number of 
samples analyzed.  Two-way analysis of variance (ANOVA) was performed on all quantitative data to 
determine effects of photoinitiator concentration and time on cell response (proliferation, mineralization, 
and collagen deposition), as well as hydrogel characterization (young’s modulus, shear modulus, 
diameter, weight, and swelling ratio).  The Tukey–Kramer post-hoc test was used for all pair-wise 
comparisons, and statistical significance was attained at p<0.05.  All statistical analyses were performed 
using the JMP IN software (4.0.4, SAS Institute, Cary, NC). 
5.3 Results 
5.3.1 Scaffold Characterization  
 Hydrogel diameter significantly increased on day 42 for all groups and was significantly larger in 
0.3% photoinitiator group compared to 0.1% photoinitiator group as confirmed with hydrogel images 
shown in Figure 5.1 A&E. Gel wet weight significantly increased over time for all groups and was 
significantly higher in 0.3% photoinitiator group compared to 0.1% group photoinitiator over time (Figure 
5.1B). Gel dry weight significantly decreased on day 21 for 0.3% photoinitiator group and day 42 for 0.1% 
and 0.2% photoinitiator groups (Figure 5.1C). Swelling ratio significantly increased over time for all groups 





Gel young’s modulus decreased significantly over time for all groups and there was no difference 
between groups (Figure 5.2A). Gel storage modulus decreased significantly over time for all groups and 
storage modulus of 0.1% photoinitiator hydrogel group was significantly lower than others on day 1 
(Figure 5.2B). 
5.3.2 Cell Viability, Morphology, and Proliferation 
Live and dead staining (Figure 5.3A) showed that cells were viable in PEG-fibrinogen hydrogels 
over 42 days culture period for all groups. However, there was less viable cells within PEG-fibrinogen with 
0.3% photoinitiator on day 1 compared to other groups. Changes in cell morphology and spreading were 
found over time for all groups. The cell network was densest in the group with 0.1% photoinitiator 
concentration on day 42. On day 1, cell number was lower with higher photoinitiator concentration. Cell 
number in all groups decreased significantly on day 7 and stabilized overtime. By day 42, cell number in 
the 0.1% photoinitiator group was the highest and it increased significantly over time (Figure 5.3B). 
5.3.3 Cell Biosynthesis 
ALP activity increased on day 7 for all groups and on day 21 for 0.1% and 0.2% photoinitiator 
groups. However, alizarin red staining showed no calcium staining in all groups overtime (Figure 5.4A). 
Collagen content remained stable over time for all groups. In addition, collagen content in 0.1% 
photoinitiator hydrogel group was significantly higher than 0.3% photoinitiator group over time as 
confirmed by picrosirius red staining (Figure 5.4A). 
5.4 Discussion 
Photopolymerization of hydrogel has been used in tissue engineering as it is able to crosslink in 
situ, with fast reaction rates. However, there are important factors that have to investigate and optimize as 
studies have been shown that these factors are critical to hydrogel network formation and cell response. 
In this study, the effect of photoinitiator concentration in PEG-fibrinogen hydrogel to human dental pulp 
cell response and hydrogel mechanical properties was evaluated. As a result of increasing photoinitiator 
(Irgacure®2959) concentration, gel storage modulus increased indicating higher crosslinking density 
based on the assumption that the maximum shear storage modulus of the hydrogel is proportional to the 
crosslinking density of the hydrogel(47;159). To illustrate, increasing photoinitiator concentration increase 




Decrease in cell number on day 1 between groups demonstrates that the photoinitiator 
(Irgacure®2959) is cytotoxic to human dental pulp cell in PEG-fibrinogen hydrogel at high concentration 
(0.2% and 0.3%) due to higher radical and by-product formation. This result is in agreement with Williams 
et al. (2005) and Sabnis et al. (2009) which relative cell survival decreased at higher photoinitiator 
concentration(146;148). In addition, collagen content in hydrogel was lower in 0.2% and 0.3% 
photoinitiator groups due to lower cell network formation, thus less bioactive sites for cellular 
interaction(40) 
 5.5 Conclusions 
This study focuses on the investigation of the effect of photoinitiator concentration on hydrogel 
properties and HDPC response over time. The result demonstrated that increasing photoinitiator 
concentration increase PEG-fibrinogen hydrogel network formation but adversely affect HDPC viability, 
proliferation, and collagen deposition over time. Therefore, the optimized photoinitiator (Irgacure®2959) 
concentration for PEG-fibrinogen formation that is suitable for HDPC culture is 0.1% w/v. Future studies 
will focus on further scaffold optimization including PEGDA concentration in order to balance hydrogel 















































































































Figure 5.1: Gel Diameter, Wet Weight, Dry Weight, and 
Swelling Ratio of PEG-fibrinogen hydrogels over time. Number 
represents percent of photoinitiator used for PEG-fibrinogen 
polymerization. (A) Gel diameter significantly increased on day 
42 for all groups and was significantly higher in 0.3% 
photoinitiator group compared to 0.1% group. (B) Gel wet weight 
significantly increased over time for all groups, Wet weight of 
1%photoinitiator group was significantly lower than 0.3% groups 
over time. (C) Gel dry weight significantly decreased on day 21 
for 0.3% group and day 42 for 0.1% and 0.2% groups. (D) 
Swelling ratio significantly increased over time for all groups. 
Swelling ratio of 0.3%photoinitiator group was significantly higher 
than others on day 28 and 42. (E) Images of PEG-fibrinogen 



























































Figure 5.2: Gel Young’s Modulus and Storage Modulus (G’) of PEG-fibrinogen hydrogels over 
time. (A) Gel young’s modulus decreased significantly over time for all groups and there was no 
difference between groups. (B) Gel storage modulus decreased significantly over time for all groups 
and storage modulus of 0.1% photoinitiator hydrogel group was significantly lower than others on day 



















































Figure 5.3: (A) Cell Viability of human 
dental pulp cells seeded within PEG-
fibrinogen hydrogels over time. Cells were 
viable in PEG-fibrinogen hydrogels over 42 
days culture period for all groups. However, 
there was less viable cells within PEG-
fibrinogen with 0.3% photoinitiator on day 1 
and day 42 compared to other groups. 
Changes in cell morphology and spreading 
were found over time for all groups. The cell 
network was densest in the group with 0.1% 
photoinitiator concentration on day 42. (n=2, 
10x, scale = 300 µm) (B) Cell Proliferation 
within PEG-fibrinogen hydrogels over time. 
Cell number in all groups decreased 
significantly on day 7 and stabilized overtime. 
By day 42, cell number in the 0.1% 
photoinitiator group was the highest and it 





















Figure 5.4: Cell Mineralization and Collagen Deposition within PEG-fibrinogen overtime. (A) ALP 
activity increased on day 7 for all groups and on day 21 for 0.1% and 0.2% photoinitiator groups. 
(n=6, *,^p<0.05) However, alizarin red staining showed no calcium staining in all groups overtime. 
(n=3, 20x, scale = 300 µm) (B) Collagen content remained stable over time for all groups. Collagen 
content in 0.1% photoinitiator hydrogel group was significantly higher than 0.3% photoinitiator group 
over time. (n=6, *,^p<0.05) The result was confirmed by picrosirius red staining. (n=3, 20x, scale = 









































































CHAPTER 6: EFFECT OF PEGDA 
CONCENTRATION IN PEG-FIBRINOGEN 
















 In Chapter 5, we optimized photoinitiator concentration in PEG-fibrinogen and showed that 0.1% 
w/v concentration is an optimal concentration that supports dental pulp cell response. In this study, we 
further optimized PEGDA concentration within PEG-fibrinogen hydrogel in order to enhance dental pulp 
cell phenotypic response and hydrogel degradation and mechanical properties over time. 
6.1.1 Background and Motivation 
Several studies have shown that increasing PEGDA content in PEG-fibrinogen will increase 
hydrogel crosslinking density which results in enhanced hydrogel mechanical properties and decreased 
rate of gel degradation(45;46;160). However, increasing PEGDA concentration also affects cell response 
and cell spreading does not occur at high PEGDA concentration(43). Therefore, it is necessary to 
maintain the balance between cell-mediated matrix deposition and scaffold degradation(46;161) avoids 
loss of structural integrity before the cells have had a chance to make their own matrix.   
6.1.2 Objectives 
The purpose of this study is to evaluate the effect of PEGDA cross-linker concentration on human 
dental pulp cell response and hydrogel mechanical properties over time. It is anticipated that optimized 
PEGDA concentration within PEG-fibrinogen hydrogel will support human dental pulp cell phenotypic 
response including growth, differentiation, biosynthesis, and expression of dental pulp-related makers 
while balancing hydrogel degradation with structural integrity over time. 
6.2 Materials and Methods 
6.2.1 Cells and Cell Culture 
Dental pulp cells were isolated from 7 healthy third molars of 19 and 24 years old male and 
female (College of Dental Medicine, Columbia University, NY) by cellular outgrowth according to 
published protocols(155;156). Briefly,  four pulp tissues (2x2x1 mm fragments) were placed in 75cm2 
tissue culture plate (Corning,Tewksbury,MA) with 7 ml of fully supplemented medium (F/S medium), 
consisting of Dulbecco’s modified Eagle’s medium (DMEM, Cellgro-Mediatech, Manassas, VA), 10% fetal 
bovine serum (FBS, Atlanta Biologicals, Atlanta, GA), 0.1% amphotericin B (AMP-B, Cellgro-Mediatech, 
Manassas, VA), 1% penicillin streptomycin (P/S, Cellgro-Mediatech, Manassas, VA), 0.1% gentamicin 




Manassas, VA) and maintained under humidified conditions at 37ºC and 5% CO2 until outgrowth cells 
reach confluence. Once confluence was reached, the pulp tissues were removed and plated on new 
tissue culture plates.  First migration cells were discarded. Only second and third migration cells were 
used for all subsequent analysis. Briefly, medium was removed from plates, and the plates were washed 
thoroughly with 15ml phosphate buffered saline (PBS, Sigma-Aldrich, St.Louis, MO). Trypsin (Cellgro-
Mediatech, Manassas, VA) 5 ml was added per plate and incubated for 3 minutes. F/S medium (15 mI) 
was used to wash the plates, and the cell suspension was again collected.  The plates were also washed 
with PBS to make sure all the cells have been collected.  The cell suspension was then centrifuged at 
4,000 rpm for 10 minutes, and 10 ml fresh F/S medium was added to the cell pellet.  The cells were 
counted by diluting (1:10) the cell suspension with trypan blue (Cellgro-Mediatech, Herndon, VA) and 
using a hemacytometer. Cells were continuously passaged at a 1:3 ratio when confluence until passage 4 
and kept frozen in liquid nitrogen. 
6.2.2 PEG-fibrinogen Hydrogels Fabrication, Characterization, and Culture 
PEG-fibrinogen hydrogels were made according to Dikovsky et al. (2006)(43). Briefly, PEG-
fibrinogen precursor solution in 50 mM PBS (Sigma, St. Louis, MO) (9 mg/ml fibrinogen, 10 kDa, provided 
from Dr.Dror Seliktar, Technion-Israel Institute of Technology, Haifa, ISRAEL) was mixed with 0.1% w/v 
photoinitiator stock solution in 70% ethanol and three different PEGDA (10 kDa) concentration including 
10, 17.5 and 20 mg/ml (1%, 1.75%, and 2% w/v respectively) in 50 mM PBS. PEG-fibrinogen hydrogels 
were made from 100 µl aliquots in a flat bottom 96-assay plate (Corning, Corning, NY). The solution was 
placed under a UV light (365 nm, 730 µW/cm2, Cole-Parmer, IL) for 5 min to polymerize. Cell seeded 
hydrogels were polymerized in the presence of passage 4 from 3rd migration human dental pulp cells at 
4.8 million cells/ml. PEG-fibrinogen cellular constructs as well as monolayer (25% confluence) were 
cultured in 24 well-plates under humidified conditions at 37ºC and 5% CO2 with 1.5 ml of F/S DMEM 
medium. The media was changed every other day and freshly supplemented with 50 µg/ml ascorbic acid. 
The experimental groups consisted of cells in PEG-fibrinogen hydrogels at different PEGDA 
concentration, whereas the control group included monolayer. 
In this study, hydrogel mechanical properties and human dental pulp cell responses in the PEG-




gel storage modulus, (iii) cell viability, (iv) proliferation, (v) mineralization, and (vi) collagen deposition 
were determined and compared between groups as well as over time. In addition, hydrogel diameter was 
measured, then samples was weighed and desiccated for 24 hours (CentriVap Concentrator, Labconco 
Co., Kansas City, MO), after which the scaffold swelling ratio (n=6, wet weight/dry weight) was calculated. 
6.2.3 Hydrogel Rheological Characterization 
Hydrogel mechanical properties (n = 5) were determined according to published 
protocols(157;158) using a strain-controlled rheometer (ARES,TA Instruments, New Castle, DE). Briefly, 
hydrogels diameter (d) was measured using a vernier caliper and placed between two flat porous patterns 
using 2.5g tare load. The equilibrium compressive Young’s modulus (Eeq) of the sample was calculated 
using 50 sec of the measurement at the equilibrium.  
The equilibrium compressive Young’s modulus (Eeq) of the sample was calculated at 15% 




   where  𝜎 = ΔF
¶𝑑2/4
 
The dynamic frequency-sweep test was done with a frequency range of 0.1–10Hz up to 15% maximum 
strain according to published studies(42) and the storage modulus (G’) was measured at 1 Hz. 
6.2.4 Cell Viability and Morphology 
Cell viability (n = 2) was visualized using Live/Dead staining (Molecular Probes, Eugene, OR), 
following the manufacturer’s suggested protocol. After washing in PBS, samples were visualized under 
confocal microscope (Olympus Fluoview FV1000, Center Valley, PA) at 473 nm excitation/ 519nm 
emission wavelengths for FITC and 559 nm excitation/ 612 nm emission for Texas Red.  
6.2.5 Cell Proliferation 
Cell proliferation (n=6) was determined using the PicoGreen® total DNA assay (Molecular 
Probes, Eugene, OR).  Briefly, samples were first rinsed with PBS and 500 μl of 0.1% Triton-X solution 
(Sigma-Aldrich, St.Louis, MO) was used to lyse the cells.  An aliquot of the sample (25 μl) was then 
added to 175 μl of the PicoGreen® working solution.  Fluorescence was measured with a microplate 
reader (Tecan, Research Triangle Park, NC), at the excitation and emission wavelengths of 485 and 535 
nm, respectively.  Total cell number was obtained by converting the amount of DNA per sample to cell 





Mineralization potential was determined by measuring ALP activity (n=6) using a colorimetric 
assay based on the hydrolysis of p-nitrophenyl phosphate (pNPP) to p-nitrophenol (pNP)(142).  Briefly, 
samples were lysed in 0.1% Triton-X solution, then added to pNPP solution (Sigma-Aldrich, St.Louis, MO) 
and allowed to react for 30 min at 37°C. The reaction was terminated with 0.1 N NaOH (Sigma-Aldrich, 
St.Louis, MO), and sample absorbance was measured at 415 nm using a microplate reader (Tecan, 
Research Triangle Park, NC). Additionally, samples were fixed with 4% paraformaldehyde for 48 hours, 
embedded with paraffin, and mineral distribution (n=3) was visualized histologically for calcium with 
alizarin red staining. 
6.2.7 Collagen Deposition 
Collagen deposition (n=6) was quantified using hydroxyproline assay based on alkaline 
hydrolysis of the tissue homogenate and subsequent determination of the free hydroxyproline in 
hydrolyzates(143). Briefly, samples were first desiccated for 24 hours and then digested for 16 hours at 
65ºC with papain (600 mg protein/ml, Sigma-Aldrich, St.Louis, MO) in 0.1 M sodium acetate (Sigma-
Aldrich, St.Louis, MO), 10 mM cysteine HCl (Sigma-Aldrich, St.Louis, MO), and 50 mM EDTA (Sigma-
Aldrich, St.Louis, MO). Samples were then hydrolyzed with 2 N NaOH for 25 minutes and chloramine-T 
(Sigma) was added into hydrolyzed sample to oxidize the free hydroxyproline for the production of a 
pyrrole at room temperature for 25 minutes. Then, Ehrlich's reagent (Sigma-Aldrich, St.Louis, MO) was 
added to the products and incubated at 65ºC for 20 minutes resulting in the formation of a chromophore. 
The solution was transferred to 96-well plate and sample absorbance was measured at 555 nm using a 
microplate reader (Tecan, Research Triangle Park, NC). Additionally, samples were fixed with 4% 
paraformaldehyde for 48 hours, embedded with paraffin, and collagen distribution (n=3) was visualized 
histologically with picrosirius red staining.  
6.2.8 Statistical Analysis 
Results are presented in the form of mean ± standard deviation, with n equal to the number of 
samples analyzed.  Two-way analysis of variance (ANOVA) was performed on all quantitative data to 
determine effects of PEGDA concentration and time on cell response (proliferation, mineralization, and 




weight, and swelling ratio).  The Tukey–Kramer post-hoc test was used for all pair-wise comparisons, and 
statistical significance was attained at p<0.05.  All statistical analyses were performed using the JMP IN 
software (4.0.4, SAS Institute, Cary, NC). 
6.3 Results 
6.3.1 Scaffold Characterization  
Gel diameter increased significantly over time with no significant difference between groups as 
confirmed with hydrogel images shown in Figure 6.1A&E. Gel wet weight increased over time for all 
groups. In addition, wet weight of 1%PEGDA hydrogel group was significantly lower than 1.75% and 
2%PEGDA hydrogel groups over time (Figure 6.1B). Gel dry weight of 1% and 2%PEGDA groups 
significantly decreased on day 42. In addition, dry weight of 1%PEGDA group was significantly lower than 
1.75% and 2%PEGDA hydrogel groups over time (Figure 6.1C). Swelling ratio increased over time for all 
groups. Swelling ration of 1%PEGDA group was significantly lower than others on day 28 and 42 (Figure 
6.1D). Gel young’s modulus and storage modulus were higher with higher PEGDA content and 
decreased significantly over time for all groups (Figure 6.2A&B). In addition, gel storage modulus of 
1%PEGDA group was significantly lower than 1.75% and 2%PEGDA hydrogel groups on day 21 and 42. 
6.3.2 Cell Viability, Morphology, and Proliferation 
Cells were viable in PEG-fibrinogen hydrogels over 42 days culture period for all groups. 
Changes in cell morphology and spreading were found earlier in hydrogels with lower PEGDA content 
(Figure 6.3A). Cell number was lower in higher PEGDA content on day 1. In addition, cell number 
decreased significantly on day 7 and stabilized overtime in all groups. Cell number within hydrogel with 
1%PEGDA was significantly higher than cell number in 2%PEGDA group on day 21, 28, and 42 (Figure 
6.3B). 
6.3.3 Cell Biosynthesis 
ALP activity increased overtime in all groups. The lowest ALP activity was detected in the 1% 
PEGDA hydrogel group on both day 21 and 42. However, alizarin red staining showed no calcium 
staining in all groups overtime (Figure 6.4A). A significant increase in collagen content was found in the 





As a result of increasing PEGDA cross-linker concentration in PEG-fibrinogen hydrogel, (i) gel 
young’s modulus and storage modulus increased since addition of PEGDA cross-linker increase hydrogel 
crosslinking density and stiffness(45;160), (ii) cell morphology became less spindle and cell number was 
lower over time as studies showed that addition of PEGDA decreases polymer mesh size which 
decreases protease diffusion through PEG-fibrinogen hydrogel network resulting in a  lower proteolytic 
degradation rate of PEG-fibrinogen hydrogels(43), (iii) cell ALP activity and collagen content increased 
over time.  
6.5 Conclusions 
These results demonstrated that altering PEGDA cross-linker from 1% to 1.75% and 2% w/v 
affects PEG-fibrinogen stiffness, HDPC viability, morphology, proliferation, and biosynthesis and 1.75% 
w/v is an optimal additional PEGDA concentration for cell proliferation and biosynthesis. Future studies 
will evaluate efficacy of the optimized hydrogel scaffold for maintenance of the neo pulp tissue formation 






















Figure 6.1: Gel Diameter, Wet Weight, Dry Weight, and 
Swelling Ratio of PEG-fibrinogen hydrogels over time. Number 
represents the percent addition of PEGDA in the hydrogels. (A) 
Gel diameter increased significantly over time for all groups. (B) 
Gel wet weight increased over time for all groups. In addition, wet 
weight of 1%PEGDA hydrogel group was significantly lower than 
1.75% and 2%PEGDA hydrogel groups over time. (C) Gel dry 
weight of 1% and 2%PEGDA groups significantly decreased on 
day 42. In addition, dry weight of 1%PEGDA group was 
significantly lower than 1.75% and 2%PEGDA hydrogel groups 
over time. (D) Swelling ratio increased over time for all groups. 
Swelling ration of 1%PEGDA group was significantly lower than 
others on day 28 and 42. (E) Images of PEG-fibrinogen 
















































































































Figure 6.2: Gel Young’s Modulus and Storage Modulus (G’) of PEG-fibrinogen hydrogels over 
time. (A) Gel young’s modulus was higher with higher PEGDA content and decreased significantly 
over time for all groups. (B) Gel storage modulus was higher with higher PEGDA content and 

























































































1%DA 1.75%DA 2%DA 
Figure 6.3: (A) Cell Viability of human 
dental pulp cells seeded within PEG-
fibrinogen hydrogels over time. Cells were 
viable in PEG-fibrinogen hydrogels over 42 
days culture period for all groups. Changes in 
cell morphology and spreading were found 
earlier in hydrogels with lower PEGDA 
content. (n=2, 10x, scale = 300 µm) (B) Cell 
Proliferation within PEG-fibrinogen 
hydrogels over time. Cell number was lower 
in higher PEGDA content on day 1. Cell 
number decreased significantly on day 7 and 
stabilized overtime in all groups. Cell number 
within hydrogel with 1%PEGDA was 
significantly higher than cell number in 


















































Figure 6.4: Cell Mineralization and Collagen Deposition within PEG-fibrinogen and PEGDA 
overtime. (A) ALP activity increased overtime in all groups. The lowest ALP activity was detected in 
the 1% PEGDA hydrogel group on both day 21 and 42. Alizarin red staining showed no calcium 
staining in all groups overtime. (n=3, 20x, scale = 300 µm) (B) A significant increase in collagen 
content was found in the 1.75% and 2%PEGDA groups on day 42 as confirmed by picrosirius red 







































































CHAPTER 7: EFFECT OF CIPROFLOXACIN 













7.1 Introduction  
In Chapter 2-4, we optimized a scaffold for dental pulp regeneration and the results demonstrated 
that PEG-fibrinogen hydrogel is a promising scaffold for dental pulp regeneration. One of the scaffold 
design parameters for dental pulp tissue engineering is to reduce residual bacteria post-treatment. Our 
approach is to incorporate antibiotic into a scaffold in order to protect against infection while minimizing 
any adverse effect on the dental pulp cells. Therefore, we first optimized antibiotic dosage so that it did 
not adversely affect human dental pulp cell viability, growth, and phenotype response over time. 
7.1.1 Background and Motivation 
  Post-treatment bacterial infection is one of the most important aspects of endodontic treatment 
failure(9;162;163). In addition, endodontic treatment success rate is associated with residual bacterial 
infection in the root canal. Sjögren et al. (1997) found a 94% success rate with complete periapical 
healing in non-infection canal and 68% success rate in positive residual infection in root canal(164). The 
use of an antibiotic may reduce residual pulpal infection and increase the chance for successful ingrowth 
of pulp tissue. Therefore, antibiotic release system is used in this thesis. 
Ciprofloxacin is a fluoroquinolones antimicrobial agent 
(Figure 7.1) that is suitable for this approach, as it exhibits dosage-
dependent antimicrobial activity against most bacteria involved in 
pulpal infection(48) with minimal side effects(49). It exerts 
bactericidal effects by inhibiting bacterial DNA gyrase, a type II 
topoisomerase(165). It exhibits antimicrobial activity against most 
Gram-negative bacilli and cocci, but limited activity against most Gram-positive organisms. Moreover, 
Schacht et al. (1989)(49) demonstrated that this antibiotic is relatively safe, with mild side effects. In 
addition, it is a useful agent in the treatment of endodontic infections(166). However, ciprofloxacin can be 
toxic to cells via eukaryotic topoisomerases inhibition(167). This cytotoxic effect is dose-dependent, time-
dependent, and may vary based on cell type(50;168-174). Therefore, it is necessary to evaluate the dose-
dependent effects of ciprofloxacin on pulp cell response over time 







The goal of this study is to evaluate the dose-dependent effects of ciprofloxacin to human dental 
pulp response. It is anticipated that the exposure of optimized ciprofloxacin dosage will not adversely 
affect HDPC viability, growth, and phenotype response over time.   
7.2 Materials and Methods 
7.2.1 Cells and Cell Culture 
Human dental pulp cells were isolated from an intact molar of 20-year-old female (College of 
Dental Medicine, Columbia University, NY) by enzymatic digestion. Briefly, minced pulp tissues were 
digested for 45 minutes at 37ºC with 0.1% w/v collagenase type II (Sigma, St. Louis, MO) in Dulbecco’s 
modified Eagle’s medium (DMEM, Cellgro-Mediatech, Manassas, VA) supplemented with 5% fetal bovine 
serum (FBS, Atlanta Biologicals, Atlanta, GA), 2% penicillin streptomycin (P/S, Cellgro-Mediatech),  and 
0.1% amphotericin B (AMP-B, Cellgro-Mediatech). The cell suspension was then filtered (30 μm, 
Spectrum, Rancho Dominguez, CA)  before plating at 30% confluence seeding density and maintained in 
fully supplemented (F/S) DMEM with 10% FBS, 1% P/S, 0.1% AMP-B, 0.1% gentamicin (Cellgro-
Mediatech), 1% non-essential amino acids (NEAA, Cellgro-Mediatech) under humidified conditions at 
37ºC and 5% CO2. Cells were continuously passaged at a 1:3 ratio when confluent until passage 4 and 
kept frozen in liquid nitrogen. 
For the study, passage 6 human dental pulp cells were seeded at 25% confluence (50,000 cells 
per well) and cultured in 24 well-plates under humidified conditions at 37ºC and 5% CO2 with 1 ml of fully 
supplemented medium. Ciprofloxacin was dissolved in 0.9% sodium chloride (NaCl) first before mixing in 
F/S media at 1:9 ratio and media containing ciprofloxacin at different concentration including 25, 50, 100, 
and 150 µg/ml were added after 2 day of seeding. The media was collected every two days to determine 
ciprofloxacin concentration and exchange with fresh media with or without ciprofloxacin according to 
experimental groups. In this study, human dental pulp cells responses were evaluated after 1, 3, 7, and 
14 days of culture. Specifically, (i) cell viability, (ii) cell proliferation, (iv) mineralization, (v) collagen 
deposition, and (vi) human dental pulp cell related markers were determined and compared between 





7.2.2 Ciprofloxacin Concentration 
Ciprofloxacin concentration in media collected from each well (n=6) were determined by 
fluorescence spectrophotometer.  Hydrochloric acid (HCl, 100 µl, 0.5N) was added into 1 ml of sample in 
order to dissolve all ciprofloxacin precipitation. Then, samples (50 µl) were diluted with 950 µl distilled 
water before used in the assay. Diluted samples (20 µl) and 180 µl distilled water were added into 96 
well-plates. For the standard, 20µl of media with different concentration of ciprofloxacin solution (0, 0.01, 
0.05, 0.1, 0.5, 1, 5, 10, 50 µg/ml) and 180µl distilled water were added into 96 well-plates. Fluorescence 
was measured with a microplate reader (Biotek synergy 4 hybrid multimode), at the excitation and 
emission wavelengths of 278 and 465 nm, respectively. This essay was modified from Schneider et al. 
(2005) (175). 
7.2.3 Cell Viability and Morphology 
Cell viability (n = 2) was visualized using Live/Dead staining (Molecular Probes, Eugene, OR), 
following the manufacturer’s suggested protocol. After washing in PBS, samples were visualized under 
confocal microscope (Olympus Fluoview FV1000, Center Valley, PA) at 473 nm excitation/ 519nm 
emission wavelengths for FITC and 559 nm excitation/ 612 nm emission for Texas Red.  
7.2.4 Cell Proliferation 
Cell proliferation (n=6) was determined using the PicoGreen® total DNA assay (Molecular 
Probes, Eugene, OR).  Briefly, samples were first rinsed with PBS and 500 μl of 0.1% Triton-X solution 
(Sigma-Aldrich, St.Louis, MO) was used to lyse the cells.  An aliquot of the sample (25 μl) was then 
added to 175 μl of the PicoGreen® working solution.  Fluorescence was measured with a microplate 
reader (Tecan, Research Triangle Park, NC), at the excitation and emission wavelengths of 485 and 535 
nm, respectively.  Total cell number was obtained by converting the amount of DNA per sample to cell 
number using the conversion factor of 8 pg DNA/cell. 
7.2.5 Mineralization 
Mineralization potential was determined by measuring ALP activity (n=6) using a colorimetric 
assay based on the hydrolysis of p-nitrophenyl phosphate (pNPP) to p-nitrophenol (pNP)(142).  Briefly, 
samples were lysed in 0.1% Triton-X solution, then added to pNPP solution (Sigma-Aldrich, St.Louis, MO) 




Aldrich, St.Louis, MO), and sample absorbance was measured at 415 nm using a microplate reader 
(Tecan, Research Triangle Park, NC).  
7.2.6 Collagen Deposition 
Collagen deposition (n=6) was quantified using the hydroxyproline assay based on alkaline 
hydrolysis of the tissue homogenate and subsequent determination of the free hydroxyproline in 
hydrolyzates(143). Briefly, samples were first desiccated for 24 hours and then digested for 16 hours at 
65ºC with papain (600 mg protein/ml, Sigma-Aldrich, St.Louis, MO) in 0.1 M sodium acetate (Sigma-
Aldrich, St.Louis, MO), 10 mM cysteine HCl (Sigma-Aldrich, St.Louis, MO), and 50 mM EDTA (Sigma-
Aldrich, St.Louis, MO). Samples were then hydrolyzed with 2 N NaOH for 25 minutes and chloramine-T 
(Sigma) was added into hydrolyzed sample to oxidize the free hydroxyproline for the production of a 
pyrrole at room temperature for 25 minutes. Then, Ehrlich's reagent (Sigma-Aldrich, St.Louis, MO) was 
added to the products and incubated at 65ºC for 20 minutes resulting in the formation of a chromophore. 
The solution was transferred to 96-well plate and sample absorbance was measured at 555 nm using a 
microplate reader (Tecan, Research Triangle Park, NC).  
7.2.7 Human Dental Pulp Cell-related Gene Expression 
The expression of HDPC-related marker (n=3), such as collagen I, collagen III, and dentin 
sialophosphoprotein (DSPP) were determined using reverse transcription followed by polymerase chain 
reaction (RT-PCR). Total RNA of dental pulp cells was isolated using the TRIzol® (Invitrogen, Carlsbad, 
CA) extraction method, with the isolated RNA reverse-transcribed into cDNA using the SuperScript III 
First-Strand Synthesis System (Invitrogen).  The cDNA product was then amplified for 40 cycles with 
recombinant Platinum Taq DNA polymerase (Invitrogen).  PCR products were size-fractionated on a 1% 
w/v agarose gel and visualized by ethidium-bromide staining. Expression band intensities of relevant 
genes were analyzed semi-quantitatively by ImageJ and normalized to the housekeeping gene human 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH).  The olignonucleiotide primer sequences are: 
GAPDH (target size, 177bp) 5’-ATCATCCCTGCCTCTACTGG-3’ (sense), 5’-
CTGCTTCACCACCTTCTTGA-3’ (antisense); Collagen I (target size, 152bp) 5’-
GCCATCAAAGTCTTCTGCAA-3’ (sense), 5’-AACTGGAATCCATCGGTCAT-3’ (antisense); Collagen III 




(antisense); DSPP (target size, 172bp) 5’-AGCCGAGGAGATGCTTCTTA-3’ (sense),  5’-
TGCCACTGTCTGATTTGTCA-3’ (antisense). 
7.2.8 Statistical Analysis 
Results are presented in the form of mean ± standard deviation, with n equal to the number of 
samples analyzed.  Two-way analysis of variance (ANOVA) was performed on all quantitative data to 
determine effects of ciprofloxacin concentration and time on cell response (proliferation, mineralization, 
collagen deposition, and gene expression).  The Tukey–Kramer post-hoc test was used for all pair-wise 
comparisons, and statistical significance was attained at p<0.05.  All statistical analyses were performed 
using the JMP IN software (4.0.4, SAS Institute, Cary, NC). 
7.3 Results 
7.3.1. Ciprofloxacin Profile  
The ciprofloxacin in 100 and 150 μg/ml media groups was not stable after day 7 (Figure 7.2) 
because ciprofloxacin at these concentrations precipitated and this precipitation attached to the cell layer. 
7.3.2 Cell Viability and Proliferation 
Observation of live/dead images shows that cells cultured with 100 and 150 µg/ml ciprofloxacin 
were less viable over time (Figure 7.3A). This was supported by the quantitative results of the total DNA 
(Figure 7.3B), which show that cell number increased over time for all groups except for 100 and 
150μg/ml ciprofloxacin media groups. Cell number was significantly lower for 100 and150 μg/ml groups 
compared with all other groups on days 3, 7, and day 14. 
7.3.3 Cell Biosynthesis 
Cells cultured without and with ciprofloxacin mixed into supplemented media exhibited ALP 
activity on day 7 and day 14. There were significant increases in ALP activity per cell for the control, 
antibiotic-free group and for groups with 100 and 150µg/ml ciprofloxacin added to media on day 14 
(Figure 7.3C). Collagen production of human dental pulp cells in groups cultured with 25 µg/ml 
ciprofloxacin mixed in media was significantly higher when compared to other groups on both day 1 and 




7.3.4 Gene Expression 
The expression of DSPP, collagen I, and collagen III was detected in all groups. There was no 
significant difference in collagen III gene expression for cells in any groups (Figure 7.4A). Collagen I gene 
expression of cells cultured with 100 µg/ml ciprofloxacin was significantly lower than the control group, 
while DSPP gene expression was significantly higher than control group (p<0.05) (Figure 7.4B).  
7.4 Discussion 
A dose-dependent effect of ciprofloxacin on pulp cell response was observed in this study. To 
illustrate, no difference in cell number was found between 0, 25, 50 µg/ml groups and ALP activity was 
detectable in all groups up to day 14.  However, cell number decreased significantly over time with the 
addition of both 100 and 150 μg/ml ciprofloxacin.  In addition, an increase in collagen was observed in 
both control and the 25 µg/ml groups over time. Our results were in agreement with (50;169).  In both 
studies, they found that cytotoxicity was not observed in the ciprofloxacin concentration range 5-150 
µg/ml when the cells were incubated for 24 hours but marked decreases in the viability of fibroblasts were 
observed at concentrations 50 and 75 µg/ml, and >/=50 µg/ml, following 48 and 72 hours exposure, 
respectively (p < 0.05). This delayed effect was shown earlier by (173) as a usual feature of ciprofloxacin-
induced growth inhibition. The expression of this effect needed three to four cell doublings. Importantly, 
they reported that the mechanism of the observed cytotoxicity has been related to selective depletion of 
mtDNA through an interference with a mitochondrial topoisomerase II-like activity. 
7.5 Conclusions 
These results establish the existence of a dose-dependent cytotoxic effect of ciprofloxacin on 
HDPC viability, proliferation, matrix deposition, and collagen I and DSPP gene expression. In this study, a 
ciprofloxacin concentration of up to 50 µg/ml exerts no adverse effects on pulp cells. Future studies will 
incorporate ciprofloxacin in PEG-fibrinogen and determine the effect of ciprofloxacin dosage on PEG-
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Figure 7.2: Ciprofloxacin Concentration in medium overtime. When added to the media, the 
ciprofloxacin concentration of 100 and 150 µg/ml were not stable after day 7 because ciprofloxacin at 
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Figure 7.3: Cell Viability, Proliferation, ALP Activity, and Collagen Production (A) Cells cultured 
without and with 25 and 50 µg/ml ciprofloxacin were viable (green) after 14 days in culture.  Non-viable 
cells (red) were noted in cultures with ciprofloxacin 100 and 150 µg/ml after 7 days in culture.  
(n=2,10x, scale = 300 µm)(B) Cell number increased over time for control and with additional of 25 and 
50µg/ml ciprofloxacin in media groups. (C) There were significant increases in ALP activity per cell for 
control and additional of 100 and 150µg/ml ciprofloxacin in media on day 14. (D) Collagen production 
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Figure 7.4: Collagen I, Collagen III, and DSPP Gene Expression on Day 3 Collagen I gene 
expression of pulp cells cultured with 100 µg/ml ciprofloxacin on day 3 is significantly lower than 
control group. DSPP gene expression of pulp cells cultured with 100 µg/ml ciprofloxacin  is 

















CHAPTER 8: EFFECT OF CIPROFLOXACIN 
DOSAGE ON PEG-FIBRINOGEN CROSSLINKING 


















  In Chapter 7, dose-dependent effects on dental pulp cell response were evaluated and showed 
that the optimized ciprofloxacin concentration that has no adverse effect on dental pulp cell is 50 µg/ml. 
For this study, the optimized ciprofloxacin concentration was incorporated into PEG-fibrinogen hydrogels 
in order to use as a drug vehicle for vital endodontic therapy. However, addition of ciprofloxacin might 
interfere with the polymerization of the hydrogel since ciprofloxacin contains several nucleophiles. 
Therefore, dosage-dependent effects of ciprofloxacin release on dental pulp cell response and hydrogel 
stability were determined in this chapter. 
8.1.1 Background and Motivation 
Several methods are used to crosslink a hydrogel. Radical photopolymerization, which crosslinks 
liquid macromolecular precursors into a hydrogel by using a long-wave ultraviolet to activate free radical 
in order to initiate polymerization(176), is interesting for endodontic treatment because the reaction can 
be carried out in situ for a clinically acceptable curing time(47;139) at physiological temperature and pH. 
In addition, photopolymerizable hydrogels have the advantages of being able to incorporate growth 
factors, drugs, or cell suspensions into the gel network. 
Photopolymerization of PEG-fibrinogen is carried out via a photoinitiator and irradiation with a 
long-wave ultraviolet (UV) light (365nm) (2;138;139), whereby the photoinitiator molecules absorb UV 
light and dissociate into free radicals. In free radical polymerization, there are initiation and propagation 
steps. The initiation occurs when the monomer generates active center and then propagates through the 
carbon-carbon double bonds. A crosslinking network will be formed through vinyl group by radical 
propagation. The 3D hydrogel network was formed using radical chain polymerization. The ciprofloxacin 
molecule also contains many carbon-carbon double bonds(1), which might interfere with the reaction by 
reacting with free radicals, resulting in decreased hydrogel crosslinking efficiency and a loss of 
antibacterial efficacy of ciprofloxacin.     
8.1.2 Objectives 
A preliminary study showed that incorporation of ciprofloxacin in PEG-fibrinogen hydrogel 
decreased PEG-fibrinogen crosslinking density. Therefore, we first need to optimize UV exposure time 




ciprofloxacin concentrations, as hydrogel crosslinking density can be enhanced by increasing 
photoinitiator concentration and photopolymerization time(47). Next, the dose-dependent effects of 
ciprofloxacin released from PEG-fibrinogen on dental pulp cells will be evaluated. It is anticipated that the 
exposure of ciprofloxacin released from PEG-fibrinogen will not adversely affect the viability, growth, or 
phenotypic response of human dental pulp cells. 
8.2 Materials and Methods 
8.2.1 PEG-fibrinogen Synthesis 
PEG-fibrinogen was synthesized according to Almany et al. (2005)(2). Briefly, PEGDA molecules 
were attached to the 29 cysteines (HO2CCH(NH2)CH2SH)  residue in the sequence of the fibrinogen 
protein by Michael-type reaction. First, 48.9 mg of tris (2-carboxyethyl) phosphine hydrochloride (TCEP 
HCl, 4x excess, Sigma-Aldrich, St.Louis, MO) was added to 71 ml of a 7 mg/ml solution of fibrinogen (I-S 
from bovine plasma, Desert Biological) in 50mM PBS with 8M urea. The solution was left stirring for 15 
min at room temperature to fully dissolve. After dissolution, the solution was adjusted to pH 8, then adds 
12.2 ml of a 280 mg/ml solution of PEGDA (4x excess, 10 kDa, provided from Dr.Seliktar) in 50mM PBS 
and 8M urea and reacted for 3 hours in the dark at room temperature. PBS with 8M urea (84 ml) was 
added after the reaction and the final PEG-fibrinogen product was precipitated in 4X excess acetone at 
20ºC for 10 minutes in separatory funnel. The precipitated solution was homogenized and centrifuged for 
1 minute at 2,500 RPM (Fisher Scientific) and the pellet was dissolved to approximately 20 mg/ml protein 
concentration in 50mM PBS and 8M urea. The PEG-fibrinogen product solution was dialyzed against 2 
liters of 50mM PBS at 4ºC for 2 days with twice-daily changes of PBS (6–8 kDa MW cutoff, Fisher 
Scientific). The dialyzed product was kept frozen at -30ºC. The net fibrinogen concentration was 
determined using a standard BCATM Protein Assay (Thermo Scientific). 
8.2.2 Cells and Cell Culture 
Dental pulp cells were isolated from healthy third molars of 19 and 24 years old males (College of 
Dental Medicine, Columbia University, NY) by cellular outgrowth according to published 
protocols(155;156). Briefly,  four pulp tissues (2x2x1 mm fragments) were placed in 75cm2 tissue culture 
plate (Corning,Tewksbury,MA) with 7 ml of fully supplemented medium (F/S medium), consisting of 




serum (FBS, Atlanta Biologicals, Atlanta, GA), 0.1% amphotericin B (AMP-B, Cellgro-Mediatech, 
Manassas, VA), 1% penicillin streptomycin (P/S, Cellgro-Mediatech, Manassas, VA), 0.1% gentamicin 
(Cellgro-Mediatech, Manassas, VA), 1% non-essential amino acids (NEAA, Cellgro-Mediatech, 
Manassas, VA) and maintained under humidified conditions at 37ºC and 5% CO2 until outgrowth cells 
reach confluence. Once confluence was reached, the pulp tissues were removed and plated on new 
tissue culture plates.  First migration cells were discarded. Only second and third migration cells were 
used for all subsequent analysis. Briefly, medium was removed from plates, and the plates were washed 
thoroughly with 15ml phosphate buffered saline (PBS, Sigma-Aldrich, St.Louis, MO). Trypsin (Cellgro-
Mediatech, Manassas, VA) 5 ml was added per plate and incubated for 3 minutes. F/S medium (15 mI) 
was used to wash the plates, and the cell suspension was again collected.  The plates were also washed 
with PBS to make sure all the cells have been collected.  The cell suspension was then centrifuged at 
4,000 rpm for 10 minutes, and 10 ml fresh F/S medium was added to the cell pellet.  The cells were 
counted by diluting (1:10) the cell suspension with trypan blue (Cellgro-Mediatech, Herndon, VA) and 
using a hemacytometer. Cells were continuously passaged at a 1:3 ratio when confluence until passage 4 
and kept frozen in liquid nitrogen. 
8.2.3 PEG-fibrinogen Hydrogels Fabrication, and Characterization 
For hydrogel crosslinking density evaluation, PEG-fibrinogen loaded with ciprofloxacin were made 
by mixing PEG-fibrinogen precursor solution (7.7 mg/ml with 19.75 mg/ml PEGDA) with different 
ciprofloxacin concentration (0, 250, or 500 µg/ml in 0.9% NaCl), and photoinitiator stock solution (0.1% 
w/v, 0.3% w/v, or 0.5% w/v) which made of 20% w/v Irgacure®2959 (Ciba Specialty Chemical Corp., 
Tarrytown, NY) in 70% ethanol. PEG-fibrinogen solution (100 µl each) was polymerized under UV light for 
5 or 10 minutes (365 nm, 730 µW/cm2, Cole-Parmer, IL) in a flat bottom 96-assay plate (Corning, 
Corning, NY). Samples were swelled to equilibrium in 50 mM PBS at 37ºC for 48 hours and the 
crosslinking density (n=6) was determined using hydrogel swelling ratio based on mass (QM) which was 
calculated by diving the wet weight (mass after swelling) by the dry weight (mass after lyophilization). 
For dental pulp cell response study, PEG-fibrinogen precursor solution (7.7 mg/ml with 19.75 
mg/ml PEGDA) was mixed with ciprofloxacin (0, 250, or 500 µg/ml in 0.9% NaCl), and 100 µl of the 




human dental pulp cells were seeded at 25% confluence (50,000 cells per well), cultured in 24 well-plates 
and maintained in fully supplemented medium for 2 days before adding PEG-fibrinogen loaded with 
ciprofloxacin on top of the monolayer. Media were collected, changed every other day, and freshly 
supplemented with 50 µg/ml ascorbic acid. The experimental groups consisted of monolayer cultured with 
ciprofloxacin loaded PEG-fibrinogen, whereas the control groups included monolayer with and without 
PEG-fibrinogen. In this study, human dental pulp cell responses were evaluated over two weeks of 
culture.  Specifically, (i) cell viability, (ii) proliferation, (iii) mineralization, and (iv) collagen production were 
determined and compared between groups as well as over time  
8.2.4 Ciprofloxacin Release Profile 
Ciprofloxacin concentration in media collected from each well (n=6) were determined by 
fluorescence spectrophotometer.  Hydrochloric acid (HCl, 100 µl, 0.5N) was added into 1 ml of sample in 
order to dissolve all ciprofloxacin precipitation. Then, samples (50 µl) were diluted with 950 µl distilled 
water before used in the assay. Diluted samples (20 µl) and 180 µl distilled water were added into 96 
well-plates. For the standard, 20µl of media with different concentration of ciprofloxacin solution (0, 0.01, 
0.05, 0.1, 0.5, 1, 5, 10, 50 µg/ml) and 180µl distilled water were added into 96 well-plates. Fluorescence 
was measured with a microplate reader (Biotek synergy 4 hybrid multimode), at the excitation and 
emission wavelengths of 278 and 465 nm, respectively. This essay was modified from Schneider et al. 
(2005)(175). 
8.2.5 Cell Viability  
Cell viability (n = 2) was visualized using Live/Dead staining (Molecular Probes, Eugene, OR), 
following the manufacturer’s suggested protocol. After washing in PBS, samples were visualized under 
confocal microscope (Olympus Fluoview FV1000, Center Valley, PA) at 473 nm excitation/ 519nm 
emission wavelengths for FITC and 559 nm excitation/ 612 nm emission for Texas Red  
8.2.6 Cell Proliferation 
Cell proliferation (n=6) was determined using the PicoGreen® total DNA assay (Molecular 
Probes, Eugene, OR).  Briefly, samples were first rinsed with PBS and 500 μl of 0.1% Triton-X solution 
(Sigma-Aldrich, St.Louis, MO) was used to lyse the cells.  An aliquot of the sample (25 μl) was then 




reader (Tecan, Research Triangle Park, NC), at the excitation and emission wavelengths of 485 and 535 
nm, respectively.  Total cell number was obtained by converting the amount of DNA per sample to cell 
number using the conversion factor of 8 pg DNA/cell. 
8.2.7 Mineralization 
Mineralization potential was determined by measuring ALP activity (n=6) using a colorimetric 
assay based on the hydrolysis of p-nitrophenyl phosphate (pNPP) to p-nitrophenol (pNP)(142).  Briefly, 
samples were lysed in 0.1% Triton-X solution, then added to pNPP solution (Sigma-Aldrich, St.Louis, MO) 
and allowed to react for 30 min at 37°C. The reaction was terminated with 0.1 N NaOH (Sigma-Aldrich, 
St.Louis, MO), and sample absorbance was measured at 415 nm using a microplate reader (Tecan, 
Research Triangle Park, NC).  
8.2.8 Collagen Deposition 
Collagen deposition (n=6) was quantified using the hydroxyproline assay based on alkaline 
hydrolysis of the tissue homogenate and subsequent determination of the free hydroxyproline in 
hydrolyzates(143). Briefly, samples were first desiccated for 24 hours and then digested for 16 hours at 
65ºC with papain (600 mg protein/ml, Sigma-Aldrich, St.Louis, MO) in 0.1 M sodium acetate (Sigma-
Aldrich, St.Louis, MO), 10 mM cysteine HCl (Sigma-Aldrich, St.Louis, MO), and 50 mM EDTA (Sigma-
Aldrich, St.Louis, MO). Samples were then hydrolyzed with 2 N NaOH (NaOH) for 25 minutes and 
chloramine-T (Sigma) was added into hydrolyzed sample to oxidize the free hydroxyproline for the 
production of a pyrrole at room temperature for 25 minutes. Then, Ehrlich's reagent (Sigma-Aldrich, 
St.Louis, MO) was added to the products and incubated at 65ºC for 20 minutes resulting in the formation 
of a chromophore. The solution was transferred to 96-well plate and sample absorbance was measured 
at 555 nm using a microplate reader (Tecan, Research Triangle Park, NC).  
8.2.9 Statistical Analysis 
Results are presented in the form of mean ± standard deviation, with n equal to the number of 
samples analyzed.  For hydrogel crosslinking density study, a multi-way analysis of variance (ANOVA) 
was performed on all quantitative data to determine effects of ciprofloxacin concentration in PEG-
fibrinogen, photoinitiator concentration, UV time on swelling ratio. For dental pulp cell response study, a 




ciprofloxacin concentration in PEG-fibrinogen and time on cell response (proliferation, mineralization, and 
collagen deposition). The Tukey–Kramer post-hoc test was used for all pair-wise comparisons, and 
statistical significance was attained at p<0.05.  All statistical analyses were performed using the JMP IN 
software (4.0.4, SAS Institute, Cary, NC). 
8.3 Results 
8.3.1. Effect of ciprofloxacin concentration on PEG-fibrinogen swelling ratio 
There was no significant difference in swelling ratio between PEG-fibrinogen without and with 250 
µg/ml ciprofloxacin for 0.3% w/v and 0.5% w/v photoinitiator concentrations (Figure 8.1). However, PEG-
fibrinogen with 500 µg/ml ciprofloxacin could not polymerize with 0.1% w/v photoinitiator but increasing 
photoinitiator to 0.3% and 0.5% enabled PEG-fibrinogen with 500 µg/ml ciprofloxacin to form a hydrogel. 
In addition, swelling ratio of PEG-fibrinogen with 500 µg/ml ciprofloxacin decreased significantly for 10 
minutes compared to 5 minutes photopolymerization time (Figure 8.1). 
8.3.2. Ciprofloxacin Release Profile 
Ciprofloxacin release study of PEG-fibrinogen hydrogel was carried in fully supplemented media 
and media was collect and changed with fresh media every 2 hours. The calculation of percent release 
was calculated by assuming 100% incorporation (25 µg for 250 µg/ml and 50 µg for 500 µg/ml). PEG-
fibrinogen exhibited initial rapid release in 6 hours which more than 50% of incorporated ciprofloxacin was 
released in 2 hours and followed with gradually release phase (Figure 8.2). Both release profile of 250 
and 500 µg/ml ciprofloxacin from PEG-fibrinogen were the same. 
8.3.3. Cell Viability and Proliferation 
Most cells were viable over time for all groups (Figure 8.3A). Observation of live/dead images 
was supported by the quantitative results of the Picogreen DNA assay which cell number increased over 
time for all groups (Figure 8.3B). Interestingly, cells cultured with PEG-fibrinogen hydrogels with and 
without ciprofloxacin showed higher cell number on day 14.  
8.3.4. Cell Biosynthesis 
ALP activity increased significantly over time for all groups except in plain PEG-fibrinogen group. 
In addition, ALP activity of cells cultured with ciprofloxacin loaded PEG-fibrinogen at 25 and 50 µg was 




stable for all groups but there was a significant increase in collagen content for cell cultured with 
ciprofloxacin loaded PEG-fibrinogen at 25 µg (Figure 8.3B). 
8.4 Discussion 
Gel crosslinking density can be estimated from equilibrium swelling ratio, as they are inversely 
proportional to each other for the PEG-based hydrogel system(177;178). We found that incorporating 250 
and 500 µg/ml (25 and 50 µg) ciprofloxacin significantly increased PEG-fibrinogen swelling ratio, 
indicating decreased crosslinking density. These findings suggest that ciprofloxacin can inhibit 
photopolymerization, since ciprofloxacin contains several nucleophiles which can react with free radicals 
during the reaction(1). However, increasing photoinitiator and UV time can compensate for this issue, to 
increase crosslinking density. In this study, we optimized photoinitiator concentration and UV exposure 
time for PEG-fibrinogen with 250 µg/ml and 500 µg/ml ciprofloxacin and found that crosslinking density 
remained stable using 0.3% w/v photoinitiator and 10 minutes UV exposure time.  
For effects of ciprofloxacin release on dental pulp cell response, we found no adverse effect on 
cell viability or proliferation when ciprofloxacin was released from the PEG-fibrinogen hydrogels. Also, a 
significant increase in ALP was seen in groups with 25 and 50 µg ciprofloxacin in PEG-fibrinogen, and an 
increase in collagen content was observed in groups exposed to 25 µg ciprofloxacin in PEG-fibrinogen on 
day 14. Increase in cell number, ALP activity, and collagen content might be from fibrinogen within PEG-
fibrinogen hydrogel as fibrinogen has been shown to regulates fibroblast cell functions such as the 
cleavage products of fibrinogen including fibrinopeptides A and B regulate fibroblast proliferation(37), and 
Aα and Bβ chains of fibrinogen stimulate proliferation(154).  
8.5 Conclusion 
 The results demonstrate that ciprofloxacin can be successfully incorporated in PEG-fibrinogen 
hydrogels and will remain stable over time following optimization of photoinitiator concentration and 
crosslinking time. Also, controlled release of 25 and 50 µg ciprofloxacin from PEG-fibrinogen has no 
adverse effects on dental pulp cell viability, growth, mineralization, and collagen deposition. Future 
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Figure 8.1: Effect of Ciprofloxacin Concentration on PEG-fibrinogen Swelling Ratio (A) Images 
of PEG-fibrinogen loaded with different ciprofloxacin concentration after fabrication. (scale = 1 mm) 
(B) Swelling Ratio of ciprofloxacin loaded PEG-fibrinogen hydrogel. No significant difference 
between 0 and 250 µg/ml ciprofloxacin for 0.3w/v% and 0.5w/v% photoinitiator concentrations. 
Increasing UV time from 5 to 10 minutes decreased swelling ratio of PEG-fibrinogen with 500 µg/ml 

















































































Figure 8.2: Ciprofloxacin Release Profile 
from PEG-fibrinogen over time. Media was 
collect and changed with fresh media every 2 
hours.  The results showed that PEG-fibrinogen 
exhibited initial rapid release in 6 hours which 
more than 50% of ciprofloxacin incorporated in 
PEG-fibrinogen was released in 2 hours. 








0 8 16 24 32 40 48 56
Hours


































Figure 8.3: (A) Cell Viability of human dental pulp cells cultured with ciprofloxacin loaded PEG-
fibrinogen hydrogels over time. Cells were viable over 14 days culture period for all groups. (n=2, 4x, 
scale = 1 mm) (B) Cell Number increased over time for all groups. Cell proliferated over time for all 
groups. Interestingly, cells cultured with PEG-fibrinogen hydrogels with and without ciprofloxacin 
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Figure 8.4: Cell Mineralization and Collagen Deposition of human dental pulp cells cultured with 
ciprofloxacin loaded PEG-fibrinogen hydrogels over time. (A) ALP activity increased over time for all 
groups except plain PEG-fibrinogen group. In addition, ALP activity of cells cultured with ciprofloxacin 
loaded PEG-fibrinogen at 25 and 50 µg was significantly higher than control groups on day 7 and day 
14. (B) There was a significant increase in collagen content for cell cultured with ciprofloxacin loaded 















CHAPTER 9: EFFECT OF CIPROFLOXACIN 
CONCENTRATION ON ANTIMICROBIAL 


















 In Chapter 7 and 8, we optimized a ciprofloxacin concentration that does not have adverse effects 
on human dental pulp cells. In this study, anaerobic bacteria from infected pulp were exposed to the 
optimized PEG-fibrinogen hydrogels and ciprofloxacin to determine bacteria susceptibility. 
9.1.1 Background and Motivation 
PEG-fibrinogen is suitable for use as a drug delivery vehicle in endodontic treatment. To illustrate, 
when dentin is soaked in fibrinogen-containing media, bacterial invasion was inhibited(179) and similarly, 
fibrinogen coatings have been shown to inhibit infection of dentin(35). Therefore, an injectable hydrogel 
such as PEG-fibrinogen can readily mold to the tooth cavity and provide a superior seal against infection 
with addition of antibiotics in it. However, photopolymerization of PEG-fibrinogen which form through vinyl 
groups might react with carbon-carbon double bonds in the ciprofloxacin molecule and interfere with the 
antibacterial efficacy of ciprofloxacin.    
9.1.2 Objectives 
The goal of this study is to determine the effect of ciprofloxacin concentration within PEG-
fibrinogen on its antibacterial efficacy on bacteria from infected dental pulp under anaerobic condition in 
vitro. It is anticipated that incorporating ciprofloxacin in PEG-fibrinogen will not affect the antibacterial 
activity of ciprofloxacin, and increasing ciprofloxacin concentration will further reduce the number of 
bacteria from infected human dental pulp over time.   
9.2 Materials and Methods 
9.2.1 PEG-fibrinogen Hydrogels Fabrication 
PEG-fibrinogen precursor solution (9 mg/ml with 17.53 mg/ml PEGDA) was mixed with 
ciprofloxacin (0, 250, or 500 µg/ml in 0.9% NaCl), and 100 µl of the mixture was polymerized with 0.3% 
w/v photoinitiator stock solution made of 20% w/v Irgacure2959® (Ciba Specialty Chemical Corp., 
Tarrytown, NY) in 70% ethanol for 10 minutes under UV light (365 nm, 15 mW/cm2, Cole-Parmer, IL).  
9.2.2 Bacteria Culture 
Infected pulp tissue samples were obtained from deep carious lesions teeth of patients aged 
between 17 - 60 years old at the College of Dental Medicine, Columbia University and kept in anaerobic 




anaerobic bacteria from the sample, samples were placed into 1 ml of 40 mM potassium phosphate buffer 
(pH 7.0) in a culture test tube and homogenized using the motor drive homogenizer at a low speed. Then, 
aliquot 100 µl of the homogenized mixture was mixed into each thioglycollate broth vial (Anaerobe 
System) and cultured in anaerobic condition using anaerobic bio-bag type A (BD scientific) incubated at 
37°C with orbital shaking for 24 hours. After bacteria were isolated from infected tissue samples, the 
suspension was measured for bacteria turbidity for turbidity test and disk diffusion test.  
In this study, the effect of ciprofloxacin concentration in PEG-fibrinogen on antimicrobial activity of 
bacteria from infected pulp was evaluated from (i) bacteria growth inhibition using turbidity test and disk 
diffusion test and (ii) bacteria viability. For turbidity test (n=5) and viability test (n=2), anaerobic bacteria 
with turbidity of 0.25 McFarland standard was grown in thioglycollate broth with ciprofloxacin loaded 
hydrogels (0, 25, or 50 µg) or addition of ciprofloxacin (0, 25, or 50 μg/ml) as a control under anaerobic 
conditions for 20, 36, and 48 hours. For the disk diffusion test (n=3), bacteria suspension with turbidity of 
0.5 McFarland standard was applied on brucella blood agar plate (Anaerobe System). PEG-fibrinogen 
hydrogels and filter paper disks (6mm) as a control loaded with different amount of ciprofloxacin (0, 25, or 
50 µg) were placed on top of the blood agar. Disk diffusion test plates were incubated in anaerobic 
conditions using anaerobic bio-bag type A (BD scientific) incubated at 37°C. After 72 hours incubation, 
inhibition zone diameters were measured with the aid of calipers. 
9.2.3 Turbidity Test 
McFarland standard number was used to standardize the turbidity of bacteria suspension (n=5). 
In this study, McFarland standard was made by mixing 1.175 % (w/v) barium chloride and 1%(v/v) sulfuric 
acid and then diluted with thioglycollate broth at 1:9 ratio as shown. 
Making 50 µl McFarland standards for 1:10 dilutions in broth 
McFarland Standard No. 2.5 5 10 20 30 40 50 
1.175 % (w/v) Barium chloride (µl) 1.25 2.5 5 10 15 20 25 
1.0%(v/v) Sulfuric acid (µl) 48.75 47.5 45 40 35 30 25 
 
The solution is transferred to 96-well plate and sample absorbance is measured at 620 nm using a 




9.2.4 Bacteria Viability 
Bacteria viability (n = 2) was visualized using LIVE/DEAD® BacLightTM Bacterial Viability Kits 
(Molecular Probes, Eugene, OR), following the manufacturer’s suggested protocol. After washing with 
0.85% NaCl, samples were visualized under confocal microscope (Olympus Fluoview FV1000, Center 
Valley, PA) at excitation/emission 480/500 nm for SYTO® 9 stain (live) and 490/635 nm for propidium 
iodide (dead). Escherichia coli were used as a control.  
9.2.5 Ciprofloxacin Release Measurement 
Thioglycollate broth was collected from each sample after culture for 20 hours (n=5) and the 
concentration of ciprofloxacin released from PEG-fibrinogen was determined by fluorescence 
spectrophotometer.  Hydrochloric acid (HCl, 100 µl, 0.5N) was added into 1 ml of sample in order to 
dissolve all ciprofloxacin precipitation. Then, samples (50 µl) were diluted with 950 µl distilled water 
before used in the assay. Diluted samples (20 µl) were mixed with 180 µl distilled water and were added 
into 96 well-plates. For the standard, 20µl of media with different concentration of ciprofloxacin solution 
(0, 0.01, 0.05, 0.1, 0.5, 1, 5, 10, 50 µg/ml) and 180µl distilled water were added into 96 well-plates. 
Fluorescence was measured with a microplate reader (Biotek synergy 4 hybrid multimode), at the 
excitation and emission wavelengths of 278 and 465 nm, respectively. This essay was modified from 
Schneider et al. (2005)(175). 
9.2.6 Statistical Analysis 
Results are presented in the form of mean ± standard deviation, with n equal to the number of 
samples analyzed.  Two-way analysis of variance (ANOVA) was performed on all quantitative data to 
determine effects of ciprofloxacin concentration and incorporation in PEG-fibrinogen on antibacterial 
efficacy (turbidity and inhibition zone).  The Tukey–Kramer post-hoc test was used for all pair-wise 
comparisons, and statistical significance was attained at p<0.05.  All statistical analyses were performed 
using the JMP IN software (4.0.4, SAS Institute, Cary, NC). 
9.3 Results 
9.3.1. Turbidity Bacteria Growth and Bacteria Viability 
Effects of ciprofloxacin dose and release from PEG-fibrinogen were tested on anaerobic bacteria 




over time (Figure 9.2A, 9.3A), both media addition and controlled release of ciprofloxacin significantly 
reduced bacterial turbidity (Figure. 9.1B, 9.2B, 9.3B), with no apparent difference observed between 25 
and 50 µg/ml groups. These results were also confirmed by the live and dead staining and qualitative 
observation of the culture broths as shown in Figure 9.1A, which shows that there less viable bacteria are 
present in broth containing ciprofloxacin. The concentration of accumulated ciprofloxacin released from 
hydrogels in bacteria broth after 20 hours of incubation was 15.62+0.43 µg/ml for the 25 µg-PEG-
fibrinogen group, and 34.65+1.07 µg/ml for the 50 µg-PEG-fibrinogen group (Figure. 9.1D).  
The percentage of bacteria inhibition was calculated from the ratio of turbidity of the broth without 
ciprofloxacin to the broth with ciprofloxacin or PEG-fibrinogen loaded ciprofloxacin. Statistical analysis 
showed that there was no significant difference between both media addition and controlled release from 
PEG-fibrinogen groups. However, % bacteria inhibition of 25 µg/ml group was lower than 50 µg/ml group 
in both media addition and controlled release from PEG-fibrinogen groups (Figure. 9.1C). In addition, % 
bacteria inhibition of controlled release from PEG-fibrinogen groups was lower than media addition 
groups.  
9.3.2. Disk Diffusion Test 
A disk diffusion test was also done to test ciprofloxacin antimicrobial effect on the bacteria from 
infected dental pulp (Figure. 9.4). Both bacteria cultured with filter disks and PEG-fibrinogen loaded with 
ciprofloxacin had a distinct inhibition zone after 72 hours of culture under anaerobic condition. Both 
inhibition diameters of PEG-fibrinogen containing 25 and 50 µg of ciprofloxacin were significantly higher 
than filter disk containing the same amount of ciprofloxacin. In addition, the inhibition diameter of PEG-
fibrinogen containing 50 µg ciprofloxacin was significantly higher than 25 µg ciprofloxacin. However, there 
was no statistical difference of inhibition diameter between filter disks containing 25 and 50 µg 
ciprofloxacin.  
9.4 Discussion 
 In this study, we evaluated the effect of ciprofloxacin concentration within PEG-fibrinogen on the 
antibacterial efficacy of the antibiotic on bacteria from infected dental pulp under anaerobic condition. We 
found that while there was a difference in bacteria growth between patients, the addition of ciprofloxacin 




infected pulp over time. These results were similar to Hoshino et al. (1996), who found that ciprofloxacin 
concentration of 25, 50, and 75 µg/ml substantially decreased growth of bacteria from infected dentin and 
root canal wall and (180). Further, a dose-dependent decrease in bacterial number was found in PEG-
fibrinogen groups loaded with ciprofloxacin. To illustrate, samples containing PEG-fibrinogen with 50 µg 
ciprofloxacin exhibited higher % bacteria inhibition in broth culture and a larger inhibition zone in blood 
agar culture. This might due to the fact that the ciprofloxacin released from 25 µg-PEG-fibrinogen group 
was 15.62+0.43 µg/ml, which is lower than the concentration that is effective against anaerobic bacteria 
from deep caries. 
9.5 Conclusions 
  These results demonstrate that photopolymerization of PEG-fibrinogen does not affect the 
antimicrobial efficacy of ciprofloxacin, and that controlled release of 25 and 50 µg ciprofloxacin from PEG-
fibrinogen is effective in reducing anaerobic bacterial infection, therefore PEG-fibrinogen is suitable as a 
ciprofloxacin carrier and delivery vehicle for endodontic treatment. Future studies will evaluate this 












Figure 9.1: (A) Viability of Bacteria culture in broth with different 
ciprofloxacin concentration. There were less viable bacteria in broth 
with ciprofloxacin. (n=2, 10x, scale = 400 µm) This observation was 
confirmed by images of culture broths. (B) Turbidity of Bacteria 
Growth in Broth Both media addition and controlled release of 
ciprofloxacin significantly reduced bacterial turbidity with no difference 
observed between 25 and 50 µg/ml groups. (n=5,*p<0.05) (C) 
Percentage of Bacteria Growth Inhibition in Broth was similar 
between both media addition and controlled release from PEG-
fibrinogen groups.  (n=5,*p<0.05) (D) Accumulated Hydrogel 
Ciprofloxacin Release in Bacteria Broth after 20 hours incubation 
was 15.62+0.43 µg/ml for the 25 µg-PEG-fibrinogen group, and 
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Figure 9.2: Effect of Patient Age and Gender on Bacteria Growth in Broth (A) Turbidity of 
bacteria growth in broth with PEG-fibrinogen Significant difference between bacteria growth in 
broth with PEG-fibrinogen was found between patients. Controlled release of ciprofloxacin significantly 
reduced bacterial turbidity in all groups.) (B) Percentage of bacteria growth inhibition in broth with 
PEG-fibrinogen was different between patients in broth with PEG-fibrinogen containing 25 and 50 µg 






































































Figure 9.3: (A) Turbidity of Bacteria Growth in Broth with PEG-fibrinogen Hydrogels over Time 
Turbidity of bacteria growth in broth with plain PEG-fibrinogen increased over time for both patients. 
There was no difference in turbidity of bacteria growth in broth with PEG-fibrinogen containing 
ciprofloxacin over time. (B) Percentage of Bacteria Growth Inhibition in Broth over Time was 

















Figure 9.4: Disk Diffusion Test between ciprofloxacin loaded 
filter disks and PEG-fibrinogen hydrogels showed distinct 
inhibition zone after culture 72 hours. Interestingly, both inhibition 
diameters of PEG-fibrinogen containing 25 and 50 µg 
ciprofloxacin were significantly higher than filter disk containing 
the same amount of ciprofloxacin. In addition, the inhibition 
diameter of PEG-fibrinogen containing 50 µg ciprofloxacin was 
significantly higher than 25 µg ciprofloxacin. However, there was 
no statistical difference of inhibition diameter between filter disks 
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CHAPTER 10: EFFECT OF FIBRINOGEN 

















Our goal is to design a bioactive scaffold that can be used to harness the intrinsic repair potential 
of the native pulp. The optimal scaffold for guiding pulp regeneration must enable cell migration, support 
pulp cell phenotypic maintenance/biosynthesis and ultimately, regenerate the dentin-pulp complex. 
Previous chapters demonstrate that PEG-fibrinogen hydrogel supports dental pulp cell viability, growth, 
phenotypic morphology, collagen deposition, and expression of dental pulp cell-related markers. In this 
chapter, a pulp explant model was established to evaluate the potential of PEG-fibrinogen to induce host 
cell migration and examine the effect of fibrinogen concentration on cell migration distance, rate, and 
pulp-like matrix production in PEG-fibrinogen over time. 
10.1.1 Background and Motivation 
Most teeth with exposed pulp still have healthy root pulps(181-185), which may be stimulated for 
pulp repair.  Thus, for guided pulp regeneration, it is envisioned that the inflamed pulp can first be 
removed with endodontic instruments and a cell-instructive scaffold such as PEG-fibrinogen(2) can then 
be used to stimulate the remaining pulp tissue to regenerate and re-fill the pulpal cavity. PEG-fibrinogen 
is uniquely suited for pulp repair, as fibrinogen has been shown to be important for pulp wound 
healing(37). Izumi et al. (1998) reported that after cavity induction in a rat model, fibrinogen was 
detectable within six hours and persists thereafter during healing of the dentin-pulp complex(36). 
Moreover, fibrinogen promotes cell homing by inducing chemotactic migration of endothelial cells(186), 
monocytes(187) and smooth muscle cells(188).  Yet another advantage is that cell-mediated proteolytic 
degradation of the fibrinogen backbone(2;37) enables pulp cells to spread and exhibit a spindle-shaped 
morphology, rather than the spherical cell morphology commonly observed in synthetic hydrogels.  A 
proteolytically responsive gel is attractive, as its degradation is mediated by cells, thus making space for 
new matrix formation at a biologically relevant pace.  Moreover, PEG-fibrinogen is bioactive even without 
the addition of cells or growth factors, and is already in clinical trials in Europe for cartilage repair.  
Successful application of such a cell-instructive scaffold for guided pulp repair will increase the life span 
of the restored teeth and reduce the need for retreatment procedures that have a low success 





Preliminary studies have revealed that the two key steps for initiating pulp regeneration in the 
hydrogel are rapid cell infiltration and subsequent cell spreading. To enhance these outcomes, fibrinogen 
concentration was optimized through utilization of a pulp explant model. The objective of this study is to 
evaluate the effect of fibrinogen concentration on dental pulp cellular migration into PEG-fibrinogen 
hydrogel. Chapter 4 showed that increasing fibrinogen concentration enhances cell response, in terms of 
cellular network formation, cell proliferation, collagen production, and mineralization potential over time. 
Therefore, it is anticipated that 1) pulp cells will be able to migrate into the PEG-fibrinogen hydrogel and 
2) higher fibrinogen concentration will result in enhancing rate and distance of cell infiltration and pulp-like 
matrix formation within the hydrogel.     
10.2 Materials and Methods 
10.2.1 PEG-fibrinogen Synthesis 
PEG-fibrinogen was synthesized according to Almany et al. (2005)(2). Briefly, PEGDA molecules 
were attached to the 29 cysteines (HO2CCH(NH2)CH2SH)  residue in the sequence of the fibrinogen 
protein by Michael-type reaction. First, 48.9 mg of tris (2-carboxyethyl) phosphine hydrochloride (TCEP 
HCl, 4x excess, Sigma-Aldrich, St.Louis, MO) was added to 71 ml of a 7 mg/ml solution of fibrinogen (I-S 
from bovine plasma, Desert Biological) in 50mM PBS with 8M urea. The solution was left stirring for 15 
min at room temperature to fully dissolve. After dissolution, the solution was adjusted to pH 8, then adds 
12.2 ml of a 280 mg/ml solution of PEGDA (4x excess, 10 kDa, provided from Dr.Seliktar) in 50mM PBS 
and 8M urea and reacted for 3 hours in the dark at room temperature. PBS with 8M urea (84 ml) was 
added after the reaction and the final PEG-fibrinogen product was precipitated in 4X excess acetone at 
20ºC for 10 minutes in separatory funnel. The precipitated solution was homogenized and centrifuged for 
1 minute at 2,500 RPM (Fisher Scientific) and the pellet was dissolved to approximately 20 mg/ml protein 
concentration in 50mM PBS and 8M urea. The PEG-fibrinogen product solution was dialyzed against 2 
liters of 50mM PBS at 4ºC for 2 days with twice-daily changes of PBS (6–8 kDa MW cutoff, Fisher 
Scientific). The dialyzed product was kept frozen at -30ºC. The net fibrinogen concentration was 




10.2.2 PEG-fibrinogen Hydrogels Preparation 
PEG-fibrinogen hydrogels were made according to Dikovsky et al. (2006)(43). Briefly, PEG-
fibrinogen hydrogel are made from a precursor solution of PEGylated by a radical chain polymerization 
reaction of acrylate end groups. Additional PEGDA (10 kDa) was added to increase cross-linking density 
of the PEGylated protein network as well as to minimize steric hindrances that may result in poor gelation. 
Total PEGDA concentration (32.92 mg/ml) was the same for all groups. PEG-fibrinogen precursor 
solution (7.7 and 9 mg/ml fibrinogen ,10 kDa) was mixed with additional of 19.75 and 17.53 mg/ml 
PEGDA, respectively (10 kDa, provided from Dr.Seliktar) and 0.1% (v/v) photoinitiator stock solution 
made of 10% w/v Irgacure®2959 (Ciba Specialty Chemical Corp., Tarrytown, NY) in 70% ethanol and 
deionized water.  
10.2.3 Pulp Explant Model Preparation 
Human dental pulp was isolated from healthy third molars of patients aged between 18 – 70 
years old (College of Dental Medicine, Columbia University, NY). Isolated human pulp was sectioned 
(1x1mm) using a sterile scalpel, and then embedded in the hydrogel by pipetting 100 µl of precursor 
PEG-fibrinogen solution into the flat bottom 96-assay plate (Corning, Corning, NY) with explant at the 
bottom of the plate (Figure 10.1), and polymerized under UV light for 5 minutes (365 nm, 15 mW/cm2, 
Cole-Parmer, IL). All samples were maintained in 24 well-plates under humidified conditions at 37ºC and 
5% CO2 with 1 ml of fully supplemented medium with 10% FBS, 1% antibiotics, 0.1% antifungal, 0.1% 
gentamicin, and 1% non-essential amino acids. The medium was changed every other day and freshly 
supplemented with 50 µg/ml ascorbic acid. The experimental groups consisted of pulp in PEG-fibrinogen 
hydrogels at 9 mg/ml fibrinogen concentration, whereas the control group included pulp in PEG-fibrinogen 
hydrogels at 7.7 mg/ml fibrinogen concentration. In this study, human dental pulp cell migration in the 
PEG-fibrinogen hydrogels were evaluated over 32 days of culture for cell migration and matrix 
distribution. Cell migration was compared between each patients, as well as fibrinogen concentration. 
Matrix distribution was evaluated for total collagen, collagen I, and collagen III and compared across 




10.2.4 Cell Infiltration and Distribution 
Cell migration distance (n=5) from the explant into the acellular hydrogel was monitored weekly 
via phase-contrast light microscopy (Axiovert 25, Zeiss) and calculated using ImageJ. 
10.2.5 Matrix Deposition 
Matrix distribution was evaluated by histological methods. Additionally, samples were rinsed with 
PBS and fixed with 4% paraformaldehyde for 3 hours. After fixation, samples were embedded in paraffin 
(Fisher Scientific) and 8-micrometer thick sections were obtained using a cryostat (Hacker-Bright OTF 
model, Hacker Instruments and Industries, Winnsboro, SC). Collagen distribution (n=3) was visualized 
histologically with picrosirius red staining. Deposition of collagen I and collagen III (n = 2) was evaluated 
using immunohistochemistry.  After rehydration, samples were incubated with primary antibody (collagen I 
or collagen III (1:100 dilution, Abcam)) overnight. Then, a FITC-conjugated secondary antibody (1:200 
dilution, Abcam) was added and incubated for 1 hour. Finally, samples were stained with DAPI staining. 
Sections were visualized under confocal microscopy at excitation and emission wavelengths of 488 nm 
and 568 nm, respectively. 
10.2.6 Statistical Analysis 
Results are presented in the form of mean ± standard deviation, with n equal to the number of 
samples analyzed.  For cell migration study, a two-way analysis of variance (ANOVA) was performed on 
all quantitative data to determine effects of patient age and gender on cell migration distance. The Tukey–
Kramer post-hoc test was used for all pair-wise comparisons, and statistical significance was attained at 
p<0.05.  All statistical analyses were performed using the JMP IN software (4.0.4, SAS Institute, Cary, 
NC). 
10.3 Results 
10.3.1. Dental Pulp Cellular Migration into PEG-fibrinogen  
 Dental pulp tissue was successfully encapsulated into PEG-fibrinogen hydrogel which the pulp 
tissue was centered and at the bottom of the hydrogel in order to mimic the position of the vital pulp tissue 
that would reside in the root beneath the hydrogel (Figure 10.1). Cellular invasion into the hydrogel was 
evident on day 7 for both fibrinogen concentrations, with cell penetration advancing continuously and 




for 7.7 and 9 mg/ml groups were 1.92 + 0.33 mm and 1.90 + 0.15 mm, respectively with no significant 
difference between groups over time.  Initially, the migrated cells in the gel appeared polarized and 
oriented radially outward from the embedded pulp tissue.  Over time, the cells began to orientate toward 
each other and connect within the hydrogel (Figure 10.2). Differences in cell outgrowth from pulp into 
PEG-fibrinogen between patients were also determined (Figure 10.3).  
10.3.2. Collagen Distribution  
As shown in Figure 10.4, the migrated cells remain viable in both the pulp explant and the 
hydrogel for over 32 days of culture.  Positive staining for collagen I and III were observed with no 
difference found between groups within the hydrogel as well as in the pulp explant on day 32, indicating 
that migrated cells produced both collagen I and collagen III inside acellular PEG-fibrinogen.  
10.4 Discussion 
In this study, a dental pulp explant model was established to evaluate the potential of PEG-
fibrinogen to induce host cell migration. To do this, human dental pulp tissue was sectioned and 
embedded in PEG-fibrinogen hydrogel. Observation of cell migration via phase-contrast light microscopy 
showed that PEG-fibrinogen supports dental pulp cellular infiltration from pulp tissue with cell penetration 
advancing continuously and uniformly throughout the hydrogels with no difference between 7.7 and 9 
mg/ml fibrinogen groups over time. Other studies also showed that the fibrinogen backbone of the 
hydrogel is used to initiate cell migration via a cell adhesion site and a protease degradation site(2;37), as 
cells synthesize matrix metalloproteinases (e.g. MMP-2, MMP-9)(42) and tunnel through the hydrogel via 
proteolytic breakdown of fibrinogen fragments(2;37). Additionally, collagen I and collagen III were 
observed within the hydrogel, indicating that PEG-fibrinogen supports dental pulp cell biosynthesis. 
10.5 Conclusions 
  These results demonstrate that the pulp explant model can be used to study pulp-hydrogel 
interactions, and PEG-fibrinogen hydrogel has a potential to support neo pulp regeneration, as it has 
been shown to support pulp cell migration infiltration, spreading, and collagen synthesis. However, 
increasing fibrinogen concentration within the PEG-fibrinogen hydrogel did not enhance the rate or 
distance of cell infiltration or the amount of matrix formation within the hydrogel. Future studies will 
























Figure 10.1: Dental Pulp Explant Model was established to 
evaluate the potential of PEG-fibrinogen to induce host cell 
migration. Human pulp explant (1 x 1 mm) was successfully 
embedded in PEG-fibrinogen hydrogel which centered and at the 
bottom to mimic the position of the vital pulp tissue that would 




















7.7 mg/ml fibrinogen 9 mg/ml fibrinogen 
Figure 10.2: (A) Cell Migration into PEG-fibrinogen Hydrogel over Time (n=6, 5X, scale=500µm) 
(*:p<0.05) Cellular invasion into the hydrogel was evident on day 7 for both fibrinogen concentrations, 
with cell penetration advancing continuously and uniformly throughout the hydrogels at a rate of 0.062 
mm/day. (B Cell Migration throughout the Gel on day 32 (5x, scale=1mm) (C) The Average 
Migration Distance increased linearly over time for both groups and rate of cell migration was higher 
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Figure 10.3: Dental Pulp Cellular Migration into 
PEG-fibrinogen from Different Patients.                                
(n=1, day 28, 5X, scale = 1mm)           
Female,  aged 24 Male,  aged 65 
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Figure 10.4: (A) Collagen Distribution within PEG-fibrinogen hydrogel on day 32 (n=3, 5X, scale = 
1mm) (B) Collagen I and Collagen Staining within PEG-fibrinogen hydrogel on day 32. Positive 
collagen I and collagen III staining (green) within PEG-fibrinogen hydrogels: A-indicate the area at the 
edge of pulp tissue B-indicate pulp tissue within PEG-F hydrogel (n=3, 20X, scale = 200µm) 
















CHAPTER 11: EFFECT OF CIPROFLOXACIN 



















Previous chapters demonstrate that PEG-fibrinogen hydrogel supports host dental pulp cell 
migration and biosynthesis over time. In this chapter, the optimized ciprofloxacin dosage from Chapter 7 
and 8 was incorporated into the explant model in order to test the feasibility of a PEG-fibrinogen hydrogel 
with ciprofloxacin incorporated as a scaffold for guiding host pulp repair. 
11.1.1 Background and Motivation 
From Chapter 8, we optimized photoinitiator concentration and UV exposure time for PEG-
fibrinogen containing 250 µg/ml and 500 µg/ml ciprofloxacin and found that crosslinking density remained 
stable using 0.3% w/v photoinitiator and 10 minutes UV exposure time. The explant model, which 
consists of pulp tissue sections encapsulated in PEG-fibrinogen hydrogel, is used to test the feasibility of 
our proposed endodontic treatment. In this case, the optimized PEG-fibrinogen is loaded with 
ciprofloxacin and is used to fill the inside of the pulp chamber, atop the remaining pulp tissue.  
11.1.2 Objectives 
The objective of this study is to further evaluate the effect of ciprofloxacin dosage on cellular 
migration and pulp-like matrix formation in optimized PEG-fibrinogen hydrogel utilizing a pulp explant 
model. It is anticipated that incorporation of optimized ciprofloxacin concentration will have no adverse 
effects on cellular migration into the PEG-fibrinogen hydrogel.     
11.2 Materials and Methods 
11.2.1 PEG-fibrinogen Hydrogels Preparation 
PEG-fibrinogen hydrogels were made according to Dikovsky et al. (2006)(43). Briefly, PEG-
fibrinogen hydrogels are made from a precursor solution of PEGylated by a radical chain polymerization 
reaction of acrylate end groups. Additional of PEGDA was added to increase cross-linking density of the 
PEGylated protein network as well as to minimize steric hindrances that may result in poor gelation. PEG-
fibrinogen precursor solution (9 mg/ml, 10kDa, provided from Dr.Dror Seliktar, Technion-Israel Institute of 
Technology, Haifa, ISRAEL) was mixed with 17.53 mg/ml PEGDA (10kDa, provided from Dr.Dror Seliktar, 
Technion-Israel Institute of Technology, Haifa, ISRAEL), ciprofloxacin (0, 250, or 500 µg/ml in 0.9% 
NaCl), and 0.3% w/v photoinitiator stock solution made of 20% w/v Irgacure2959® (Ciba Specialty 




11.2.2 Pulp Explant Model Preparation 
Human dental pulp was isolated from healthy third molars of 17-year-old female patients (College 
of Dental Medicine, Columbia University, NY). Isolated human pulp was sectioned (1x1mm) using a 
sterile scalpel, and then embedded in the hydrogel by pipetting 100 µl of precursor PEG-fibrinogen 
solution into the flat bottom 96-assay plate (Corning, Corning, NY) with explant at the bottom of the plate, 
and polymerized under UV light for 10 minutes (365 nm, 15 mW/cm2, Cole-Parmer, IL). All samples were 
maintained in 24 well-plates under humidified conditions at 37ºC and 5% CO2 with 1 ml of fully 
supplemented medium with 10% FBS, 1% antibiotics, 0.1% antifungal, 0.1% gentamicin, and 1% non-
essential amino acids. The medium was changed every other day and freshly supplemented with 50 
µg/ml ascorbic acid. The experimental groups consisted of pulp in PEG-fibrinogen hydrogels loaded with 
ciprofloxacin, whereas the control group included pulp in plain PEG-fibrinogen hydrogels. In this study, 
human dental pulp cell response in the PEG-fibrinogen hydrogels were evaluated over 1, 14, and 28 days 
of culture. Specifically, (i) cell viability, (ii) cell infiltration and distribution, (iii) proliferation, (iv) 
mineralization, and (v) collagen production were determined and compared between groups as well as 
over time. In addition, samples were weighed and desiccated for 24 hours (CentriVap Concentrator, 
Labconco Co., Kansas City, MO), at which point the scaffold swelling ratio (n=5, wet weight/dry weight) 
was calculated.   
11.2.3 Cell Viability  
Cell viability (n = 2) was visualized using Live/Dead staining (Molecular Probes, Eugene, OR), 
following the manufacturer’s suggested protocol. After washing in PBS, samples were visualized under 
confocal microscope (Olympus Fluoview FV1000, Center Valley, PA) at 473 nm excitation/ 519nm 
emission wavelengths for FITC and 559 nm excitation/ 612 nm emission for Texas Red.  
11.2.4 Cell Infiltration, Distribution, and Proliferation 
Cell migration distance (n=5) from the explant into the acellular hydrogel is monitored weekly via 
phase-contrast light microscopy (Axiovert 25, Zeiss) and calculated using ImageJ. Cell proliferation (n=5) 
was determined using the PicoGreen® total DNA assay (Molecular Probes, Eugene, OR).  Briefly, 
samples were first rinsed with PBS and 500 μl of 0.1% Triton-X solution (Sigma-Aldrich, St.Louis, MO) 




working solution.  Fluorescence was measured with a microplate reader (Tecan, Research Triangle Park, 
NC), at the excitation and emission wavelengths of 485 and 535 nm, respectively.  Total cell number was 
obtained by converting the amount of DNA per sample to cell number using the conversion factor of 8 pg 
DNA/cell. 
11.2.5 Mineralization 
Mineralization potential was determined by measuring ALP activity (n=5) using a colorimetric 
assay based on the hydrolysis of p-nitrophenyl phosphate (pNPP) to p-nitrophenol (pNP)(142).  Briefly, 
samples were lysed in 0.1% Triton-X solution, then added to pNPP solution (Sigma-Aldrich, St.Louis, MO) 
and allowed to react for 30 min at 37°C. The reaction was terminated with 0.1 N NaOH (Sigma-Aldrich, 
St.Louis, MO), and sample absorbance was measured at 415 nm using a microplate reader (Tecan, 
Research Triangle Park, NC).  
11.2.6 Collagen Deposition 
Collagen deposition (n=5) was quantified using the hydroxyproline assay based on alkaline 
hydrolysis of the tissue homogenate and subsequent determination of the free hydroxyproline in 
hydrolyzates(143). Briefly, samples were first desiccated for 24 hours and then digested for 16 hours at 
65ºC with papain (600 mg protein/ml, Sigma-Aldrich, St.Louis, MO) in 0.1 M sodium acetate (Sigma-
Aldrich, St.Louis, MO), 10 mM cysteine HCl (Sigma-Aldrich, St.Louis, MO), and 50 mM EDTA (Sigma-
Aldrich, St.Louis, MO). Samples were then hydrolyzed with 2 N NaOH for 25 minutes and chloramine-T 
(Sigma) was added into hydrolyzed sample to oxidize the free hydroxyproline for the production of a 
pyrrole at room temperature for 25 minutes. Then, Ehrlich's reagent (Sigma-Aldrich, St.Louis, MO) was 
added to the products and incubated at 65ºC for 20 minutes resulting in the formation of a chromophore. 
The solution was transferred to 96-well plate and sample absorbance was measured at 555 nm using a 
microplate reader (Tecan, Research Triangle Park, NC).  
11.2.7 Histology 
Samples were rinsed with PBS and fixed with 4% paraformaldehyde for 48 hours. After fixation, 
samples were embedded in paraffin (Fisher Scientific) and 8-micrometer thick sections were obtained 
using a cryostat (Hacker-Bright OTF model, Hacker Instruments and Industries, Winnsboro, SC). Overall 




Mineral distribution (n=3) was visualized histologically for calcium with alizarin red staining. Deposition of 
collagen III and CD31 (n = 3) was evaluated using immunohistochemistry.  After rehydration, samples 
were digested with trypsin for CD31 staining, and incubated with primary antibody (collagen III (1:60 
dilution, Abcam) or CD31 (1:100 dilution, Abcam)) overnight. Then, a FITC-conjugated secondary 
antibody (1:200 dilution, Abcam) was added and incubated for 1 hour. Finally, samples were stained with 
DAPI staining. Sections were visualized under confocal microscopy at excitation and emission 
wavelengths of 488 nm and 568 nm, respectively. 
11.2.8 Statistical Analysis 
Results are presented in the form of mean ± standard deviation, with n equal to the number of 
samples analyzed.  Two-way analysis of variance (ANOVA) was performed on all quantitative data to 
determine effects of ciprofloxacin concentration and time on cell response (migration distance, 
proliferation, mineralization, and collagen deposition), as well as hydrogel parameters (weight and 
swelling ratio).  The Tukey–Kramer post-hoc test was used for all pair-wise comparisons, and statistical 
significance was attained at p<0.05.  All statistical analyses were performed using the JMP IN software 
(4.0.4, SAS Institute, Cary, NC). 
11.3 Results 
11.3.1 Scaffold Characterization  
Gel wet weight significantly increased on day 14 for all groups. On day 28, wet weight of PEG-
fibrinogen hydrogels containing 50 µg ciprofloxacin was significantly decreased and was lower than 
others (Figure 11.1A). Gel dry weight remained stable over time for the plain hydrogels and hydrogels 
containing 25 µg ciprofloxacin. However, gel dry weight of the hydrogels containing 50 µg ciprofloxacin 
significantly decreased on day 28 and was lower than others (Figure 11.1B). Gel swelling ratio changed 
overtime for all groups. Specially, swelling ratio of the plain hydrogels and hydrogels containing 25 µg 
ciprofloxacin increased over time but decreased on day 28 for 50 µg group (Figure 11.1C). 
11.3.2 Cell Viability  
Live and dead staining on day 1 showed that cells in encapsulated explants remain viability for all 
groups while explants inside PEG-fibrinogen hydrogels with 25 and 50 µg ciprofloxacin showed some 




PEG-fibrinogen hydrogels over 28 days culture period for all groups. Moreover, the cell network was 
denser at 50 µg ciprofloxacin group compare to others over time (Figure 11.2). 
11.3.3. Dental Pulp Cellular Migration and Proliferation 
Cellular migration into PEG-fibrinogen hydrogels was observed in all groups over time, and a 
difference in cellular invasion into the hydrogel was found between groups (Figure 11.3A). To illustrate, 
cellular invasion was observed earlier in PEG-fibrinogen hydrogel containing 50 µg ciprofloxacin. The 
average migration distance of cells penetrating into PEG-fibrinogen containing 50 µg ciprofloxacin was 
significantly higher than migration distance of cells into plain hydrogels and hydrogels containing 25 µg 
ciprofloxacin over time. The rate of cellular migration was liner in all groups, with R2 value higher than 
0.98 in hydrogels with no ciprofloxacin and 0.99 in hydrogels with ciprofloxacin (Figure 11.3B). In addition, 
the rate of cellular migration into hydrogels containing 50 µg ciprofloxacin (78.04µm/day) was higher than 
the rate of cellular migration into plain hydrogels (45.62µm/day) and hydrogels containing 25 µg 
ciprofloxacin (50.88µm/day). PicoGreen® total DNA assay showed that cell number inside PEG-
fibrinogen hydrogels increased significantly for all groups and cell number in hydrogels containing 50 µg 
ciprofloxacin was significantly higher than others on day 28 (Figure 11.3C). This result was confirmed with 
modified Goldner’s Masson trichrome staining of the samples over time showing more cells inside 
hydrogels containing 50 µg ciprofloxacin (Figure 11.5) 
11.3.4 Cell Biosynthesis and Matrix Distribution 
ALP activity significantly decreased on day 28 for cells inside plain PEG-Fibrinogen hydrogels 
and hydrogels with 25 µg ciprofloxacin (Figure 11.4A). In addition, there was no significant difference in 
ALP activity between groups over time as confirmed by alizarin red staining which showed no mineral 
deposition in all groups overtime (Figure 11.6). Collagen content within PEG-fibrinogen hydrogels 
remained stable over time for all groups except for plain PEG-Fibrinogen hydrogels which there was a 
significant increase in collagen content on day 14 (Figure 11.4B).  
Modified Goldner’s Masson Trichrome staining of paraffin embedded samples showed the 
distribution of migrated cell, collagen distribution, and blood plasma over time (Figure 11.5). The pulp 
explants which contains collagen matrix were stained blue. Images showed that cell migrated uniformly 




the hydrogel containing ciprofloxacin compared to none-ciprofloxacin control group. Collagen III staining 
on day 28 showed that there was collagen III deposition inside the hydrogels in all groups (Figure 11.7A). 
Also, CD31 staining was evident in the explants and inside the hydrogels on day 28 (Figure 11.7B). 
11.4 Discussion 
The ciprofloxacin dosages that were used in this study were based on previous studies, which 
indicate that these dosages effectively reduce anaerobic bacterial infection while minimizing adverse 
effects on dental pulp cell viability, growth, and biosynthesis. Also, photoinitiator concentration and UV 
exposure time were optimized by increasing photoinitiator concentration to 0.3% w/v and UV exposure 
time to 10 minutes, in order to increase crosslinking density and maintain hydrogel stability over time. 
Several studies have found that photoinitiator type, cell types, crosslinking time, and UV light irradiation 
(47;144;146-148) can all affect the extent of cytotoxicity. The photoinitiator 2-hydroxy-1-[4-
(hydroxyethoxy)phenyl]-2-methyl-1-propanone (Irgacure®2959) was used in this study, due to its 
moderate water solubility, stability, and lower cytotoxicity compared to other commercially available 
photoinitiators (47;144). However, the effects of ciprofloxacin dosage, photoinitiator concentration, and 
UV exposure time on dental pulp tissue cytotoxicity, cell migration, and cell biosynthesis have not been 
addressed.  
Live and dead staining of the explants inside PEG-fibrinogen without ciprofloxacin showed some 
non-viable cells on day 1, indicating that increasing photoinitiator to 0.3% w/v and UV exposure time to 10 
minutes affects cell viability. Furthermore, the addition of ciprofloxacin at 500 µg/ml (or 50 µg per gel) in 
PEG-fibrinogen hydrogel decreased cell viability in the encapsulated pulp explants. However, there was 
no significant difference in cell number between non-ciprofloxacin and ciprofloxacin groups on day 1. 
Phase contrast images of the explants over time show that there was a difference in cellular infiltration 
between groups. Specifically, both the migration distance and rate of migration was highest in hydrogels 
containing 50 µg ciprofloxacin. In addition, cell number was highest in hydrogels containing 50 µg 
ciprofloxacin on day 28, and was confirmed with modified Goldner’s Masson trichrome staining. The 
increases in cell migration and proliferation in PEG-fibrinogen containing 50 µg ciprofloxacin were 
associated with an increase in swelling ratio, according to Dikovsky et al. (2006) who found that rate of 




distance increase in hydrogels with higher swelling ratio(43). Cell mineralization was not observed within 
any of the hydrogel groups over time. Interestingly, collagen III and CD31 staining was evident in all 
groups as well as control group and pulp tissue indicating that PEG-fibrinogen containing 25 and 50 µg 
ciprofloxacin supports pulp-like matrix production. 
11.5 Conclusions 
 These results demonstrate that there is a dose-dependent effect of ciprofloxacin on dental pulp 
cell migration and proliferation within PEG-fibrinogen hydrogels. Specifically, PEG-fibrinogen containing 
500µg/ml (or 50 µg) ciprofloxacin enhances cell migration and proliferation. In conclusion, PEG-fibrinogen 
hydrogels containing 25 and 50 µg ciprofloxacin are suitable to use for vital endodontic therapy, as gels 
containing these doses have been shown to support pulp cell viability, migration, proliferation, and pulp-
like matrix production.  Future studies will evaluate the optimized PEG-fibrinogen hydrogels in a tooth 













































































^ Figure 11.1: Wet Weight, Dry Weight, and Swelling Ratio of PEG-fibrinogen hydrogels 
over time. Number represents amount of 
ciprofloxacin within PEG-fibrinogen hydrogels. 
(A) Gel wet weight significantly increased on day 
14 for all groups. On day 28, wet weight of 50 µg 
group was significantly lower than others. (B) 
Gel dry weight significantly decreased on day 28 
for 50 µg group. (D) Swelling ratio significantly 
increased over time for all groups except in 50 
























Figure 11.2: Cell Viability of human dental pulp encapsulated within PEG-fibrinogen hydrogels over 
time. Live and dead staining on day 1 showed that cells in encapsulated explants remain viability for 
all groups while explants inside PEG-fibrinogen hydrogels with 25 and 50 µg ciprofloxacin showed 
some degree of cell death compared to plain PEG-fibrinogen hydrogel. Migrated pulp cells remained 
viable in PEG-fibrinogen hydrogels over 28 days culture period for all groups. Moreover, the cell 
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Figure 11.3: (A) Cell Migration into PEG-fibrinogen Hydrogel Over Time A difference in cellular 
invasion into PEG-fibrinogen hydrogel was found between groups, which cellular invasion was 
observed earlier in hydrogels containing 50 µg ciprofloxacin (n=5, 5X, scale=1 mm) (B) Average 
Migration Distance and Rate of Cellular Migration of cells penetrating into hydrogels containing 50 
µg ciprofloxacin was significantly higher than migration distance of cells into plain hydrogels and 
hydrogels containing 25 µg ciprofloxacin over time. (n=5,*:p<0.05) (C) Cell Number inside PEG-
fibrinogen hydrogels increased significantly over time for all groups and cell number in hydrogels 
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Figure 11.4: Cell Mineralization and Collagen Deposition within PEG-fibrinogen overtime. (A) ALP 
activity significantly decreased on day 28 for cells inside plain PEG-Fibrinogen hydrogels and 
hydrogels with 25 µg ciprofloxacin. In addition, there was no significant difference in ALP activity 
between groups over time. (B) Collagen content within PEG-fibrinogen hydrogels remained stable 
over time for all groups except for plain PEG-Fibrinogen hydrogels which there was a significant 





















Figure 11.5: Modified Goldner’s Masson Trichrome Staining of paraffin embedded samples over 
time which hematoxylin stained nuclei (black), ponceau-acid fuchsin stained blood plasma (red), and 
light green stains collagen (green). The pulp explants which contains collagen matrix were stained 
green. Images showed that cell migrated uniformly throughout the PEG-fibrinogen hydrogels over time 
in all groups and there were more migrated cell inside the hydrogel containing ciprofloxacin compared 
to none-ciprofloxacin control group. There was no evident collagen deposition inside the hydrogels in 
all groups. Also, ponceau-acid fuchsin stained was evident in the explants and in the hydrogels on day 























Figure 11.6: Alizarin Red S Staining of paraffin embedded samples showed no calcium staining 









Figure 11.7: (A) Collagen III Staining of paraffin embedded samples on day 28. Positive collagen III 
staining (green) was evident within both dental pulp tissue and PEG-fibrinogen hydrogels in all groups. 
(B) CD31 Staining was observed (red) in PEG-fibrinogen in all groups similar to pulp tissue. (DAPI-





























CHAPTER 12: EVALUATION OF PULP 



















Chapter 10 and 11 focused on optimizing hydrogel properties for host cell outgrowth and pulp 
formation in the hydrogel. This chapter investigates the potential for pulp regeneration and dentin-pulp 
complex formation by evaluating the interaction of the hydrogel with surrounding dentin using a tooth slice 
explant model.  Specifically, we examined the effects of the dentin on pulp repair in vitro, i.e. whether co-
culture with dentin will alter pulp cell response in the hydrogel, assessing whether a robust and non-
calcified pulp tissue can be formed and maintained in the explant model.  Similar to other soft and hard 
tissue junctions that we have studied(189-192), dentin is likely to play a cooperative role in pulp repair 
and homeostasis.  
12.1.1 Background and Motivation 
The restoration of the dentin-pulp complex is an important design parameter for the development 
of a clinically relevant option for guided dental pulp regeneration. Dental pulp connects to surrounding 
dentin through an odontoblast-lined peripheral layer. The pulp plays a regulatory role in odontoblast-
mediated dentin formation which protects the tooth against infection or injury(4;53;54). Specifically, 
odontoblasts differentiate from dental pulp cells and align in a layer at the edge of dental pulp (Figure 
1.2). These cells synthesize and secrete predentin matrix. This predentin matrix then mineralizes to from 
dentin(61;193).   
A tooth slice explant model has been developed to mimic the anticipated interaction between the 
hydrogel and tooth cavity post pulpotomy and implantation, by embedding excised human pulp tissue 
sections in the hydrogel within the tooth cavity. The tooth slice model has been used to evaluate tooth 
regeneration(18;19;51), with its main advantage being that nutrient transport to both dentin and the 
hydrogel-pulp complex is not compromised. The tooth cavity is also readily accessible, which increases 
ease of analysis.  
12.1.2 Objectives 
The objective of this study is to evaluate the hypothesis that the optimized PEG-fibrinogen will 
support cell migration and dentin-pulp complex formation once enclosed in the dental cavity and exposed 




12.2 Materials and Methods 
12.2.1 PEG-fibrinogen Hydrogels Preparation 
PEG-fibrinogen hydrogels were made according to Dikovsky et al. (2006)(43). Briefly, PEG-
fibrinogen hydrogel are made from a precursor solution of PEGylated by a radical chain polymerization 
reaction of acrylate end groups. Additional of PEGDA was added to increase cross-linking density of the 
PEGylated protein network as well as to minimize steric hindrances that may result in poor gelation. PEG-
fibrinogen precursor solution (9 mg/ml, 10kDa, provided from Dr.Dror Seliktar, Technion-Israel Institute of 
Technology, Haifa, ISRAEL) was mixed with 17.53 mg/ml PEGDA (10kDa, provided from Dr.Dror Seliktar, 
Technion-Israel Institute of Technology, Haifa, ISRAEL) and 0.1% w/v photoinitiator stock solution made 
of 20% w/v Irgacure2959® (Ciba Specialty Chemical Corp., Tarrytown, NY) in 70% ethanol.  
12.2.2 Tooth Slice Model Preparation 
Tooth slices were prepared according to Cordeiro et al. (2008) (19). Briefly, healthy human teeth 
from patients age between 13 - 35 years old who undergoing tooth extraction due to malposition at a 
clinic of the College of Dental Medicine, Columbia University were cleaned with 70% ethanol and kept in 
fully supplemented medium within 24 hours. The residual periodontal tissues were removed with a 
scalpel. Teeth were cut transversely at the cervical region to obtain 2mm-thick slices with the volume of 
the chamber ranging 40 – 50 mm3 with a diamond-edge saw (Buehler, IsometIM, IL, USA) at low speed 
under cooling with DMEM medium.  Sections were wiped with 70% ethanol and pulp tissues were 
removed while preserving the predentin layer using forceps. The sections were then soaked in fully 
supplemented medium overnight prior to scaffold fabrication.  
Dental pulp explants obtained from healthy teeth of 29 and 80 years old male patients were 
sectioned into 1x1mm and the number of pulp explants (1 or 2 pieces) was varied to examine any effect 
on cell response.  By changing the number of pulp pieces in the gel, we can also simulate partial 
pulpotomy, whereby much more of the host pulp tissue remains compared to pulpotomy. The explants 
were encapsulated within the optimized PEG-fibrinogen hydrogel (10kDa) inside a pulp chamber of the 
tooth slice via photopolymerization under UV light for 5 minutes and maintained in fully supplemented 
medium. The experimental groups included 1 or 2 pieces of pulp (1x1 mm) embedded in hydrogels.  The 




pulp pieces and culture time on host pulp cell migration out of the explant and into the hydrogel were 
determined after 28 and 42 days of culture. 
12.2.3 Cell Viability  
Cell viability (n = 2) was visualized using Live/Dead staining (Molecular Probes, Eugene, OR), 
following the manufacturer’s suggested protocol. After washing in PBS, samples were visualized under 
confocal microscope (Olympus Fluoview FV1000, Center Valley, PA) at 473 nm excitation/ 519nm 
emission wavelengths for FITC and 559 nm excitation/ 612 nm emission for Texas Red.  
12.2.4 Matrix Distribution  
Tooth slice samples (n=3) were washed with PBS and fixed with 4% paraformaldehyde 
containing PBS for 5 days. Immunohistochemistry was used to evaluate 1) deposition of collagen III, 2) 
proteins that are associated with dentin formation, dentin sialophosphoprotein (DSPP), and 3) platelet 
endothelial cell adhesion molecule (CD31). First, samples were washed with PBS and antigens were 
retrieved with 1% triton-x for DSPP and CD31 antibody. Then, samples were incubated with primary 
antibody (collagen III (1:60 dilution, Abcam), DSPP (1:150 dilution, Sigma), or CD31 (1:100 dilution, 
Abcam)) overnight. Then, a FITC-conjugated secondary antibody (1:200 dilution, Abcam) was added and 
incubated for 1 hour. Finally, samples were stained with DAPI staining. Tooth slice samples were 
visualized under confocal microscopy (Olympus Fluoview FV1000, Center Valley, PA) at excitation and 
emission wavelengths of 488 nm and 568 nm, respectively. 
12.3 Results 
12.3.1 Pulp Regeneration and Dentin-Pulp Complex Formation  
PEG-fibrinogen with pulp explant was successfully encased in tooth slice and was stable over 42 
days of culture (Figure 12.1). Live and dead staining showed that cell viability was maintained in tooth 
slice model and cell migrated continuously from the explants into the hydrogel advanced into the dentin 
and attached on dentin surface over time (Figure 12.2). Positive collagen III staining (green) was 
observed in PEG-fibrinogen hydrogel within pulp chamber in all explants indicating that migrated cells 
produced collagen III inside acellular PEG-F over time (Figure 12.3). In addition, more collagen content 




was only evident in the explants encased within tooth slices on day 28 (Figure 12.4A). CD31 staining was 
observed in all groups on day 42 (Figure 12.4B). 
12.4 Discussion  
Our goal is to devise a functional scaffold for dental pulp regeneration that will restore normal 
tooth function by utilizing PEG-fibrinogen, a bioactive hydrogel-based scaffold to harness the intrinsic 
repair potential of the native pulp. In this study, the optimized PEG-fibrinogen hydrogel was investigated 
for the potential for pulp regeneration and dentin-pulp complex formation using a tooth slice explant 
model by embedding healthy human pulp tissue sections in the hydrogel within the tooth cavity in order to 
mimic the interaction of the hydrogel with surrounding dentin post pulpotomy and implantation. The 
results showed that pulp tissue viability was preserved in tooth slice model and cells migrated from pulp 
towards dentin layer over time which cells were able to attach on the dentin surface. More deposition of 
collagen III were found and expedited with more pre-embedded pulp sections similar to the result from 
previous study which more collagen deposition was found in PEG-fibrinogen with higher seeding density. 
In addition, CD31 staining was observed in PEG-fibrinogen hydrogel within pulp chamber indicating the 
potential for PEG-fibrinogen to support endothelial cells migration from embedded pulp since study has 
been shown that fibrinogen promotes cell homing by inducing chemotactic migration of endothelial 
cells(186). Dentin sialophosphoprotein (DSPP) staining which is odontoblast-specific(60;149) was 
observed only in the explants encased within tooth slices indicating that the differential of pulp cell into 
odontoblasts-like occurs in the presence of dentin similar to Huang et al. (2006) which human dental pulp 
stem cells were seeded onto dentin surface and found that pulp cell established an odontoblast-like 
morphology over time(194). 
12.5 Conclusions 
 These results demonstrate that PEG-fibrinogen is a promising scaffold for vital endodontic 
therapy as it is shown to support neo-pulp formation including collagen III, CD31, and DSPP which DSPP 
is found in the presence of dentin only and collagen III formation is enhanced with more pulp explants. 
Future studies will validate the efficacy of the hydrogel within a tooth cavity-like environment, prior to in 












Figure 12.1: Tooth Slice Model of Pulpotomy (A) Tooth were cut from 
the cervical region to get 2mm thickness slice (B) PEG-fibrinogen 
precursor solution was added in the pulp chamber (C) Healthy pulp section 
(1 x 1 mm) was encapsulated in PEG-fibrinogen hydrogel by photo-
polymerization with UV light for 5 minutes (D) Explant was culture in 24 


































Figure 12.2: (A) Cell Viability of dental pulp explant cultured inside PEG-fibrinogen hydrogel 
encased within pulp chamber of human tooth slice over time. Cell viability was maintained in tooth 
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Figure 12.3: Collagen III Staining of dental pulp explant cultured inside PEG-fibrinogen hydrogel 
encased within pulp chamber of human tooth slice over time. Positive collagen III staining (green) was 
observed in PEG-fibrinogen hydrogel within pulp chamber in all explants indicating that migrated cells 
produced collagen III inside acellular PEG-F over time. In addition, more collagen content was 
observed on day 42 in tooth slice with 2 pulp sections compared to 1 pulp section.   









































Figure 12.4: DSPP and CD31 Staining of dental pulp explant cultured inside PEG-fibrinogen 
hydrogel encased within pulp chamber of human tooth slice over time. (A) DSPP staining was only 
evident in the groups with tooth slice.   (B) CD31 staining was observed in all groups on day 42 (red). 

















































The objective of this thesis was to devise a functional scaffold for dental pulp regeneration that 
will harness the intrinsic repair potential of the native pulp while eliminating the residual bacteria after 
treatment to obtain long-term clinical success. The ideal scaffold should (i) be biocompatible and 
biodegradable; (ii) enable cell migration; (iii) maintain dental pulp cell phenotype and biosynthesis; (iv) 
reduce residual bacteria; and (v) regenerate the dentin-pulp complex. It was hypothesized that a bioactive 
hydrogel-based scaffold with antibiotic release can be used to harness the intrinsic repair potential of the 
native pulp while reducing residual bacteria after treatment. To evaluate these hypotheses, studies were 
designed to address three specific aims. In Aim 1 we designed a bioactive hydrogel-based scaffold 
comprised of a fibrinogen backbone and cross-linked with difunctional poly(ethylene glycol) side chains 
(PEG-fibrinogen) that will support human dental pulp cell growth and differentiation. First, pulp cell 
responses were evaluated in this scaffold system (Chapter 2). Next, the effects of cell seeding density on 
cell response were examined (Chapter 3). Furthermore, the PEG-fibrinogen hydrogel was further 
optimized by assessing the effects of increasing fibrinogen concentration (Chapter 4), photoinitiator 
concentration (Chapter 5), and PEGDA cross-linker concentration (Chapter 6) to pulp cell response and 
gel mechanical properties in order to enhance cell biosynthesis and hydrogel properties. In Aim 2, we 
designed an antibiotic release system based on the PEG-fibrinogen hydrogel, optimized from Aim 1, in 
order to reduce residual bacteria after pulpotomy treatment. Ciprofloxacin was chosen as it has 
demonstrated antimicrobial activity against most bacteria from pulpal infection, exhibits dosage-
dependent bacterial death(48) and has minimal side effects(49). However, dosage-dependent cell 
cytotoxicity of ciprofloxacin has also been reported(50). First, ciprofloxacin dosage was optimized in order 
to minimize adverse effects on dental pulp cell response (Chapter 7). Next, the optimized ciprofloxacin 
was incorporated into PEG-fibrinogen hydrogels and any dosage-dependent effects of ciprofloxacin 
release on dental pulp cell response and hydrogel stability were determined (Chapter 8). Finally, an 
anaerobic bacterium from infected pulp was exposed to the optimized PEG-fibrinogen hydrogels and 
ciprofloxacin from Chapter 8 to determine bacterial resistance to treatment (Chapter 9). Building upon the 
results from the previous aims, the optimized hydrogel and antibiotic dosage was implemented to guide 




the effect of fibrinogen concentration from Aim 1 (Chapter 10) and optimized ciprofloxacin dosage from 
Aim 2 (Chapter 11) in the PEG-fibrinogen hydrogel on the rate and distance of host cell infiltration and 
cell biosynthesis were examined using a pulp explant model.  To this end, we investigated the feasibility 
of pulp and dentin-pulp complex formation using a tooth slice explant model to mimic the interaction 
between the hydrogel and dentin within the pulp chamber after pulpotomy. The excised pulp was 
embedded in the optimized PEG-fibrinogen within the tooth slice, and the subsequent cell infiltration, 
pulp-like matrix formation in the hydrogel, and integration of hydrogel and dentin were tested (Chapter 
12). The major findings of each chapter are briefly highlighted below.   
13.1.1 Bioactive Hydrogel-based Scaffold Design for Pulp Regeneration 
 A bioactive hydrogel-based scaffold for pulp regeneration was design based on; (i) 
biocompatibility and biodegradability and (ii) ability to support human dental pulp cell phenotype and 
biosynthesis. A hydrogel-based scaffold is suitable for dental pulp regeneration, as 1) it can completely fill 
the pulpal chamber, which has an anatomically irregular geometry and 2) the dental pulp is a soft tissue 
with high water content (~80%)(33). Guided by these design parameters, PEG-fibrinogen is suitable 
because cell-mediated proteolytic degradation and cell-adhesion motifs of the fibrinogen backbone(2;37) 
enable pulp cells to exhibit a phenotypic spindle-shaped morphology within the hydrogel. In addition, 
fibrinogen also plays an important role in pulp wound healing(35;36).  
First, human dental pulp cell response in PEG-fibrinogen was evaluated and results showed that 
human dental pulp cells were able to maintain their morphology, viability and phenotypic response over 
time in PEG-fibrinogen hydrogels. However, no cell biosynthesis was observed, in terms of ALP activity 
and collagen production, over time (Chapter 2). In an effort to overcome these shortcomings, we then 
evaluated the effect of cell seeding density, as many studies have shown that altering seeding density 
can affect cell response, in terms of cell viability, morphology, proliferation, and biosynthesis(39;150-153). 
It was found that there was a critical cell seeding density of 4.8 million cells/ml resulting in optimal dental 
pulp cell phenotypic morphology and biosynthesis in PEG-fibrinogen hydrogel (Chapter 3). In addition, 
fibrinogen concentration within PEG-fibrinogen was optimized in order to enhance pulp cell growth and 
biosynthesis, as fibrinogen has been shown to regulate fibroblast cell functions(37;154). The results 




cell proliferation, cell mineralization potential, collagen production, and gel stiffness (Chapter 4). 
Furthermore, photoinitiator concentration was optimized in order to enhance pulp cell proliferation, 
biosynthesis and hydrogel mechanical properties. The result demonstrated that increasing photoinitiator 
concentration increase PEG-fibrinogen hydrogel network formation but adversely affect HDPC viability, 
proliferation, and collagen deposition over time. Therefore, the optimized photoinitiator (Irgacure®2959) 
concentration for PEG-fibrinogen formation that is suitable for HDPC culture is 0.1% w/v (Chapter 5).   
Lastly, PEGDA crosslinker concentration was optimized and found that altering PEGDA cross-linker from 
1% to 1.75% and 2% w/v affects PEG-fibrinogen stiffness, HDPC viability, morphology, proliferation, and 
biosynthesis and 1.75% w/v is an optimal additional PEGDA concentration for cell proliferation and 
biosynthesis (Chapter 6). In summary, PEG-fibrinogen hydrogel is a promising scaffold for dental pulp 
regeneration, and 9 mg/ml is an optimal protein concentration for cell proliferation and biosynthesis. 
13.1.2 Scaffold with Antibiotic Release Design to Reduce Bacterial Infection Post Pulpotomy 
One of the essential scaffold design parameters for dental pulp tissue engineering is the 
reduction of residual bacteria post-treatment. Our approach was to incorporate antibiotic into the scaffold 
in order to protect against infection, while also circumventing any adverse effects on the dental pulp cells. 
Therefore, we first optimized ciprofloxacin dosage to ensure that it did not adversely affect human dental 
pulp cell viability, growth, and phenotype response over time (Chapter 7). Dental pulp cells were cultured 
with media containing ciprofloxacin at varying concentrations, including 25, 50, 100, and 150 µg/ml, 
based on the concentration typically used to treat infected dental pulp(180). The results showed that a 
ciprofloxacin concentration of up to 50 µg/ml exerts no adverse effects on pulp cells. Based on this 
finding, the optimized ciprofloxacin concentration was incorporated into PEG-fibrinogen hydrogels and 
tested for hydrogel crosslinking density and effects of ciprofloxacin released from PEG-fibrinogen on 
dental pulp cell response over time. It was found that incorporating 250 and 500 µg/ml (25 and 50 µg) 
ciprofloxacin into PEG-fibrinogen significantly decreased gel crosslinking density. Therefore, we 
optimized photoinitiator concentration and UV exposure time for PEG-fibrinogen with 250 µg/ml and 500 
µg/ml ciprofloxacin and found that crosslinking density remained stable using 0.3% w/v photoinitiator and 
10 minutes UV exposure time. We also found that controlled release of 25 and 50 µg total ciprofloxacin 




viability, growth, mineralization, and collagen deposition (Chapter 8). Lastly, anaerobic bacteria from 
infected pulp were exposed to the optimized PEG-fibrinogen hydrogels containing ciprofloxacin to 
determine bacteria susceptibility to the antibiotic. The results demonstrated that controlled release of 25 
and 50 µg ciprofloxacin from PEG-fibrinogen was effective in reducing anaerobic bacterial infection 
(Chapter 9). Therefore, PEG-fibrinogen is suitable as a ciprofloxacin carrier and delivery vehicle for 
endodontic treatment. 
13.1.3 Scaffold Testing in a Tooth Slice Model In Vitro 
Most teeth with exposed pulp still have healthy root pulps(181-185), which may be stimulated for 
pulp repair.  Thus, for guided pulp regeneration, it is envisioned that the inflamed pulp can first be 
removed with endodontic instruments and a cell-instructive scaffold such as PEG-fibrinogen(2) can then 
be used to stimulate the remaining pulp tissue to regenerate and fill the pulpal cavity. The pulp explant 
model, which consists of human dental pulp explants encapsulated in PEG-fibrinogen hydrogels, was 
established to evaluate the potential of PEG-fibrinogen to induce host cell migration and support pulp-like 
matrix formation. The effects of fibrinogen concentration (Chapter 10) and ciprofloxacin dosage (Chapter 
11) within optimized PEG-fibrinogen from previous chapters were evaluated based on the rate and 
distance of host cell infiltration and extent of cell biosynthesis. The results demonstrate that PEG-
fibrinogen hydrogel has the potential to support neo pulp regeneration, as it supports pulp cell migration, 
infiltration, spreading, and collagen synthesis. Increasing fibrinogen concentration within the PEG-
fibrinogen hydrogel did not enhance the rate or distance of cell infiltration, and did not impact matrix 
formation within the hydrogel. In addition, pulp cell migration depended on patient gender and age. 
However, a dose-dependent effect of ciprofloxacin on dental pulp cell migration and proliferation inside 
PEG-fibrinogen hydrogel was found, in which PEG-fibrinogen with 500µg/ml (or 50 µg) ciprofloxacin 
enhanced cell migration and proliferation. Next, an optimized PEG-fibrinogen hydrogel was investigated 
for the feasibility of pulp and dentin-pulp complex formation by evaluating the interaction of the hydrogel 
with surrounding dentin using a tooth slice explant model(18;19;51). The model consisted of a PEG-
fibrinogen hydrogel encased within a healthy tooth slice. The results showed that PEG-fibrinogen with 
pulp explant was successfully encased in tooth slice and pulp-like matrix including collagen III, CD31, and 




is enhanced with more pulp explants (Chapter 12). Therefore, PEG-fibrinogen is suitable scaffold for vital 
endodontic treatment as it harnesses the intrinsic repair potential of the native pulp, enables cell 
migration, and maintains dental pulp cell phenotype and biosynthesis 
13.2 Future Directions 
The findings of this thesis demonstrate the feasibility of using a bioactive hydrogel-based scaffold 
with antibiotic release to harness the intrinsic repair potential of the native pulp while reducing residual 
bacteria after endodontic treatment.  However, to realize the clinical translation of the scaffold system, 
several areas of study are needed and are described below.   
13.2.1 Evaluation of Pulp formation in Tooth Slice from Full Pulpotomy Model 
 The explant and tooth slice model used in this thesis utilized healthy teeth, but teeth requiring 
endodontic treatment are normally infected in clinical practice. Therefore, it is necessary to develop a 
more relevant model to mimic clinically relevant treatment conditions. To this end, a full pulpotomy model 
will be developed and used to determine the feasibility of the optimized PEG-fibrinogen with ciprofloxacin 
to support neo-pulp formation, reduction of residual bacteria, and ultimately, generation of dentin-pulp 
complex after treatment. This model will be achieved by inducing bacterial infection in healthy teeth in 
vitro using methods from Meire et al. (2009)(195). Then, a full pulpotomy will be performed and the 
optimized PEG-fibrinogen precursor solution with different ciprofloxacin concentrations (0, 250, 500 
µg/ml) will then be added to the pulp chamber with healthy pulp sections. It is anticipated that optimized 
ciprofloxacin release from PEG-fibrinogen will be able to reduce residual bacteria and the PEG-fibrinogen 
hydrogel will enable pulp regeneration and support the formation of a dentin-pulp complex in this model. 
13.2.2 In Vivo Evaluation of Hydrogel Explant Model 
In order to fully understand the feasibility of the optimized PEG-fibrinogen hydrogel with 
ciprofloxacin release for partial or full pulpotomy treatment, in vivo evaluation in a relevant animal model 
is required, since there are many complicating factors that cannot be addressed with in vitro studies. For 
example, (1) the geometry of the pulpal chamber is anatomically irregular and varies across individual 
teeth, thus the remaining host pulp tissue is different; (2) the presence of vascularization, cytokines, and 
stem cells from host pulp tissue need to be taken into account. The subcutaneous athymic rat model will 




advantages include the availability of rat-specific antibodies and molecular probes. This in vivo evaluation 
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 An understanding of human dental pulp mechanical properties and collagen content will provide 
the design parameter and criteria for the development and testing of a scaffold design for dental pulp 
tissue engineering. 
A.1.2 Objectives 
 The objective of this study is to evaluate healthy human dental pulp collagen content and 
mechanical properties including equilibrium compressive young’s modulus at different region of the pulp. 
A.2 Materials and Methods 
A.2.1 Human Dental Pulp Isolation and Rheological Characterization 
Human dental pulp was isolated from healthy third molars of 18 - 20 years old female patients 
(College of Dental Medicine, Columbia University, NY). Isolated human pulps were sectioned using 2 mm 
biopsy punch at coronal and radicular regions of the pulp. Samples were maintained in 24 well-plates 
under humidified conditions at 37ºC and 5% CO2 with 1 ml of fully supplemented medium with 10% FBS, 
1% antibiotics, 0.1% antifungal, 0.1% gentamicin, and 1% non-essential amino acids prior to testing. 
A.2.2 Human Dental Pulp Rheological Characterization 
Dental pulp mechanical properties were determined according to published protocols(157;158) 
using a strain-controlled rheometer (ARES,TA Instruments, New Castle, DE). Briefly, hydrogels diameter 
(d) was measured using a vernier caliper and placed between two flat porous patterns using 2.5g tare 
load. The equilibrium compressive Young’s modulus (Eeq) of the sample was calculated using 50 sec of 
the measurement at the equilibrium.  
The equilibrium compressive Young’s modulus (Eeq) of the sample was calculated at 5% 
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A.2.3 Collagen Content 
Collagen deposition was quantified using hydroxyproline assay based on alkaline hydrolysis of 
the tissue homogenate and subsequent determination of the free hydroxyproline in hydrolyzates(143). 
Briefly, samples were first desiccated for 24 hours and then digested for 18 hours at 65ºC with papain 




10 mM cysteine HCl (Sigma-Aldrich, St.Louis, MO), and 50 mM EDTA (Sigma-Aldrich, St.Louis, MO). 
Samples were then hydrolyzed with 2 N NaOH for 25 minutes and chloramine-T (Sigma) was added into 
hydrolyzed sample to oxidize the free hydroxyproline for the production of a pyrrole at room temperature 
for 25 minutes. Then, Ehrlich's reagent (Sigma-Aldrich, St.Louis, MO) was added to the products and 
incubated at 65ºC for 20 minutes resulting in the formation of a chromophore. The solution was 
transferred to 96-well plate and sample absorbance was measured at 555 nm using a microplate reader 
(Tecan, Research Triangle Park, NC).  
A.2.4 Statistical Analysis 
Results are presented in the form of mean ± standard deviation, with n equal to the number of 
samples analyzed.  A student’s t-test was performed on all quantitative data to determine effects of pulp 
region on young’s modulus and collagen content with statistical significance was attained at p<0.05.  All 
statistical analyses were performed using the JMP IN software (4.0.4, SAS Institute, Cary, NC). 
A.3 Results 
A.3.1 Human Dental Pulp Mechanical Properties 
While there was no significant difference of compressive young’s modulus between coronal and 
radicular of pulp, collagen content from coronal region of the pulp was significantly higher than radicular 
region (Figure A.1) which no correlation between pulp young’s modulus and collagen content was found 
(R2<0.1, n=3 different third molars from female 18-year-old). In addition, there was no significant 
difference of young’s modulus between patients (n=3 different third molars). 
A.4 Discussion and Conclusion 
 In this study, human dental pulp compressive young’s modulus was evaluated and compared 
between region of the pulp and patient. The results showed that there was no significant difference of 
dental pulp young’s modulus between regions and patient. However, the standard deviation was very 
high due to low number of sample. Therefore, future study will evaluate more samples from different 










Figure A.1: (A) Compressive Young’s Modulus of dental pulp at two different regions. There was 
no significant difference of young’s modulus between coronal and radicular of pulp. (n=3, ^p<0.05)  
(B) Collagen content of dental pulp at two different regions. Collagen content from coronal region of 
the pulp was significantly higher than radicular region. (n=3, ^p<0.05) (C) Compressive Young’s 
Modulus of dental pulp from different patients. There was no significant difference of young’s 








































































APPENDIX B: CHARACTERIZATION OF AGE-

















An understanding of the ultrastructural properties of the ACL-to-bone insertion is essential for 
identifying the etiology of ACL failure and developing integrative treatment strategies for ligament injuries.   
B.1.1 Background and Motivation 
The anterior cruciate ligament (ACL) connects the femur to the tibia through two insertion sites, 
each a complex structure divided into four distinct yet contiguous zones (ligament, nonmineralized 
interface, mineralized interface, and bone), accompanied by region-dependent changes in both cellular 
and matrix composition(198-200).  Collagen fibrils originating from the ligament traverse the interface 
zones and insert into bone(200).  It has been observed that ACL tears commonly occur or begin at the 
ligament-to-bone enthesis(200-202). An understanding of the ultrastructural properties of the native ACL-
to-bone insertion is therefore essential for identifying the etiology of failure and optimizing treatment 
protocols for ACL injuries(200). 
B.1.2 Objectives 
The objective of this study is to use transmission electron microscopy (TEM) to characterize 
collagen fibrils and mineral chemistry at the ACL-to-bone insertion site as a function of age. Knowledge of 
age-related changes at the insertion site is crucial because ACL injuries are largely reported in patients 
ranging from 15 to 35 years of age(203). An in-depth evaluation of the region-dependent and age-related 
changes at the enthesis will also be important in advancing current efforts to regenerate the soft tissue-to-
bone interface. It is anticipated that collagen fibril characteristics (diameter, number of fibrils per unit area, 
and percent area occupied by collagen), will vary as a function of age. 
B.2 Materials and Methods 
B.2.1 Isolation of ACL-to-bone Insertion Samples 
Bovine knee joints (n=4) were obtained from a local abattoir (Green Village Packing) and were 
divided into two age groups: immature (4-6 months old) and mature (2 to 5 years old). A straight midline 
longitudinal incision extending from the distal femur to the tibia in the bovine knee was performed under 
aseptic conditions and the femoral and tibial insertions were identified and excised. Each sample 




B.2.2 TEM Preparation 
The samples were fixed with 0.5% glutaraldehyde and 2% paraformaldehyde in 0.05M cacodylate 
sodium buffer (pH 7.4) and post-fixed with 1% osmium tetraoxide. Samples were dehydrated with serial 
concentrations of ethanol, embedded in spurr’s resin and cut into 70–90 nm sections using a microtome. 
Sections were stained with uranyl acetate and lead citrate, and then examined using transmission 
electron microscopy (TEM, JEOL, JEM-100CX, 80kV). 
B.2.3 TEM Image Acquisition and Analysis 
For each section, after first identifying the insertion site, images were collected starting from bone 
and progressed 50µm step-wise towards the ligament region.  In short, the total distance visualized spans 
across the insertion from ligament to nonmineralized interface, mineralized interface, and bone. For each 
of these regions, a minimum of five images were collected and collagen fiber diameter, distribution, and 
total area were determined using Adobe Photoshop and Image-J software.   
B.2.4 Statistical Analysis 
Results are presented in the form of mean ± standard deviation, with n equal to the number of 
samples analyzed.  A two-way analysis of variance (ANOVA) was performed on all quantitative data to 
determine effects of age and region on collagen fiber diameter, distribution, and total area. The Tukey–
Kramer post-hoc test was used for all pair-wise comparisons, and statistical significance was attained at 
p<0.05.  All statistical analyses were performed using the JMP IN software (4.0.4, SAS Institute, Cary, 
NC). 
B.3 Results 
B.3.1 Collagen Fibrils Characterization 
TEM images of collagen fibers found at the immature and mature ACL-to-bone insertion are 
shown in Figure B.1, with each image representing an additional 50 µm step away from the ligament 
region (1 being the closest to ligament).  Collagen fiber diameter distribution across region of the ACL the 
ACL-to-bone insertion site for mature and immature bovine samples were different which the curve was 
parabolic in immature group and plateau in mature group (Figure B.1B). 
While no differences in average fiber diameter or percent area occupied by collagen fibers were 




per area or collagen fiber density was detected (Figure B.2A).  Interestingly, no significant differences in 
collagen fibril diameter or distribution were found between regions (ligament, nonmineralized interface, 
mineralized interface, and bone) (Figure B.2B).  While differences in average fiber diameter and density 
were apparent between the immature and mature groups, these differences were however not significant.   
B.4 Discussion and Conclusion 
  Previous studies have shown that the collagen fibril diameter, as well as the mineral content and 
structure at the insertion site, plays an important role in ligament mechanical properties(204-206).  
Interestingly, in this study a mean increase in collagen fiber diameter was observed in the mature group 
while fiber density decreased significantly with age as total area occupied by collagen remained the 
same.  This dual change in collagen organization will likely contribute to age-related difference in 
interface mechanical properties, and is likely a result of adaptation to physiological loading. Future studies 
will focus on elucidating the role of collagen organization and mineral distribution in the structure-function 


































































Figure B.1: (A) TEM Images of (i) immature and (m) mature bovine collagen fiber at ACL insertion 
site (n=4, 50,000X, 80kV, and scale = 500 nm) (B) Collagen Fiber Diameter Distribution across 
Region of the ACL-to-bone insertion site for mature and immature bovine samples (n=4). The curve 
is parabolic in immature group and plateau in mature group 
i1 i2 i3 i4 i5 



















































































































































































































Figure B.2: (A) Average Collagen Fibril Measurements across Region While no differences in 
average fiber diameter or percent area occupied by collagen fibers were found between the immature 
and mature groups, a significant difference in the number of collagen fibers per area or collagen fiber 
density was detected. (n=4) (B) Region Dependent Characterization of Collagen Fibrils Each 
region is 50 µm from previous, 1 is the nearest to ligament. No significant differences in collagen fibril 
diameter or distribution were found between regions (ligament, nonmineralized interface, mineralized 
interface, and bone).  While differences in average fiber diameter and density were apparent between 
the immature and mature groups, these differences were however not significant. (n=4,*p<0.05)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
